BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998;115:182-205. [PMID: 9649475 DOI: 10.1016/s0016-5085(98)70381-6] [Cited by in Crossref: 1485] [Cited by in F6Publishing: 1595] [Article Influence: 59.4] [Reference Citation Analysis]
Number Citing Articles
1 Kiernan MG, Dunne SS, Mcdermott K, Jakeman P, Gilmore B, Thompson TP, Kelly S, Coffey JC, Dunne CP. Mesenteric Microbiology and Inflammatory Bowel Disease: Improved Understanding Due to Accelerating Innovation and Sophistication of Molecular Technology. The Mesentery and Inflammation 2023. [DOI: 10.1007/978-3-031-17774-3_7] [Reference Citation Analysis]
2 Xie Z, Liu J, Ren Y, Huang J, Lin R, Wang X, Tan Q, Lv S, Song L, Liu C, Ma T, Gong X. Circular array transducer based-photoacoustic/ultrasonic endoscopic imaging with tunable ring-beam excitation. Photoacoustics 2023;29:100441. [PMID: 36606259 DOI: 10.1016/j.pacs.2022.100441] [Reference Citation Analysis]
3 Sadeghi Poor Ranjbar F, Mohammadyari F, Omidvar A, Nikzad F, Doozandeh Nargesi N, Varmazyar M, Dehghankar S, Vosoughian F, Olangian-tehrani S, Nanbakhsh S, Mansourian T, Deravi N, Tutunchian Z, Salahi M, Poudineh M, Ghayyem H. Zingiber officinale (Ginger) as a treatment for inflammatory bowel disease: A review of current literature. Front Drug Discov 2022;2. [DOI: 10.3389/fddsv.2022.1043617] [Reference Citation Analysis]
4 Rezazadeh F, Ramos N, Saliganan A, Al-hallak N, Chen K, Mohamad B, Wiesend WN, Viola NT. Detection of IL23p40 via Positron Emission Tomography Visualized Inflammatory Bowel Disease.. [DOI: 10.1101/2022.11.30.518419] [Reference Citation Analysis]
5 Scalavino V, Piccinno E, Valentini AM, Mastronardi M, Armentano R, Giannelli G, Serino G. A Novel Mechanism of Immunoproteasome Regulation via miR-369-3p in Intestinal Inflammatory Response. Int J Mol Sci 2022;23. [PMID: 36430249 DOI: 10.3390/ijms232213771] [Reference Citation Analysis]
6 Dadgar N, Altemus J, Li Y, Lightner AL. Effect of Crohn's disease mesenteric mesenchymal stem cells and their extracellular vesicles on T-cell immunosuppressive capacity. J Cell Mol Med 2022. [PMID: 36047483 DOI: 10.1111/jcmm.17483] [Reference Citation Analysis]
7 da Fonseca SRB, de Souza LP, Fillmann HS, Hartmann RM, Colares JR, Schemitt EG, Brasil MDS, Suyenaga ES, Marroni NAP. Campsiandra laurifolia Reduces Oxidative Stress and Inflammation in Rats with Ulcerative Colitis. Journal of Coloproctology 2022;42:238-244. [DOI: 10.1055/s-0042-1755346] [Reference Citation Analysis]
8 Choi SH, Huang AY, Letterio JJ, Kim B. Smad4-deficient T cells promote colitis-associated colon cancer via an IFN-γ-dependent suppression of 15-hydroxyprostaglandin dehydrogenase. Front Immunol 2022;13:932412. [DOI: 10.3389/fimmu.2022.932412] [Reference Citation Analysis]
9 Halder P, Pratap V, Madhavi M, Kanji S, Ghosh B, Bandopadhayay M. OCULAR MANIFESTATIONS OF INFLAMMATORY BOWEL DISEASE. IJAR 2022. [DOI: 10.36106/ijar/7203331] [Reference Citation Analysis]
10 Dutta P, Mukherjee K, Saha A, Das A, Badwaik HR, Giri TK. Colonic delivery of surface charge decorated nanocarrier for IBD therapy. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103754] [Reference Citation Analysis]
11 Lee H, Kim E, Jeong G. Ameliorative Effect of Citropten Isolated from Citrusaurantifolia Peel Extract as a Modulator of T Cell and Intestinal Epithelial Cell Activity in DSS-Induced Colitis. Molecules 2022;27:4633. [DOI: 10.3390/molecules27144633] [Reference Citation Analysis]
12 Gao J, Cao S, Xiao H, Hu S, Yao K, Huang K, Jiang Z, Wang L. Lactobacillus reuteri 1 Enhances Intestinal Epithelial Barrier Function and Alleviates the Inflammatory Response Induced by Enterotoxigenic Escherichia coli K88 via Suppressing the MLCK Signaling Pathway in IPEC-J2 Cells. Front Immunol 2022;13:897395. [DOI: 10.3389/fimmu.2022.897395] [Reference Citation Analysis]
13 Schmidt K, Noel-macdonnell J, Vyhlidal C, Heruth DP, Singh V, Ahmed AA, Hudson T, Williams V, Shakhnovich V. Characterization of the Mucosally-Adherent Duodenal Microbiome in Children with and without Crohn’s Disease. Pharmaceuticals 2022;15:850. [DOI: 10.3390/ph15070850] [Reference Citation Analysis]
14 Khater SI, Lotfy MM, Alandiyjany MN, Alqahtani LS, Zaglool AW, Althobaiti F, Ismail TA, Soliman MM, Saad S, Ibrahim D. Therapeutic Potential of Quercetin Loaded Nanoparticles: Novel Insights in Alleviating Colitis in an Experimental DSS Induced Colitis Model. Biomedicines 2022;10:1654. [DOI: 10.3390/biomedicines10071654] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Schaaf CR, Gonzalez LM. Use of Translational, Genetically Modified Porcine Models to Ultimately Improve Intestinal Disease Treatment. Front Vet Sci 2022;9:878952. [DOI: 10.3389/fvets.2022.878952] [Reference Citation Analysis]
16 Şimşek-Onat P, Hizarcioglu-Gulsen H, Ergen YM, Gumus E, Özen H, Demir H, Özen S, Saltık-Temizel İN. Neutrophil-to-Lymphocyte Ratio: An Easy Marker for the Diagnosis and Monitoring of Inflammatory Bowel Disease in Children. Dig Dis Sci 2022. [PMID: 35579794 DOI: 10.1007/s10620-022-07547-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
17 Jing B, Xia K, Zhang C, Jiao S, Zhu L, Wei J, Wang ZA, Chen N, Tu P, Li J, Du Y. Chitosan Oligosaccharides Regulate the Occurrence and Development of Enteritis in a Human Gut-On-a-Chip. Front Cell Dev Biol 2022;10:877892. [PMID: 35557948 DOI: 10.3389/fcell.2022.877892] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Li J, Zhao F, Qin Q, Yang L, Jiang Y, Hou Y, Wang Y, Zhou W, Fang L, Chen L. The Effect of CD226 on the Balance between Inflammatory Monocytes and Small Peritoneal Macrophages in Mouse Ulcerative Colitis. Immunol Invest 2022;:1-10. [PMID: 35468025 DOI: 10.1080/08820139.2022.2065921] [Reference Citation Analysis]
19 Guimarães Sousa S, Kleiton de Sousa A, Maria Carvalho Pereira C, Sofia Miranda Loiola Araújo A, de Aguiar Magalhães D, Vieira de Brito T, Barbosa ALDR. SARS-CoV-2 infection causes intestinal cell damage: Role of interferon’s imbalance. Cytokine 2022;152:155826. [DOI: 10.1016/j.cyto.2022.155826] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Alkushi AG, Abdelfattah-Hassan A, Eldoumani H, Elazab ST, Mohamed SAM, Metwally AS, S El-Shetry E, Saleh AA, ElSawy NA, Ibrahim D. Probiotics-loaded nanoparticles attenuated colon inflammation, oxidative stress, and apoptosis in colitis. Sci Rep 2022;12:5116. [PMID: 35332200 DOI: 10.1038/s41598-022-08915-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
21 Yang Y, Zheng X, Wang Y, Tan X, Zou H, Feng S, Zhang H, Zhang Z, He J, Cui B, Zhang X, Wu Z, Dong M, Cheng W, Tao S, Wei H. Human Fecal Microbiota Transplantation Reduces the Susceptibility to Dextran Sulfate Sodium-Induced Germ-Free Mouse Colitis. Front Immunol 2022;13:836542. [DOI: 10.3389/fimmu.2022.836542] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Kushkevych I, Jampílek J. Effect of intestinal microbiome, antibiotics, and probiotics in the prevention and management of ulcerative colitis. Probiotics in the Prevention and Management of Human Diseases 2022. [DOI: 10.1016/b978-0-12-823733-5.00016-7] [Reference Citation Analysis]
23 Vig T, Das P, Sakhuja P, Gaur K, Majumdar K, Pulimood A. Pathology of Inflammatory Bowel Diseases and Its Mimickers, Immunodeficiency and Vascular Gastrointestinal Lesions, and Drug-Induced Bowel Pathologies. Surgical Pathology of the Gastrointestinal System 2022. [DOI: 10.1007/978-981-16-6395-6_12] [Reference Citation Analysis]
24 Fagundes RR, Bourgonje AR, Saeed A, Vich Vila A, Plomp N, Blokzijl T, Sadaghian Sadabad M, von Martels JZH, van Leeuwen SS, Weersma RK, Dijkstra G, Harmsen HJM, Faber KN. Inulin-grown Faecalibacterium prausnitzii cross-feeds fructose to the human intestinal epithelium. Gut Microbes 2021;13:1993582. [PMID: 34793284 DOI: 10.1080/19490976.2021.1993582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Dacquay LC, Tsang D, Chan D, Parkinson J, Philpott DJ, McMillen DR. E.coli Nissle increases transcription of flagella assembly and formate hydrogenlyase genes in response to colitis. Gut Microbes 2021;13:1994832. [PMID: 34751631 DOI: 10.1080/19490976.2021.1994832] [Reference Citation Analysis]
26 Lai CY, Yeh KY, Liu BF, Chang TM, Chang CH, Liao YF, Liu YW, Her GM. MicroRNA-21 Plays Multiple Oncometabolic Roles in Colitis-Associated Carcinoma and Colorectal Cancer via the PI3K/AKT, STAT3, and PDCD4/TNF-α Signaling Pathways in Zebrafish. Cancers (Basel) 2021;13:5565. [PMID: 34771727 DOI: 10.3390/cancers13215565] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
27 de Vallière C, Bäbler K, Busenhart P, Schwarzfischer M, Maeyashiki C, Schuler C, Atrott K, Lang S, Spalinger MR, Scharl M, Ruiz-Castro PA, Hausmann M, Rogler G. A Novel OGR1 (GPR68) Inhibitor Attenuates Inflammation in Murine Models of Colitis. Inflamm Intest Dis 2021;6:140-53. [PMID: 34722644 DOI: 10.1159/000517474] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
28 Pelia R, Venkateswaran S, Matthews JD, Haberman Y, Cutler DJ, Hyams JS, Denson LA, Kugathasan S. Profiling non-coding RNA levels with clinical classifiers in pediatric Crohn's disease. BMC Med Genomics 2021;14:194. [PMID: 34325702 DOI: 10.1186/s12920-021-01041-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
29 Lamichhane S, Mo JS, Sharma G, Choi TY, Chae SC. MicroRNA 452 regulates IL20RA-mediated JAK1/STAT3 pathway in inflammatory colitis and colorectal cancer. Inflamm Res 2021;70:903-14. [PMID: 34283251 DOI: 10.1007/s00011-021-01486-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Miklavcic JJ, Li Q, Skolnick J, Thomson ABR, Mazurak VC, Clandinin MT. Ganglioside Alters Phospholipase Trafficking, Inhibits NF-κB Assembly, and Protects Tight Junction Integrity. Front Nutr 2021;8:705172. [PMID: 34291075 DOI: 10.3389/fnut.2021.705172] [Reference Citation Analysis]
31 Lorenzo-Pouso AI, Castelo-Baz P, Rodriguez-Zorrilla S, Pérez-Sayáns M, Vega P. Association between periodontal disease and inflammatory bowel disease: a systematic review and meta-analysis. Acta Odontol Scand 2021;79:344-53. [PMID: 33370548 DOI: 10.1080/00016357.2020.1859132] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
32 Jo H, Kim D, Cho S, Shin N, Park YM, Lee HY, Shin D. Anti-Colitic Effects of Herbal Medicine HPL-01 on Dextran Sulfate Sodium Induced Ulcerative Colitis in Rat. kjopp 2021;35:64-70. [DOI: 10.15188/kjopp.2021.02.35.2.64] [Reference Citation Analysis]
33 Mu Y, Kinashi Y, Li J, Yoshikawa T, Kishimura A, Tanaka M, Matsui T, Mori T, Hase K, Katayama Y. Polyvinyl Butyrate Nanoparticles as Butyrate Donors for Colitis Treatment. ACS Appl Bio Mater 2021;4:2335-2341. [DOI: 10.1021/acsabm.0c01105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Doulabi MSH, Moghaddam RG, Ghasemian R, Salehzadeh A. Association between p53 and p21 genes polymorphisms and ulcerative colitis in an Iranian population. Gene Reports 2021;22:101016. [DOI: 10.1016/j.genrep.2021.101016] [Reference Citation Analysis]
35 Tyagi RK, Jacobse J, Li J, Allaman MM, Otipoby KL, Sampson ER, Wilson KT, Goettel JA. HLA-Restriction of Human Treg Cells Is Not Required for Therapeutic Efficacy of Low-Dose IL-2 in Humanized Mice. Front Immunol 2021;12:630204. [PMID: 33717161 DOI: 10.3389/fimmu.2021.630204] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
36 Shen S, Prame Kumar K, Wen SW, Shim R, Wanrooy BJ, Stanley D, Moore RJ, Van TTH, Robert R, Hickey MJ, Wong CHY. Deficiency of Dietary Fiber Modulates Gut Microbiota Composition, Neutrophil Recruitment and Worsens Experimental Colitis. Front Immunol 2021;12:619366. [PMID: 33708211 DOI: 10.3389/fimmu.2021.619366] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
37 Franzin M, Stefančič K, Lucafò M, Decorti G, Stocco G. Microbiota and Drug Response in Inflammatory Bowel Disease. Pathogens 2021;10:211. [PMID: 33669168 DOI: 10.3390/pathogens10020211] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
38 Kushkevych I, Abdulina D, Dordević D, Rozehnalová M, Vítězová M, Černý M, Svoboda P, Rittmann SKR. Basic Bioelement Contents in Anaerobic Intestinal Sulfate-Reducing Bacteria. Applied Sciences 2021;11:1152. [DOI: 10.3390/app11031152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Tarris G, de Rougemont A, Charkaoui M, Michiels C, Martin L, Belliot G. Enteric Viruses and Inflammatory Bowel Disease. Viruses 2021;13:104. [PMID: 33451106 DOI: 10.3390/v13010104] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
40 Sumaily I, Alromaih S, Abuhaimed A, Alkhowaiter S, Alkethiri K, Alfarhan O, Alkhurayji S, Alhazmi N. The prevalence of chronic sinusitis symptoms among inflammatory bowel disease patients at tertiary hospital in Riyadh. Saudi J Otorhinolaryngol Head Neck Surg 2021;23:117. [DOI: 10.4103/sjoh.sjoh_22_21] [Reference Citation Analysis]
41 Dutta A, Datta S, Snehlata. Epigenetic regulations in gastrointestine: Implications on sensitivity to ionizing radiation, inflammatory diseases, and cancer development. Epigenetics and Metabolomics 2021. [DOI: 10.1016/b978-0-323-85652-2.00011-7] [Reference Citation Analysis]
42 Manicassamy S, Prasad PD, Swafford D. Mouse Models of Colitis-Associated Colon Cancer. Methods Mol Biol 2021;2224:133-46. [PMID: 33606212 DOI: 10.1007/978-1-0716-1008-4_10] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Dong F, Perdew GH. The aryl hydrocarbon receptor as a mediator of host-microbiota interplay. Gut Microbes 2020;12:1859812. [PMID: 33382356 DOI: 10.1080/19490976.2020.1859812] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
44 Kondreddy V, Keshava S, Esmon CT, Pendurthi UR, Rao LVM. A critical role of endothelial cell protein C receptor in the intestinal homeostasis in experimental colitis. Sci Rep 2020;10:20569. [PMID: 33239717 DOI: 10.1038/s41598-020-77502-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
45 Wei C, Wang JY, Xiong F, Wu BH, Luo MH, Yu ZC, Liu TT, Li DF, Tang Q, Li YX, Zhang DG, Xu ZL, Jin HT, Wang LS, Yao J. Curcumin ameliorates DSS‑induced colitis in mice by regulating the Treg/Th17 signaling pathway. Mol Med Rep 2021;23:34. [PMID: 33179078 DOI: 10.3892/mmr.2020.11672] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
46 Di Gioia S, Hossain MN, Conese M. Biological properties and therapeutic effects of plant-derived nanovesicles. Open Med (Wars) 2020;15:1096-122. [PMID: 33336066 DOI: 10.1515/med-2020-0160] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
47 Chong Y, Han C, Li J, Long X. Mapping global research trends in stem cell therapy for inflammatory bowel disease: a bibliometric analysis from 1991 to 2019. J Int Med Res 2020;48:300060520965824. [PMID: 33115290 DOI: 10.1177/0300060520965824] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
48 Zhou Y, Zhu Y, Jiang H, Chen Z, Lu B, Li J, Shen X. Polymorphism rs6478109 in the TNFSF15 gene contributes to the susceptibility to Crohn's disease but not ulcerative colitis: a meta-analysis. J Int Med Res 2020;48:300060520961675. [PMID: 33026276 DOI: 10.1177/0300060520961675] [Reference Citation Analysis]
49 Zurita-Turk M, Mendes Souza B, Prósperi de Castro C, Bastos Pereira V, Pecini da Cunha V, Melo Preisser T, Caetano de Faria AM, Carmona Cara Machado D, Miyoshi A. Attenuation of intestinal inflammation in IL-10 deficient mice by a plasmid carrying Lactococcus lactis strain. BMC Biotechnol 2020;20:38. [PMID: 32703192 DOI: 10.1186/s12896-020-00631-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
50 Jeong S, Oh J, Lim JS, Kim S, Jeong D, Kim SR, Kim JS. Inhibitory Effect of Steamed Soybean Wastewater Against DSS-Induced Intestinal Inflammation in Mice. Foods 2020;9:E954. [PMID: 32708415 DOI: 10.3390/foods9070954] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Li L, Xu P, Zhang Z, Zhou X, Chen C, Lu C. Platelets can reflect the severity of Crohn's disease without the effect of anemia. Clinics (Sao Paulo) 2020;75:e1596. [PMID: 32667493 DOI: 10.6061/clinics/2020/e1596] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
52 Can G, Tezel HA. Inflammatory bowel diseases and genetic. Anadolu Güncel Tıp Dergisi 2020. [DOI: 10.38053/acmj.689278] [Reference Citation Analysis]
53 Can G, Tezel HA. İnflamatuvar barsak hastalıkları ve genetik. Anadolu Güncel Tıp Dergisi 2020. [DOI: 10.38053/agtd.689278] [Reference Citation Analysis]
54 Kekik Cinar C, Demir K, Temurhan S, Akyuz F, Pinarbasi B, Savran Oguz F. MHC Class I related chain A (MICA), Human Leukocyte Antigen (HLA)-DRB1, HLA-DQB1 genotypes in Turkish patients with ulcerative colitis. Turkish Journal of Biochemistry 2020;45:587-592. [DOI: 10.1515/tjb-2019-0296] [Reference Citation Analysis]
55 Kushkevych I, Castro Sangrador J, Dordević D, Rozehnalová M, Černý M, Fafula R, Vítězová M, Rittmann SKR. Evaluation of Physiological Parameters of Intestinal Sulfate-Reducing Bacteria Isolated from Patients Suffering from IBD and Healthy People. J Clin Med 2020;9:E1920. [PMID: 32575467 DOI: 10.3390/jcm9061920] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
56 Liu Q, Zuo R, Wang K, Nong FF, Fu YJ, Huang SW, Pan ZF, Zhang Y, Luo X, Deng XL, Zhang XX, Zhou L, Chen Y. Oroxindin inhibits macrophage NLRP3 inflammasome activation in DSS-induced ulcerative colitis in mice via suppressing TXNIP-dependent NF-κB pathway. Acta Pharmacol Sin 2020;41:771-81. [PMID: 31937929 DOI: 10.1038/s41401-019-0335-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
57 von Martels JZH, Bourgonje AR, Klaassen MAY, Alkhalifah HAA, Sadaghian Sadabad M, Vich Vila A, Gacesa R, Gabriëls RY, Steinert RE, Jansen BH, Bulthuis MLC, van Dullemen HM, Visschedijk MC, Festen EAM, Weersma RK, de Vos P, van Goor H, Faber KN, Harmsen HJM, Dijkstra G. Riboflavin Supplementation in Patients with Crohn's Disease [the RISE-UP study]. J Crohns Colitis 2020;14:595-607. [PMID: 31873717 DOI: 10.1093/ecco-jcc/jjz208] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 11.7] [Reference Citation Analysis]
58 Decara J, Rivera P, López-Gambero AJ, Serrano A, Pavón FJ, Baixeras E, Rodríguez de Fonseca F, Suárez J. Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases. Front Pharmacol 2020;11:730. [PMID: 32536865 DOI: 10.3389/fphar.2020.00730] [Cited by in Crossref: 28] [Cited by in F6Publishing: 35] [Article Influence: 9.3] [Reference Citation Analysis]
59 Li N, Mao J, Tang H, Zhu L, Tan X, Bi J, Wu H, Chen X, Wang Y. Efficacy and safety of adsorptive granulomonocytapheresis in Chinese patients with ulcerative colitis: A retrospective analysis of 50 cases with focus on factors impacting clinical efficacy. J Clin Apher 2020;35:271-80. [PMID: 32378240 DOI: 10.1002/jca.21787] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
60 Wei M, Gao X, Liu L, Li Z, Wan Z, Dong Y, Chen X, Niu Y, Zhang J, Yang G. Visceral Adipose Tissue Derived Exosomes Exacerbate Colitis Severity via Pro-inflammatory MiRNAs in High Fat Diet Fed Mice. ACS Nano 2020;14:5099-110. [PMID: 32275391 DOI: 10.1021/acsnano.0c01860] [Cited by in Crossref: 45] [Cited by in F6Publishing: 51] [Article Influence: 15.0] [Reference Citation Analysis]
61 Cantarelli BCF, de Oliveira RS, Alves AMA, Ribeiro BJ, Velloni F, D'Ippolito G. Evaluating inflammatory activity in Crohn's disease by cross-sectional imaging techniques. Radiol Bras 2020;53:38-46. [PMID: 32313336 DOI: 10.1590/0100-3984.2018.0096] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
62 Cui C, Lu Y, Yue Y, Wu S, Wang S, Yu M, Sun Z. Camel milk regulates T‐cell proliferation to alleviate dextran sodium sulphate‐induced colitis in mice. Int J Food Sci Technol 2020;55:1648-60. [DOI: 10.1111/ijfs.14434] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
63 Jing B, Wang ZA, Zhang C, Deng Q, Wei J, Luo Y, Zhang X, Li J, Du Y. Establishment and Application of Peristaltic Human Gut-Vessel Microsystem for Studying Host-Microbial Interaction. Front Bioeng Biotechnol 2020;8:272. [PMID: 32296697 DOI: 10.3389/fbioe.2020.00272] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
64 Bondarenko KR, Dobrokhotova YE, Rumyantseva TA, Nasyrova NI. Crohn's disease of the vulva: A tough diagnosis (a case report of a 47 y.o. patient). Clin Case Rep 2020;8:563-7. [PMID: 32185060 DOI: 10.1002/ccr3.2707] [Reference Citation Analysis]
65 Lyons DO, Pullen NA. Beyond IgE: Alternative Mast Cell Activation Across Different Disease States. Int J Mol Sci 2020;21:E1498. [PMID: 32098318 DOI: 10.3390/ijms21041498] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 10.7] [Reference Citation Analysis]
66 Choi SY, Kang B, Choe YH. Serum Infliximab Cutoff trough Level Values for Maintaining Hematological Remission in Pediatric Inflammatory Bowel Disease. Gut Liver 2019;13:541-8. [PMID: 30970435 DOI: 10.5009/gnl18129] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
67 Oh WS, Jung JC, Choi YM, Mun JY, Ku SK, Song CH. Protective effects of fermented rice extract on ulcerative colitis induced by dextran sodium sulfate in mice. Food Sci Nutr 2020;8:1718-28. [PMID: 32180979 DOI: 10.1002/fsn3.1460] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
68 Szymańska S, Matuszczyk M, Osuch M, Meglicka M, Szymanska E, Bierła J, Kierkuś J. Inflammatory bowel disease - one entity with many molecular faces. Prz Gastroenterol 2019;14:228-32. [PMID: 31988668 DOI: 10.5114/pg.2019.90249] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
69 Marvi-khorasani H, Usefi H. Feature Clustering Towards Gene Selection. 2019 18th IEEE International Conference On Machine Learning And Applications (ICMLA) 2019. [DOI: 10.1109/icmla.2019.00240] [Reference Citation Analysis]
70 Lleal M, Sarrabayrouse G, Willamil J, Santiago A, Pozuelo M, Manichanh C. A single faecal microbiota transplantation modulates the microbiome and improves clinical manifestations in a rat model of colitis. EBioMedicine 2019;48:630-41. [PMID: 31628021 DOI: 10.1016/j.ebiom.2019.10.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 8.3] [Reference Citation Analysis]
71 Ni Y, Liu M, Yu H, Chen Y, Liu Y, Chen S, Ruan J, Da A, Zhang Y, Wang T. Desmethylbellidifolin From Gentianella acuta Ameliorate TNBS-Induced Ulcerative Colitis Through Antispasmodic Effect and Anti-Inflammation. Front Pharmacol 2019;10:1104. [PMID: 31616306 DOI: 10.3389/fphar.2019.01104] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
72 Assas MB, Levison S, Pennock JL. Early induction of C/EBPβ expression as a potential marker of steroid responsive colitis. Sci Rep 2019;9:13087. [PMID: 31511552 DOI: 10.1038/s41598-019-48251-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
73 Abdelmegid AM, Abdo FK, Ahmed FE, Kattaia AAA. Therapeutic effect of gold nanoparticles on DSS-induced ulcerative colitis in mice with reference to interleukin-17 expression. Sci Rep 2019;9:10176. [PMID: 31308463 DOI: 10.1038/s41598-019-46671-1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 7.3] [Reference Citation Analysis]
74 Eckert KG, Abbasi-Neureither I, Köppel M, Huber G. Structured physical activity interventions as a complementary therapy for patients with inflammatory bowel disease - a scoping review and practical implications. BMC Gastroenterol 2019;19:115. [PMID: 31266461 DOI: 10.1186/s12876-019-1034-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
75 Sureshkumar S, Jung SK, Kim D, Oh KB, Yang H, Lee HC, Jin JY, Sun LH, Lee S, Byun SJ. Oral administration of Lactobacillus reuteri expressing a 3D8 single-chain variable fragment (scFv) enhances chicken growth and conserves immune homeostasis. 3 Biotech 2019;9:282. [PMID: 31245246 DOI: 10.1007/s13205-019-1811-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
76 Mahr D, Mahr E, Rehmann-sutter C. Subjektivierungsfiguren genetischer Information. Sozialer Sinn 2019;20:1-39. [DOI: 10.1515/sosi-2019-0001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
77 Xu W, Ou W, Guo Y, Gu Y, Cui L, Zhong J, Du P. Clinical outcomes and risk factors of secondary extraintestinal manifestation in ulcerative colitis: results of a multicenter and long-term follow-up retrospective study. PeerJ 2019;7:e7194. [PMID: 31304061 DOI: 10.7717/peerj.7194] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
78 Meiners J, Palmieri V, Klopfleisch R, Ebel JF, Japtok L, Schumacher F, Yusuf AM, Becker KA, Zöller J, Hose M, Kleuser B, Hermann DM, Kolesnick RN, Buer J, Hansen W, Westendorf AM. Intestinal Acid Sphingomyelinase Protects From Severe Pathogen-Driven Colitis. Front Immunol 2019;10:1386. [PMID: 31275322 DOI: 10.3389/fimmu.2019.01386] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
79 Carty E. Inflammatory bowel disease. Drug Therapy for Gastrointestinal and Liver Diseases 2019. [DOI: 10.1201/9780429265433-5] [Reference Citation Analysis]
80 Shi Y, Li T, Zhou J, Li Y, Chen L, Shang H, Guo Y, Sun Y, Zhao J, Bao C, Wu H. Herbs-Partitioned Moxibustion Combined with Acupuncture Inhibits TGF-β1-Smad-Snail-Induced Intestinal Epithelial Mesenchymal Transition in Crohn's Disease Model Rats. Evid Based Complement Alternat Med 2019;2019:8320250. [PMID: 31275422 DOI: 10.1155/2019/8320250] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
81 Dosh RH, Jordan-Mahy N, Sammon C, Le Maitre C. Interleukin 1 is a key driver of inflammatory bowel disease-demonstration in a murine IL-1Ra knockout model. Oncotarget 2019;10:3559-75. [PMID: 31191826 DOI: 10.18632/oncotarget.26894] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
82 Tezcan G, Martynova EV, Gilazieva ZE, McIntyre A, Rizvanov AA, Khaiboullina SF. MicroRNA Post-transcriptional Regulation of the NLRP3 Inflammasome in Immunopathologies. Front Pharmacol 2019;10:451. [PMID: 31118894 DOI: 10.3389/fphar.2019.00451] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 9.0] [Reference Citation Analysis]
83 Al-Quorain AA. Extraintestinal Manifestations of Inflammatory Bowel Disease. Saudi J Med Med Sci 2019;7:65. [PMID: 31080384 DOI: 10.4103/sjmms.sjmms_111_19] [Reference Citation Analysis]
84 Pavlidis S, Monast C, Loza MJ, Branigan P, Chung KF, Adcock IM, Guo Y, Rowe A, Baribaud F. I_MDS: an inflammatory bowel disease molecular activity score to classify patients with differing disease-driving pathways and therapeutic response to anti-TNF treatment. PLoS Comput Biol 2019;15:e1006951. [PMID: 31039157 DOI: 10.1371/journal.pcbi.1006951] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
85 Bourgonje AR, von Martels JZH, Bulthuis MLC, van Londen M, Faber KN, Dijkstra G, van Goor H. Crohn's Disease in Clinical Remission Is Marked by Systemic Oxidative Stress. Front Physiol 2019;10:499. [PMID: 31080419 DOI: 10.3389/fphys.2019.00499] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
86 Burge K, Gunasekaran A, Eckert J, Chaaban H. Curcumin and Intestinal Inflammatory Diseases: Molecular Mechanisms of Protection. Int J Mol Sci 2019;20:E1912. [PMID: 31003422 DOI: 10.3390/ijms20081912] [Cited by in Crossref: 59] [Cited by in F6Publishing: 67] [Article Influence: 14.8] [Reference Citation Analysis]
87 Jang YJ, Kim WK, Han DH, Lee K, Ko G. Lactobacillus fermentum species ameliorate dextran sulfate sodium-induced colitis by regulating the immune response and altering gut microbiota. Gut Microbes 2019;10:696-711. [PMID: 30939976 DOI: 10.1080/19490976.2019.1589281] [Cited by in Crossref: 76] [Cited by in F6Publishing: 68] [Article Influence: 19.0] [Reference Citation Analysis]
88 Safaeian R, Howarth GS, Lawrance IC, Trinder D, Mashtoub S. Emu Oil reduces disease severity in a mouse model of chronic ulcerative colitis. Scand J Gastroenterol 2019;54:273-80. [PMID: 30907169 DOI: 10.1080/00365521.2019.1581253] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
89 Ge X, Chen Z, Xu Z, Lv F, Zhang K, Yang Y. The effects of dihydroartemisinin on inflammatory bowel disease-related bone loss in a rat model. Exp Biol Med (Maywood) 2018;243:715-24. [PMID: 29763384 DOI: 10.1177/1535370218769420] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
90 Zhang H, Xu CN, Mine Y. Effects of a synthetic di‐phosphoserine peptide (SS‐2) on gene expression profiling against TNF‐α induced inflammation. Int J Food Sci Technol 2019;54:2010-20. [DOI: 10.1111/ijfs.14077] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
91 Kumar S, Rao N, Taylor SA. Functional Cross-Sectional Imaging Techniques in Crohn’s Disease. Cross-Sectional Imaging in Crohn’s Disease 2019. [DOI: 10.1007/978-3-319-96586-4_6] [Reference Citation Analysis]
92 Dinda B. Pharmacology of Iridoids. Pharmacology and Applications of Naturally Occurring Iridoids 2019. [DOI: 10.1007/978-3-030-05575-2_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
93 Wang L, Wang Y, Wang Z, Qi Y, Zong B, Liu M, Li X, Zhang X, Liu C, Cao R, Ma Y. Growth differentiation factor 11 ameliorates experimental colitis by inhibiting NLRP3 inflammasome activation. Am J Physiol Gastrointest Liver Physiol 2018;315:G909-20. [PMID: 30188752 DOI: 10.1152/ajpgi.00159.2018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
94 Cronin J, Moore S, Lenihan N, O'Shea M, Woods N. The non-drug costs associated with the administration of an intravenous biologic treatment in the hospital setting. Ir J Med Sci 2019;188:821-34. [PMID: 30467804 DOI: 10.1007/s11845-018-1925-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
95 Mo JS, Han SH, Yun KJ, Chae SC. MicroRNA 429 regulates the expression of CHMP5 in the inflammatory colitis and colorectal cancer cells. Inflamm Res. 2018;67:985-996. [PMID: 30334065 DOI: 10.1007/s00011-018-1194-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
96 Ahn E, Kim S. The Improving Effect ofGastrodia elataBlume on DSS-induced Colitis in Mice. BSL 2018;24:168-174. [DOI: 10.15616/bsl.2018.24.3.168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
97 Dou YX, Zhou JT, Wang TT, Huang YF, Chen VP, Xie YL, Lin ZX, Gao JS, Su ZR, Zeng HF. Self-nanoemulsifying drug delivery system of bruceine D: a new approach for anti-ulcerative colitis. Int J Nanomedicine 2018;13:5887-907. [PMID: 30319255 DOI: 10.2147/IJN.S174146] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
98 Zackular JP, Skaar EP. The role of zinc and nutritional immunity in Clostridium difficile infection. Gut Microbes 2018;9:469-76. [PMID: 29533126 DOI: 10.1080/19490976.2018.1448354] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
99 Serpico MR, Maltz R, Crandall W, Bricker J, Dotson JL, Kim SC, Boyle B. Thiopurine Optimization Through Combination With Allopurinol in Children With Inflammatory Bowel Diseases. J Pediatr Gastroenterol Nutr 2018;67:341-5. [PMID: 29601433 DOI: 10.1097/MPG.0000000000001986] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
100 Diezmos EF, Markus I, Perera DS, Gan S, Zhang L, Sandow SL, Bertrand PP, Liu L. Blockade of Pannexin-1 Channels and Purinergic P2X7 Receptors Shows Protective Effects Against Cytokines-Induced Colitis of Human Colonic Mucosa. Front Pharmacol 2018;9:865. [PMID: 30127744 DOI: 10.3389/fphar.2018.00865] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
101 Fukata T, Mizushima T, Nishimura J, Okuzaki D, Wu X, Hirose H, Yokoyama Y, Kubota Y, Nagata K, Tsujimura N, Inoue A, Miyoshi N, Haraguchi N, Takahashi H, Hata T, Matsuda C, Kayama H, Takeda K, Doki Y, Mori M, Yamamoto H. The Supercarbonate Apatite-MicroRNA Complex Inhibits Dextran Sodium Sulfate-Induced Colitis. Mol Ther Nucleic Acids 2018;12:658-71. [PMID: 30092402 DOI: 10.1016/j.omtn.2018.07.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
102 Duff W, Haskey N, Potter G, Alcorn J, Hunter P, Fowler S. Non-pharmacological therapies for inflammatory bowel disease: Recommendations for self-care and physician guidance. World J Gastroenterol 2018; 24(28): 3055-3070 [PMID: 30065553 DOI: 10.3748/wjg.v24.i28.3055] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
103 Chan SN, Low END, Raja Ali RA, Mokhtar NM. Delineating inflammatory bowel disease through transcriptomic studies: current review of progress and evidence. Intest Res 2018;16:374-83. [PMID: 30090036 DOI: 10.5217/ir.2018.16.3.374] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
104 Bruscoli S, Sorcini D, Flamini S, Gagliardi A, Adamo F, Ronchetti S, Migliorati G, Bereshchenko O, Riccardi C. Glucocorticoid-Induced Leucine Zipper Inhibits Interferon-Gamma Production in B Cells and Suppresses Colitis in Mice. Front Immunol 2018;9:1720. [PMID: 30083167 DOI: 10.3389/fimmu.2018.01720] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
105 Abron JD, Singh NP, Price RL, Nagarkatti M, Nagarkatti PS, Singh UP. Genistein induces macrophage polarization and systemic cytokine to ameliorate experimental colitis. PLoS One. 2018;13:e0199631. [PMID: 30024891 DOI: 10.1371/journal.pone.0199631] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 9.0] [Reference Citation Analysis]
106 Azer SA, Azer S. What can we learn from top-cited articles in inflammatory bowel disease? A bibliometric analysis and assessment of the level of evidence. BMJ Open. 2018;8:e021233. [PMID: 30002009 DOI: 10.1136/bmjopen-2017-021233] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
107 Paramsothy S, Rosenstein AK, Mehandru S, Colombel JF. The current state of the art for biological therapies and new small molecules in inflammatory bowel disease. Mucosal Immunol 2018;11:1558-70. [PMID: 29907872 DOI: 10.1038/s41385-018-0050-3] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 11.2] [Reference Citation Analysis]
108 Cho J, Kweon HS, Huh SO, Sadra A. Augmented reduction in colonic inflammatory markers of dextran sulfate sodium-induced colitis with a combination of 5-aminosalicylic acid and AD-lico™ from Glycyrrhiza inflata. Anim Cells Syst (Seoul) 2018;22:189-96. [PMID: 30460097 DOI: 10.1080/19768354.2018.1476409] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
109 Nagaishi T. Exploration of Novel Mechanisms in Gut Related Mucosal Immune Disregulations in Inflammatory Bowel Diseases. Nichidai Igaku Zasshi 2018;77:197-200. [DOI: 10.4264/numa.77.3_197] [Reference Citation Analysis]
110 Gao Y, Huang Y, Zhao Y, Hu Y, Li Z, Guo Q, Zhao K, Lu N. LL202 protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting MAPK/AP-1 signaling. Oncotarget 2016;7:63981-94. [PMID: 27590510 DOI: 10.18632/oncotarget.11742] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
111 Shen S, Prame Kumar K, Stanley D, Moore RJ, Van TTH, Wen SW, Hickey MJ, Wong CHY. Invariant Natural Killer T Cells Shape the Gut Microbiota and Regulate Neutrophil Recruitment and Function During Intestinal Inflammation. Front Immunol 2018;9:999. [PMID: 29867976 DOI: 10.3389/fimmu.2018.00999] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
112 Peng Y, Tellier LE, Temenoff JS. Heparin-based hydrogels with tunable sulfation & degradation for anti-inflammatory small molecule delivery. Biomater Sci 2016;4:1371-80. [PMID: 27447003 DOI: 10.1039/c6bm00455e] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
113 Samaan MA, Pavlidis P, Papa S, Powell N, Irving PM. Gastrointestinal toxicity of immune checkpoint inhibitors: from mechanisms to management. Nat Rev Gastroenterol Hepatol 2018;15:222-34. [PMID: 29512649 DOI: 10.1038/nrgastro.2018.14] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 11.4] [Reference Citation Analysis]
114 Cui X, Ahn E, Kim E. Anti-Colitis Effects of Mulberry Root Bark and Mulberry Twig Extracts in High Protein Diet Fed Mice. EASDL 2018;28:47-55. [DOI: 10.17495/easdl.2018.2.28.1.47] [Reference Citation Analysis]
115 Mosli M, Bamarhul M, Alharbi A, Shafei S, Alharbi A, Bamahfouth K, Jawa H, Aljahdali E, Bazaraa S, Qari Y. Screening irritable bowel syndrome patients for symptoms predictive of crohn's disease using the red flag score. Saudi J Gastroenterol 2017;23:229-32. [PMID: 28721976 DOI: 10.4103/sjg.SJG_601_16] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
116 Gonçalves P, Araújo JR, Di Santo JP. A Cross-Talk Between Microbiota-Derived Short-Chain Fatty Acids and the Host Mucosal Immune System Regulates Intestinal Homeostasis and Inflammatory Bowel Disease. Inflamm Bowel Dis 2018;24:558-72. [PMID: 29462379 DOI: 10.1093/ibd/izx029] [Cited by in Crossref: 192] [Cited by in F6Publishing: 190] [Article Influence: 38.4] [Reference Citation Analysis]
117 Pan L, Farouk MH, Qin G, Zhao Y, Bao N. The Influences of Soybean Agglutinin and Functional Oligosaccharides on the Intestinal Tract of Monogastric Animals. Int J Mol Sci 2018;19:E554. [PMID: 29439523 DOI: 10.3390/ijms19020554] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
118 Bozec D, Iuga AC, Roda G, Dahan S, Yeretssian G. Critical function of the necroptosis adaptor RIPK3 in protecting from intestinal tumorigenesis. Oncotarget. 2016;7:46384-46400. [PMID: 27344176 DOI: 10.18632/oncotarget.10135] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 8.2] [Reference Citation Analysis]
119 Nelson HA, Roe MW. Molecular physiology and pathophysiology of stromal interaction molecules. Exp Biol Med (Maywood) 2018;243:451-72. [PMID: 29363328 DOI: 10.1177/1535370218754524] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
120 B. T, Khan A. Effect of lawsonia inermis on tnbs induced ulcerative colitis in rats. Int J Pharma Bio Sci 2018;9. [DOI: 10.22376/ijpbs.2018.9.1.p105-110] [Reference Citation Analysis]
121 Sun L, Dong H, Zhang Z, Liu J, Hu Y, Ni Y, Grossmann R, Zhao R. Activation of epithelial proliferation induced by Eimeria acervulina infection in the duodenum may be associated with cholesterol metabolism. Oncotarget 2016;7:27627-40. [PMID: 27050279 DOI: 10.18632/oncotarget.8490] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
122 Cheng M, Hu S, Wang Z, Pei Y, Fan R, Liu X, Wang L, Zhou J, Zheng S, Zhang T, Lin Y, Zhang M, Tao R, Zhong J. Inhibition of neddylation regulates dendritic cell functions via Deptor accumulation driven mTOR inactivation. Oncotarget 2016;7:35643-54. [PMID: 27224922 DOI: 10.18632/oncotarget.9543] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
123 Chu Y, Jiang MZ, Xu B, Wang WJ, Chen D, Li XW, Zhang YJ, Liang J. Specific changes of enteric mycobiota and virome in inflammatory bowel disease. J Dig Dis 2018;19:2-7. [PMID: 29266753 DOI: 10.1111/1751-2980.12570] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
124 Park J, Kim E. Effects of luteolin on chemical induced colon carcinogenesis in high fat diet-fed obese mouse. J Nutr Health 2018;51:14. [DOI: 10.4163/jnh.2018.51.1.14] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
125 Morshedzadeh N, Rahimlou M, Asadzadeh Aghdaei H, Shahrokh S, Reza Zali M, Mirmiran P. Association Between Adipokines Levels with Inflammatory Bowel Disease (IBD): Systematic Reviews. Dig Dis Sci 2017;62:3280-6. [PMID: 29086333 DOI: 10.1007/s10620-017-4806-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
126 Wang Q, Yang K, Han B, Sheng B, Yin J, Pu A, Li L, Sun L, Yu M, Qiu Y, Xiao W, Yang H. Aryl hydrocarbon receptor inhibits inflammation in DSS‑induced colitis via the MK2/p‑MK2/TTP pathway. Int J Mol Med 2018;41:868-76. [PMID: 29207040 DOI: 10.3892/ijmm.2017.3262] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
127 Chamaillard M. Missing Heritability of Crohn's Disease and Implications for Therapeutic Targeting and Improved Care. Inflammation - From Molecular and Cellular Mechanisms to the Clinic 2017. [DOI: 10.1002/9783527692156.ch43] [Reference Citation Analysis]
128 Mendlovic F, Cruz-Rivera M, Diaz-Gandarilla JA, Flores-Torres MA, Avila G, Perfiliev M, Salazar AM, Arriaga-Pizano L, Ostrosky-Wegman P, Flisser A. Orally administered Taenia solium Calreticulin prevents experimental intestinal inflammation and is associated with a type 2 immune response. PLoS One 2017;12:e0186510. [PMID: 29036211 DOI: 10.1371/journal.pone.0186510] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
129 Khasawneh M, Spence AD, Addley J, Allen PB. The role of smoking and alcohol behaviour in the management of inflammatory bowel disease. Best Pract Res Clin Gastroenterol 2017;31:553-9. [PMID: 29195675 DOI: 10.1016/j.bpg.2017.10.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
130 Tak KH, Ahn E, Kim E. Increase in dietary protein content exacerbates colonic inflammation and tumorigenesis in azoxymethane-induced mouse colon carcinogenesis. Nutr Res Pract 2017;11:281-9. [PMID: 28765774 DOI: 10.4162/nrp.2017.11.4.281] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
131 Gu P, Theiss A, Han J, Feagins LA. Increased Cell Adhesion Molecules, PECAM-1, ICAM-3, or VCAM-1, Predict Increased Risk for Flare in Patients With Quiescent Inflammatory Bowel Disease. J Clin Gastroenterol 2017;51:522-7. [PMID: 27552332 DOI: 10.1097/MCG.0000000000000618] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
132 Wagoner ST, Kavookjian J. The Influence of Motivational Interviewing on Patients With Inflammatory Bowel Disease: A Systematic Review of the Literature. J Clin Med Res 2017;9:659-66. [PMID: 28725313 DOI: 10.14740/jocmr3081w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
133 Nie Y, Lin Q, Luo F. Effects of Non-Starch Polysaccharides on Inflammatory Bowel Disease. Int J Mol Sci. 2017;18:pii: E1372. [PMID: 28654020 DOI: 10.3390/ijms18071372] [Cited by in Crossref: 76] [Cited by in F6Publishing: 83] [Article Influence: 12.7] [Reference Citation Analysis]
134 Sang LX, Chang B, Zhu JF, Yang FL, Li Y, Jiang XF, Wang DN, Lu CL, Sun X. Sodium selenite ameliorates dextran sulfate sodium-induced chronic colitis in mice by decreasing Th1, Th17, and γδT and increasing CD4(+)CD25(+) regulatory T-cell responses. World J Gastroenterol 2017; 23(21): 3850-3863 [PMID: 28638225 DOI: 10.3748/wjg.v23.i21.3850] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
135 Cramer H, Schäfer M, Schöls M, Köcke J, Elsenbruch S, Lauche R, Engler H, Dobos G, Langhorst J. Randomised clinical trial: yoga vs written self-care advice for ulcerative colitis. Aliment Pharmacol Ther 2017;45:1379-89. [PMID: 28378342 DOI: 10.1111/apt.14062] [Cited by in Crossref: 35] [Cited by in F6Publishing: 86] [Article Influence: 5.8] [Reference Citation Analysis]
136 Neudecker V, Haneklaus M, Jensen O, Khailova L, Masterson JC, Tye H, Biette K, Jedlicka P, Brodsky KS, Gerich ME, Mack M, Robertson AAB, Cooper MA, Furuta GT, Dinarello CA, O'Neill LA, Eltzschig HK, Masters SL, McNamee EN. Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome. J Exp Med. 2017;214:1737-1752. [PMID: 28487310 DOI: 10.1084/jem.20160462] [Cited by in Crossref: 228] [Cited by in F6Publishing: 237] [Article Influence: 38.0] [Reference Citation Analysis]
137 Chen Y, Park J, Joe Y, Park HJ, Jekal SJ, Sato D, Hamada H, Chung HT. Pterostilbene 4'-β-Glucoside Protects against DSS-Induced Colitis via Induction of Tristetraprolin. Oxid Med Cell Longev 2017;2017:9427583. [PMID: 28607633 DOI: 10.1155/2017/9427583] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
138 Kedia S, Bhatia V, Thareja S, Garg S, Mouli VP, Bopanna S, Tiwari V, Makharia G, Ahuja V. Low dose oral curcumin is not effective in induction of remission in mild to moderate ulcerative colitis: Results from a randomized double blind placebo controlled trial. World J Gastrointest Pharmacol Ther 2017; 8(2): 147-154 [PMID: 28533925 DOI: 10.4292/wjgpt.v8.i2.147] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 45] [Article Influence: 7.5] [Reference Citation Analysis]
139 Celiberto LS, Bedani R, Dejani NN, Ivo de Medeiros A, Sampaio Zuanon JA, Spolidorio LC, Tallarico Adorno MA, Amâncio Varesche MB, Carrilho Galvão F, Valentini SR, Font de Valdez G, Rossi EA, Cavallini DCU. Effect of a probiotic beverage consumption (Enterococcus faecium CRL 183 and Bifidobacterium longum ATCC 15707) in rats with chemically induced colitis. PLoS One 2017;12:e0175935. [PMID: 28437455 DOI: 10.1371/journal.pone.0175935] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
140 Cengiz D, Gürçay E, Karaahmet ÖZ, Karaahmet F, Umay E, Çakcı A. Inflammatory arthritis complicated by inflammatory bowel disease: two case reports. Turk J Phys Med Rehabil 2017;63:266-71. [PMID: 31453464 DOI: 10.5606/tftrd.2017.23169] [Reference Citation Analysis]
141 Van Spaendonk H, Ceuleers H, Witters L, Patteet E, Joossens J, Augustyns K, Lambeir AM, De Meester I, De Man JG, De Winter BY. Regulation of intestinal permeability: The role of proteases. World J Gastroenterol 2017; 23(12): 2106-2123 [PMID: 28405139 DOI: 10.3748/wjg.v23.i12.2106] [Cited by in CrossRef: 103] [Cited by in F6Publishing: 101] [Article Influence: 17.2] [Reference Citation Analysis]
142 Mărginean CO, Meliţ LE, Mocanu S, Mărginean MO. Inflammatory bowel diseases: a burden in pediatrics: Case series and a review of the literature. Medicine (Baltimore) 2017;96:e6329. [PMID: 28296755 DOI: 10.1097/MD.0000000000006329] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
143 Bao X, Feng Z, Yao J, Li T, Yin Y. Roles of Dietary Amino Acids and Their Metabolites in Pathogenesis of Inflammatory Bowel Disease. Mediators Inflamm. 2017;2017:6869259. [PMID: 28392631 DOI: 10.1155/2017/6869259] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
144 Ruan J, Chen Y, Zhou Y. Development and Validation of a Questionnaire to Assess the Quality of Life in Patients with Inflammatory Bowel Disease in Mainland China. Inflamm Bowel Dis 2017;23:431-9. [PMID: 28129287 DOI: 10.1097/MIB.0000000000001024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
145 Khelifi L, Soufli I, Labsi M, Touil-Boukoffa C. Immune-protective effect of echinococcosis on colitis experimental model is dependent of down regulation of TNF-α and NO production. Acta Trop 2017;166:7-15. [PMID: 27983971 DOI: 10.1016/j.actatropica.2016.10.020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
146 Park JS, Joe I, Rhee PD, Jeong CS, Jeong G. A lactic acid bacterium isolated from kimchi ameliorates intestinal inflammation in DSS-induced colitis. J Microbiol. 2017;55:304-310. [PMID: 28124779 DOI: 10.1007/s12275-017-6447-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
147 Lee LH, Iacucci M, Fort Gasia M, Ghosh S, Panaccione R, Urbanski S. Prevalence and Anatomic Distribution of Serrated and Adenomatous Lesions in Patients with Inflammatory Bowel Disease. Can J Gastroenterol Hepatol 2017;2017:5490803. [PMID: 28182112 DOI: 10.1155/2017/5490803] [Cited by in Crossref: 12] [Cited by in F6Publishing: 40] [Article Influence: 2.0] [Reference Citation Analysis]
148 Lu Y, Lin H, Zhang J, Wei J, Sun J, Han L. Sijunzi Decoction attenuates 2, 4, 6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in rats and ameliorates TNBS-induced claudin-2 damage via NF-κB pathway in Caco2 cells. BMC Complement Altern Med 2017;17:35. [PMID: 28073341 DOI: 10.1186/s12906-016-1549-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
149 Ndoja S, Lima H. Monoclonal Antibodies. Current Developments in Biotechnology and Bioengineering 2017. [DOI: 10.1016/b978-0-444-63660-7.00004-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
150 Kanai T. Leukocytapheresis Therapy of Inflammatory Bowel Disease. Crohn's Disease and Ulcerative Colitis 2017. [DOI: 10.1007/978-3-319-33703-6_49] [Reference Citation Analysis]
151 Liu Y. Impact and Application of Nutraceuticals on Inflammation-Induced Colorectal Cancer Development. Molecular Oncology: Underlying Mechanisms and Translational Advancements 2017. [DOI: 10.1007/978-3-319-53082-6_14] [Reference Citation Analysis]
152 Smythe M. Orally Delivered Peptides for Treatment of Inflammatory Bowel Disease. Comprehensive Medicinal Chemistry III 2017. [DOI: 10.1016/b978-0-12-409547-2.12417-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
153 Serpico MR, Boyle BM, Kemper KJ, Kim SC. Complementary and Alternative Medicine Use in Children With Inflammatory Bowel Diseases: A Single-Center Survey. J Pediatr Gastroenterol Nutr 2016;63:651-7. [PMID: 26960176 DOI: 10.1097/MPG.0000000000001187] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
154 Guo H, Xu Y, Huang W, Zhou H, Zheng Z, Zhao Y, He B, Zhu T, Tang S, Zhu Q. Kuwanon G Preserves LPS-Induced Disruption of Gut Epithelial Barrier In Vitro. Molecules 2016;21:E1597. [PMID: 27879681 DOI: 10.3390/molecules21111597] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
155 Zhang M, Collins JF, Merlin D. Do ginger-derived nanoparticles represent an attractive treatment strategy for inflammatory bowel diseases? Nanomedicine (Lond) 2016;11:3035-7. [PMID: 27813445 DOI: 10.2217/nnm-2016-0353] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
156 Lackeyram D, Young D, Kim CJ, Yang C, Archbold TL, Mine Y, Fan MZ. Interleukin-10 is differentially expressed in the small intestine and the colon experiencing chronic inflammation and ulcerative colitis induced by dextran sodium sulfate in young pigs. Physiol Res 2017;66:147-62. [PMID: 27782738 DOI: 10.33549/physiolres.933259] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
157 Komine-Aizawa S, Masuda H, Mazaki T, Shiono M, Hayakawa S, Takayama T. Plasma osteopontin predicts inflammatory bowel disease activities. Int Surg 2015;100:38-43. [PMID: 25594638 DOI: 10.9738/INTSURG-D-13-00160.1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
158 Irwin R, Raehtz S, Parameswaran N, McCabe LR. Intestinal inflammation without weight loss decreases bone density and growth. Am J Physiol Regul Integr Comp Physiol 2016;311:R1149-57. [PMID: 27733383 DOI: 10.1152/ajpregu.00051.2016] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
159 Menozzi A, Dall'Aglio M, Quintavalla F, Dallavalle L, Meucci V, Bertini S. Rifaximin is an effective alternative to metronidazole for the treatment of chronic enteropathy in dogs: a randomised trial. BMC Vet Res 2016;12:217. [PMID: 27716258 DOI: 10.1186/s12917-016-0851-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
160 Kaaru E, Bianchi A, Wunder A, Rasche V, Stiller D. Molecular Imaging in Preclinical Models of IBD with Nuclear Imaging Techniques: State-of-the-Art and Perspectives. Inflamm Bowel Dis 2016;22:2491-8. [PMID: 27580387 DOI: 10.1097/MIB.0000000000000904] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
161 McNamee EN, Rivera-Nieves J. Ectopic Tertiary Lymphoid Tissue in Inflammatory Bowel Disease: Protective or Provocateur? Front Immunol. 2016;7:308. [PMID: 27579025 DOI: 10.3389/fimmu.2016.00308] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
162 Kang K, Bae JH, Han K, Kim ES, Kim TO, Yi JM. A Genome-Wide Methylation Approach Identifies a New Hypermethylated Gene Panel in Ulcerative Colitis. Int J Mol Sci. 2016;17:pii E1291. [PMID: 27517910 DOI: 10.3390/ijms17081291] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
163 Sun L, Wang W, Xiao W, Yang H. The Roles of Cathelicidin LL-37 in Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:1986-91. [PMID: 27135484 DOI: 10.1097/MIB.0000000000000804] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
164 Zhou J, O'Keeffe M, Liao G, Zhao F, Terhorst C, Xu B. Design and Synthesis of Nanofibers of Self-assembled de novo Glycoconjugates towards Mucosal Lining Restoration and Anti-Inflammatory Drug Delivery. Tetrahedron 2016;72:6078-83. [PMID: 28216796 DOI: 10.1016/j.tet.2016.07.057] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
165 Zhao Y, Sun Y, Ding Y, Wang X, Zhou Y, Li W, Huang S, Li Z, Kong L, Guo Q, Lu N. GL-V9, a new synthetic flavonoid derivative, ameliorates DSS-induced colitis against oxidative stress by up-regulating Trx-1 expression via activation of AMPK/FOXO3a pathway. Oncotarget. 2015;6:26291-26307. [PMID: 26327408 DOI: 10.18632/oncotarget.4657] [Cited by in Crossref: 19] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
166 Engel T, Kopylov U. Ustekinumab in Crohn’s disease: evidence to date and place in therapy. Ther Adv Chronic Dis. 2016;7:208-214. [PMID: 27433311 DOI: 10.1177/2040622316653306] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
167 Parisi I, O'Beirne J, Rossi RE, Tsochatzis E, Manousou P, Theocharidou E, Hamilton M, Murray C, Epstein O, Burroughs AK. Elevated liver enzymes in inflammatory bowel disease: the role and safety of infliximab. Eur J Gastroenterol Hepatol 2016;28:786-91. [PMID: 27015138 DOI: 10.1097/MEG.0000000000000624] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
168 Diezmos EF, Bertrand PP, Liu L. Purinergic Signaling in Gut Inflammation: The Role of Connexins and Pannexins. Front Neurosci 2016;10:311. [PMID: 27445679 DOI: 10.3389/fnins.2016.00311] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 4.7] [Reference Citation Analysis]
169 Wan J, Xia L, Xu W, Lu N. Expression and Function of miR-155 in Diseases of the Gastrointestinal Tract.Int J Mol Sci. 2016;17. [PMID: 27187359 DOI: 10.3390/ijms17050709] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
170 Bekheit M, Baddour N, Katri K, Taher Y, El Tobgy K, Mousa E. Hyperbaric oxygen therapy stimulates colonic stem cells and induces mucosal healing in patients with refractory ulcerative colitis: a prospective case series. BMJ Open Gastroenterol 2016;3:e000082. [PMID: 27195128 DOI: 10.1136/bmjgast-2016-000082] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
171 Vezza T, Rodríguez-nogales A, Algieri F, Utrilla M, Rodriguez-cabezas M, Galvez J. Flavonoids in Inflammatory Bowel Disease: A Review. Nutrients 2016;8:211. [DOI: 10.3390/nu8040211] [Cited by in Crossref: 140] [Cited by in F6Publishing: 143] [Article Influence: 20.0] [Reference Citation Analysis]
172 Javed NH, Alsahly MB, Khubchandani J. Oral Feeding of Probiotic Bifidobacterium infantis: Colonic Morphological Changes in Rat Model of TNBS-Induced Colitis. Scientifica (Cairo) 2016;2016:9572596. [PMID: 27127686 DOI: 10.1155/2016/9572596] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
173 Sadi G, Yang Q, Dufault B, Stefanovici C, Stoffman J, El-Matary W. Prevalence of Peripheral Eosinophilia at Diagnosis in Children With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2016;62:573-6. [PMID: 26308316 DOI: 10.1097/MPG.0000000000000957] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
174 Lee CH, Ha GW, Kim JH, Kim SH. Modulation in Natriuretic Peptides System in Experimental Colitis in Rats. Dig Dis Sci 2016;61:1060-8. [PMID: 26660905 DOI: 10.1007/s10620-015-3969-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
175 Xu J, Zhou L, Ji L, Chen F, Fortmann K, Zhang K, Liu Q, Li K, Wang W, Wang H, Xie W, Wang Q, Liu J, Zheng B, Zhang P, Huang S, Shi T, Zhang B, Dang Y, Chen J, O'Malley BW, Moses RE, Wang P, Li L, Xiao J, Hoffmann A, Li X. The REGγ-proteasome forms a regulatory circuit with IκBɛ and NFκB in experimental colitis. Nat Commun 2016;7:10761. [PMID: 26899380 DOI: 10.1038/ncomms10761] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 6.1] [Reference Citation Analysis]
176 Yamada A, Arakaki R, Saito M, Tsunematsu T, Kudo Y, Ishimaru N. Role of regulatory T cell in the pathogenesis of inflammatory bowel disease. World J Gastroenterol 2016; 22(7): 2195-2205 [PMID: 26900284 DOI: 10.3748/wjg.v22.i7.2195] [Cited by in CrossRef: 109] [Cited by in F6Publishing: 112] [Article Influence: 15.6] [Reference Citation Analysis]
177 Azer SA, Azer S. Bibliometric analysis of the top-cited gastroenterology and hepatology articles. BMJ Open 2016;6:e009889. [PMID: 26857105 DOI: 10.1136/bmjopen-2015-009889] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
178 Vemu B, Selvasubramanian S, Pandiyan V. Emu oil offers protection in Crohn's disease model in rats. BMC Complement Altern Med 2016;16:55. [PMID: 26852336 DOI: 10.1186/s12906-016-1035-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
179 Wang X, Jiang Y, Zhu Y, Zhang M, Li M, Wang H, Gao P. Circulating memory B cells and plasmablasts are associated with the levels of serum immunoglobulin in patients with ulcerative colitis. J Cell Mol Med 2016;20:804-14. [PMID: 26800315 DOI: 10.1111/jcmm.12728] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
180 Kim MJ, Lee WY, Choe YH. Expression of TIM-3, Human β-defensin-2, and FOXP3 and Correlation with Disease Activity in Pediatric Crohn's Disease with Infliximab Therapy. Gut Liver 2015;9:370-80. [PMID: 25071071 DOI: 10.5009/gnl13408] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
181 Eveson JW, Pring M. Oral Cavity. Pathology of the Head and Neck 2016. [DOI: 10.1007/978-3-662-49672-5_3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
182 Maroni L, van de Graaf SF, Hohenester SD, Oude Elferink RP, Beuers U. Fucosyltransferase 2: a genetic risk factor for primary sclerosing cholangitis and Crohn's disease--a comprehensive review. Clin Rev Allergy Immunol 2015;48:182-91. [PMID: 24828903 DOI: 10.1007/s12016-014-8423-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 5.7] [Reference Citation Analysis]
183 Kumar M, Hemalatha R, Nagpal R, Singh B, Parasannanavar D, Verma V, Kumar A, Marotta F, Catanzaro R, Cuffari B, Jain S, Bissi L, Yadav H. PROBIOTIC APPROACHES FOR TARGETING INFLAMMATORY BOWEL DISEASE: AN UPDATE ON ADVANCES AND OPPORTUNITIES IN MANAGING THE DISEASE. Int J Probiotics Prebiotics 2016;11:99-116. [PMID: 31452650] [Reference Citation Analysis]
184 Kaminski J. From Community Analysis to Prototype: Creating an Online Matchmaker for Inflammatory Bowel Disease Patients. Boundaryless Hospital 2016. [DOI: 10.1007/978-3-662-49012-9_17] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
185 Alkim C, Alkim H, Koksal AR, Boga S, Sen I. Angiogenesis in Inflammatory Bowel Disease. Int J Inflam 2015;2015:970890. [PMID: 26839731 DOI: 10.1155/2015/970890] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 6.1] [Reference Citation Analysis]
186 Maheshwari RA, Balaraman R, Sailor GU, Sen DB. Protective effect of simvastatin and rosuvastatin on trinitrobenzene sulfonic acid-induced colitis in rats. Indian J Pharmacol. 2015;47:17-21. [PMID: 25821305 DOI: 10.4103/0253-7613.150311] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
187 Kim HJ, Li H, Collins JJ, Ingber DE. Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip. Proc Natl Acad Sci USA. 2016;113:E7-15. [PMID: 26668389 DOI: 10.1073/pnas.1522193112] [Cited by in Crossref: 488] [Cited by in F6Publishing: 549] [Article Influence: 61.0] [Reference Citation Analysis]
188 Lv QK, Liu JX, Li SN, Gao YJ, Lv Y, Xu ZP, Huang BX, Xu SY, Yang DX, Zeng YL, Liu DF, Wang W. Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model. Int J Mol Sci 2015;16:26654-66. [PMID: 26561804 DOI: 10.3390/ijms161125985] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
189 Singh UP, Singh NP, Murphy EA, Price RL, Fayad R, Nagarkatti M, Nagarkatti PS. Chemokine and cytokine levels in inflammatory bowel disease patients. Cytokine. 2016;77:44-49. [PMID: 26520877 DOI: 10.1016/j.cyto.2015.10.008] [Cited by in Crossref: 162] [Cited by in F6Publishing: 143] [Article Influence: 20.3] [Reference Citation Analysis]
190 Tokieda S, Komori M, Ishiguro T, Iwakura Y, Takahara K, Inaba K. Dendritic cell immunoreceptor 1 alters neutrophil responses in the development of experimental colitis. BMC Immunol 2015;16:64. [PMID: 26497661 DOI: 10.1186/s12865-015-0129-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
191 Park JS, Yi TG, Park JM, Han YM, Kim JH, Shin DH, Tak SJ, Lee K, Lee YS, Jeon MS. Therapeutic effects of mouse bone marrow-derived clonal mesenchymal stem cells in a mouse model of inflammatory bowel disease. J Clin Biochem Nutr. 2015;57:192-203. [PMID: 26566304 DOI: 10.3164/jcbn.15-56] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
192 Engel T, Ben-Horin S, Beer-Gabel M. Autonomic Dysfunction Correlates with Clinical and Inflammatory Activity in Patients with Crohn's Disease. Inflamm Bowel Dis 2015;21:2320-6. [PMID: 26181429 DOI: 10.1097/MIB.0000000000000508] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
193 Can G, Ayvaz S, Can H, Demirtas S, Aksit H, Yilmaz B, Korkmaz U, Kurt M, Karaca T. The Syk Inhibitor Fostamatinib Decreases the Severity of Colonic Mucosal Damage in a Rodent Model of Colitis. J Crohns Colitis 2015;9:907-17. [PMID: 26116555 DOI: 10.1093/ecco-jcc/jjv114] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
194 Chivese T, Esterhuizen TM, Basson AR, Watermeyer G. The Influence of Second-Hand Cigarette Smoke Exposure during Childhood and Active Cigarette Smoking on Crohn's Disease Phenotype Defined by the Montreal Classification Scheme in a Western Cape Population, South Africa. PLoS One 2015;10:e0139597. [PMID: 26422615 DOI: 10.1371/journal.pone.0139597] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
195 El-shahat MA, Erfan OS. The possible protective effect of metformin on acute experimental colitis induced by dextran sodium sulfate in mice. The Egyptian Journal of Histology 2015;38:594-604. [DOI: 10.1097/01.ehx.0000470826.98340.1b] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
196 Adar T, Grisaru-Granovsky S, Ben Ya'acov A, Goldin E, Bar-Gil Shitrit A. Pregnancy and the Immune System: General Overview and the Gastroenterological Perspective. Dig Dis Sci 2015;60:2581-9. [PMID: 25947331 DOI: 10.1007/s10620-015-3683-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
197 Carpio D, Barreiro-de Acosta M, Echarri A, Pereira S, Castro J, Ferreiro R, Lorenzo A; EIGA Group (Grupo Gallego de Enfermedad Inflamatoria Intestinal). Influence of urban/rural and coastal/inland environment on the prevalence, phenotype, and clinical course of inflammatory bowel disease patients from northwest of Spain: a cross-sectional study. Eur J Gastroenterol Hepatol 2015;27:1030-7. [PMID: 26049704 DOI: 10.1097/MEG.0000000000000395] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
198 Robertson RC, Guihéneuf F, Bahar B, Schmid M, Stengel DB, Fitzgerald GF, Ross RP, Stanton C. The Anti-Inflammatory Effect of Algae-Derived Lipid Extracts on Lipopolysaccharide (LPS)-Stimulated Human THP-1 Macrophages. Mar Drugs 2015;13:5402-24. [PMID: 26308008 DOI: 10.3390/md13085402] [Cited by in Crossref: 100] [Cited by in F6Publishing: 105] [Article Influence: 12.5] [Reference Citation Analysis]
199 Delmondes LM, Nunes MO, Azevedo AR, Oliveira MM, Coelho LE, Torres-Neto JD. Clinical and Sociodemographic Aspects of Inflammatory Bowel Disease Patients. Gastroenterology Res. 2015;8:207-215. [PMID: 27785298 DOI: 10.14740/gr649w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
200 Morys JM, Kaczówka A, Jeżewska M. Assessment of selected psychological factors in patients with inflammatory bowel disease. Prz Gastroenterol 2016;11:47-53. [PMID: 27110311 DOI: 10.5114/pg.2015.52560] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
201 Yao J, Wei C, Wang JY, Zhang R, Li YX, Wang LS. Effect of resveratrol on Treg/Th17 signaling and ulcerative colitis treatment in mice. World J Gastroenterol 2015; 21(21): 6572-6581 [PMID: 26074695 DOI: 10.3748/wjg.v21.i21.6572] [Cited by in CrossRef: 64] [Cited by in F6Publishing: 67] [Article Influence: 8.0] [Reference Citation Analysis]
202 Baird AC, Lloyd F, Lawrance IC. Prostaglandin E₂ and polyenylphosphatidylcholine protect against intestinal fibrosis and regulate myofibroblast function. Dig Dis Sci 2015;60:1603-16. [PMID: 25630423 DOI: 10.1007/s10620-015-3552-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
203 Song JL, Choi JH, Seo JH, Lim YI, Park KY. Anti-colitic effects of kanjangs (fermented soy sauce and sesame sauce) in dextran sulfate sodium-induced colitis in mice. J Med Food 2014;17:1027-35. [PMID: 25188463 DOI: 10.1089/jmf.2013.3119] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
204 Zhang D, Wei C, Yao J, Cai X, Wang L. Interleukin-10 gene-carrying bifidobacteria ameliorate murine ulcerative colitis by regulating regulatory T cell/T helper 17 cell pathway. Exp Biol Med (Maywood) 2015;240:1622-9. [PMID: 25956685 DOI: 10.1177/1535370215584901] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
205 Sun H, Lou Y, Porturas T, Morrissey S, Luo G, Qi J, Ruan Q, Shi S, Chen YH. Exacerbated experimental colitis in TNFAIP8-deficient mice. J Immunol 2015;194:5736-42. [PMID: 25948814 DOI: 10.4049/jimmunol.1401986] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
206 Hasnat MA, Pervin M, Park SR, Jang YC, Lim JH, Kim YJ, Kim YO, Kweon HJ, Lim BO. Anti-inflammatory, counteractive, and preventive effects of orally administrated oat extracts on dextran sulfate sodium-induced colitis in mice. Food Sci Biotechnol 2015;24:619-628. [DOI: 10.1007/s10068-015-0081-4] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
207 Cicchitti L, Martelli M, Cerritelli F. Chronic inflammatory disease and osteopathy: a systematic review. PLoS One 2015;10:e0121327. [PMID: 25781621 DOI: 10.1371/journal.pone.0121327] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 4.8] [Reference Citation Analysis]
208 Moskaluk CA. Non-neoplastic diseases of the small and large intestines. Silverberg's Principles and Practice of Surgical Pathology and Cytopathology 2015. [DOI: 10.1017/9781139137201.027] [Reference Citation Analysis]
209 Dodda D, Chhajed R, Mishra J, Padhy M. Targeting oxidative stress attenuates trinitrobenzene sulphonic acid induced inflammatory bowel disease like symptoms in rats: role of quercetin. Indian J Pharmacol. 2014;46:286-291. [PMID: 24987175 DOI: 10.4103/0253-7613.132160] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
210 Zhang R, Gilbert S, Yao X, Vallance J, Steinbrecher K, Moriggl R, Zhang D, Eluri M, Chen H, Cao H, Shroyer N, Denson L, Han X. Natural compound methyl protodioscin protects against intestinal inflammation through modulation of intestinal immune responses. Pharmacol Res Perspect 2015;3:e00118. [PMID: 26038694 DOI: 10.1002/prp2.118] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
211 Gonçalves P, Magro F, Martel F. Metabolic inflammation in inflammatory bowel disease: crosstalk between adipose tissue and bowel. Inflamm Bowel Dis 2015;21:453-67. [PMID: 25248003 DOI: 10.1097/MIB.0000000000000209] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 7.0] [Reference Citation Analysis]
212 Castangia I, Nácher A, Caddeo C, Merino V, Díez-Sales O, Catalán-Latorre A, Fernàndez-Busquets X, Fadda AM, Manconi M. Therapeutic efficacy of quercetin enzyme-responsive nanovesicles for the treatment of experimental colitis in rats. Acta Biomater 2015;13:216-27. [PMID: 25463498 DOI: 10.1016/j.actbio.2014.11.017] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 6.8] [Reference Citation Analysis]
213 Kim H, Mo J, Alam KJ, Park W, Kim KY, Chae S. Identification of the Polymorphisms in IFITM2 and IFITM5 Genes and their Association with Ulcerative Colitis. Journal of Life Science 2015;25:84-92. [DOI: 10.5352/jls.2015.25.1.84] [Reference Citation Analysis]
214 Osada T, Watanabe S. Current Treatment Options for Inflammatory Bowel Diseases and Future Perspectives. Juntendo Medical Journal 2015;61:588-596. [DOI: 10.14789/jmj.61.588] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
215 Lan A, Blachier F, Benamouzig R, Beaumont M, Barrat C, Coelho D, Lancha A Jr, Kong X, Yin Y, Marie JC, Tomé D. Mucosal healing in inflammatory bowel diseases: is there a place for nutritional supplementation? Inflamm Bowel Dis 2015;21:198-207. [PMID: 25208104 DOI: 10.1097/MIB.0000000000000177] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
216 Shi Y, Rupa P, Jiang B, Mine Y. Hydrolysate from eggshell membrane ameliorates intestinal inflammation in mice. Int J Mol Sci 2014;15:22728-42. [PMID: 25501329 DOI: 10.3390/ijms151222728] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
217 Spisni E, Valerii MC, De Fazio L, Cavazza E, Borsetti F, Sgromo A, Candela M, Centanni M, Rizello F, Strillacci A. Cyclooxygenase-2 silencing for the treatment of colitis: a combined in vivo strategy based on RNA interference and engineered Escherichia coli. Mol Ther 2015;23:278-89. [PMID: 25393372 DOI: 10.1038/mt.2014.222] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
218 Yu FY, Huang SG, Zhang HY, Ye H, Chi HG, Zou Y, Lv RX, Zheng XB. Effects of baicalin in CD4 + CD29 + T cell subsets of ulcerative colitis patients. World J Gastroenterol 2014; 20(41): 15299-15309 [PMID: 25386078 DOI: 10.3748/wjg.v20.i41.15299] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
219 Maisel K, Ensign L, Reddy M, Cone R, Hanes J. Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse. J Control Release. 2015;197:48-57. [PMID: 25449804 DOI: 10.1016/j.jconrel.2014.10.026] [Cited by in Crossref: 225] [Cited by in F6Publishing: 229] [Article Influence: 25.0] [Reference Citation Analysis]
220 Miranda-Bautista J, Padilla-Suárez C, Bouza E, Muñoz P, Menchén L, Marín-Jiménez I. Listeria monocytogenes infection in inflammatory bowel disease patients: case series and review of the literature. Eur J Gastroenterol Hepatol 2014;26:1247-52. [PMID: 25171025 DOI: 10.1097/MEG.0000000000000188] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
221 Jung Y, Rothenberg ME. Roles and regulation of gastrointestinal eosinophils in immunity and disease. J Immunol. 2014;193:999-1005. [PMID: 25049430 DOI: 10.4049/jimmunol.1400413] [Cited by in Crossref: 86] [Cited by in F6Publishing: 88] [Article Influence: 9.6] [Reference Citation Analysis]
222 Dou W, Zhang J, Ren G, Ding L, Sun A, Deng C, Wu X, Wei X, Mani S, Wang Z. Mangiferin attenuates the symptoms of dextran sulfate sodium-induced colitis in mice via NF-κB and MAPK signaling inactivation. Int Immunopharmacol 2014;23:170-8. [PMID: 25194678 DOI: 10.1016/j.intimp.2014.08.025] [Cited by in Crossref: 92] [Cited by in F6Publishing: 88] [Article Influence: 10.2] [Reference Citation Analysis]
223 Brennan FR. Monoclonal Antibodies in Phase 1 and 2 Studies for Immunological Disorders. Handbook of Therapeutic Antibodies 2014. [DOI: 10.1002/9783527682423.ch30] [Reference Citation Analysis]
224 Zurita-Turk M, Del Carmen S, Santos AC, Pereira VB, Cara DC, Leclercq SY, de LeBlanc Ad, Azevedo V, Chatel JM, LeBlanc JG, Miyoshi A. Lactococcus lactis carrying the pValac DNA expression vector coding for IL-10 reduces inflammation in a murine model of experimental colitis. BMC Biotechnol 2014;14:73. [PMID: 25106058 DOI: 10.1186/1472-6750-14-73] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
225 Rana SV, Sharma S, Kaur J, Prasad KK, Sinha SK, Kochhar R, Malik A, Morya RK. Relationship of cytokines, oxidative stress and GI motility with bacterial overgrowth in ulcerative colitis patients. J Crohns Colitis 2014;8:859-65. [PMID: 24456736 DOI: 10.1016/j.crohns.2014.01.007] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
226 Cianci R, Frosali S, Pagliari D, Cesaro P, Petruzziello L, Casciano F, Landolfi R, Costamagna G, Pandolfi F. Uncomplicated diverticular disease: innate and adaptive immunity in human gut mucosa before and after rifaximin. J Immunol Res. 2014;2014:696812. [PMID: 25133198 DOI: 10.1155/2014/696812] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
227 Sahin A, Calhan T, Cengiz M, Kahraman R, Aydin K, Ozdil K, Korachi M, Sokmen HM. Serum interleukin 17 levels in patients with Crohn's disease: real life data. Dis Markers 2014;2014:690853. [PMID: 25140070 DOI: 10.1155/2014/690853] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
228 Narumiya S. Physiology and pathophysiology of prostanoid receptors. Proc Jpn Acad Ser B Phys Biol Sci 2007;83:296-319. [PMID: 24367153 DOI: 10.2183/pjab/83.296] [Cited by in F6Publishing: 19] [Reference Citation Analysis]
229 Wong L, Hutson PR, Bushman W. Prostatic inflammation induces fibrosis in a mouse model of chronic bacterial infection. PLoS One 2014;9:e100770. [PMID: 24950301 DOI: 10.1371/journal.pone.0100770] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 4.6] [Reference Citation Analysis]
230 Nahidi L, Day AS, Lemberg DA, Leach ST. Paediatric inflammatory bowel disease: a mechanistic approach to investigate exclusive enteral nutrition treatment. Scientifica (Cairo) 2014;2014:423817. [PMID: 24967146 DOI: 10.1155/2014/423817] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
231 Arab HH, Al-Shorbagy MY, Abdallah DM, Nassar NN. Telmisartan attenuates colon inflammation, oxidative perturbations and apoptosis in a rat model of experimental inflammatory bowel disease. PLoS One. 2014;9:e97193. [PMID: 24831514 DOI: 10.1371/journal.pone.0097193] [Cited by in Crossref: 81] [Cited by in F6Publishing: 88] [Article Influence: 9.0] [Reference Citation Analysis]
232 Bhullar M, Macrae F, Brown G, Smith M, Sharpe K. Prediction of Crohn’s disease aggression through NOD2/CARD15 gene sequencing in an Australian cohort. World J Gastroenterol 2014; 20(17): 5008-5016 [PMID: 24803813 DOI: 10.3748/wjg.v20.i17.5008] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
233 Wen XD, Wang CZ, Yu C, Zhang Z, Calway T, Wang Y, Li P, Yuan CS. Salvia miltiorrhiza (dan shen) significantly ameliorates colon inflammation in dextran sulfate sodium induced colitis. Am J Chin Med 2013;41:1097-108. [PMID: 24117071 DOI: 10.1142/S0192415X13500742] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 4.3] [Reference Citation Analysis]
234 Li P, Liang ML, Zhu Y, Gong YY, Wang Y, Heng D, Lin L. Resveratrol inhibits collagen I synthesis by suppressing IGF-1R activation in intestinal fibroblasts. World J Gastroenterol 2014; 20(16): 4648-4661 [PMID: 24782617 DOI: 10.3748/wjg.v20.i16.4648] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
235 Balfour Sartor R. Role of Commensal Enteric Bacteria in Intestinal Inflammation: Lessons from Animal Models. Microbial Pathogenesis and the Intestinal Epithelial Cell 2014. [DOI: 10.1128/9781555817848.ch13] [Reference Citation Analysis]
236 Miao XP, Ouyang Q, Li HY, Wen ZH, Zhang DK, Cui XY. Role of selective cyclooxygenase-2 inhibitors in exacerbation of inflammatory bowel disease: A systematic review and meta-analysis. Curr Ther Res Clin Exp 2008;69:181-91. [PMID: 24692797 DOI: 10.1016/j.curtheres.2008.06.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
237 St-Pierre J, Chadee K. How the discovery of TNF-α has advanced gastrointestinal diseases and treatment regimes. Dig Dis Sci 2014;59:712-5. [PMID: 24504593 DOI: 10.1007/s10620-014-3042-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
238 Voudoukis E, Karmiris K, Koutroubakis IE. Multipotent role of platelets in inflammatory bowel diseases: A clinical approach. World J Gastroenterol 2014; 20(12): 3180-3190 [PMID: 24696603 DOI: 10.3748/wjg.v20.i12.3180] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 64] [Article Influence: 6.7] [Reference Citation Analysis]
239 Breganó J, Dichi I. Inflammatory Bowel Disease. Role of Oxidative Stress in Chronic Diseases 2014. [DOI: 10.1201/b16653-25] [Reference Citation Analysis]
240 Yoshino T, Nakase H, Minami N, Yamada S, Matsuura M, Yazumi S, Chiba T. Efficacy and safety of granulocyte and monocyte adsorption apheresis for ulcerative colitis: a meta-analysis. Dig Liver Dis 2014;46:219-26. [PMID: 24268950 DOI: 10.1016/j.dld.2013.10.011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
241 Minaiyan M, Ghassemi-Dehkordi N, Mahzouni P, Ahmadi NS. Anti-inflammatory effect of Helichrysum oligocephalum DC extract on acetic acid - Induced acute colitis in rats. Adv Biomed Res. 2014;3:87. [PMID: 24761395 DOI: 10.4103/2277-9175.128000] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
242 Nunes T, Bernardazzi C, de Souza HS. Interleukin-33 and inflammatory bowel diseases: lessons from human studies. Mediators Inflamm. 2014;2014:423957. [PMID: 24701033 DOI: 10.1155/2014/423957] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
243 Malekinejad H, Shafie-Irannejad V, Hobbenaghi R, Tabatabaie SH, Moshtaghion SM. Comparative protective effect of hawthorn berry hydroalcoholic extract, atorvastatin, and mesalamine on experimentally induced colitis in rats. J Med Food 2013;16:593-601. [PMID: 23875899 DOI: 10.1089/jmf.2012.2672] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
244 Johansson ME, Gustafsson JK, Holmén-Larsson J, Jabbar KS, Xia L, Xu H, Ghishan FK, Carvalho FA, Gewirtz AT, Sjövall H, Hansson GC. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut 2014;63:281-91. [PMID: 23426893 DOI: 10.1136/gutjnl-2012-303207] [Cited by in Crossref: 565] [Cited by in F6Publishing: 545] [Article Influence: 62.8] [Reference Citation Analysis]
245 Itagaki M, Saruta M, Saijo H, Mitobe J, Arihiro S, Matsuoka M, Kato T, Ikegami M, Tajiri H. Efficacy of zinc-carnosine chelate compound, Polaprezinc, enemas in patients with ulcerative colitis. Scand J Gastroenterol 2014;49:164-72. [PMID: 24286534 DOI: 10.3109/00365521.2013.863963] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
246 Ono K, Nimura S, Nishinakagawa T, Hideshima Y, Enjyoji M, Nabeshima K, Nakashima M. Sodium 4-phenylbutyrate suppresses the development of dextran sulfate sodium-induced colitis in mice. Exp Ther Med 2014;7:573-8. [PMID: 24520247 DOI: 10.3892/etm.2013.1456] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
247 He Q, Wang L, Wang F, Wang C, Tang C, Li Q, Li J, Zhao Q. Microbial fingerprinting detects intestinal microbiota dysbiosis in zebrafish models with chemically-induced enterocolitis. BMC Microbiology. 2013;13:289. [PMID: 24325678 DOI: 10.1186/1471-2180-13-289] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 4.2] [Reference Citation Analysis]
248 Liu X, Beaumont M, Walker F, Chaumontet C, Andriamihaja M, Matsumoto H, Khodorova N, Lan A, Gaudichon C, Benamouzig R, Tomé D, Davila AM, Marie JC, Blachier F. Beneficial effects of an amino acid mixture on colonic mucosal healing in rats. Inflamm Bowel Dis 2013;19:2895-905. [PMID: 24193156 DOI: 10.1097/01.MIB.0000435849.17263.c5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
249 Tavano F, Palmieri O, di Mola FF, Latiano A, Burbaci FP, Valvano MR, Corritore G, Augello B, Merla G, Annese V, Andriulli A, di Sebastiano P. Genetic variants of membrane metallopeptidase genes in inflammatory bowel diseases. Dig Liver Dis 2013;45:1003-10. [PMID: 23827863 DOI: 10.1016/j.dld.2013.05.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
250 Algaba A, Linares PM, Fernández-Contreras ME, Ordoñez A, Trápaga J, Guerra I, Chaparro M, de la Poza G, Gisbert JP, Bermejo F. Relationship between levels of angiogenic and lymphangiogenic factors and the endoscopic, histological and clinical activity, and acute-phase reactants in patients with inflammatory bowel disease. J Crohns Colitis 2013;7:e569-79. [PMID: 23642997 DOI: 10.1016/j.crohns.2013.04.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
251 Chhaya V, Pollok R. The impact of thiopurines on surgical outcomes in inflammatory bowel disease: do they make a difference? F1000Prime Rep 2013;5:50. [PMID: 24273651 DOI: 10.12703/P5-50] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
252 Liu M, Boussetta T, Makni-Maalej K, Fay M, Driss F, El-Benna J, Lagarde M, Guichardant M. Protectin DX, a double lipoxygenase product of DHA, inhibits both ROS production in human neutrophils and cyclooxygenase activities. Lipids 2014;49:49-57. [PMID: 24254970 DOI: 10.1007/s11745-013-3863-6] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 5.2] [Reference Citation Analysis]
253 Principi M, Giorgio F, Losurdo G, Neve V, Contaldo A, Di Leo A, Ierardi E. Fibrogenesis and fibrosis in inflammatory bowel diseases: Good and bad side of same coin? World J Gastrointest Pathophysiol 2013; 4(4): 100-107 [PMID: 24244878 DOI: 10.4291/wjgp.v4.i4.100] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
254 Uddin MJ, Jeong SO, Zheng M, Chen Y, Cho GJ, Chung HT, Joe Y. Carbon monoxide attenuates dextran sulfate sodium-induced colitis via inhibition of GSK-3β signaling. Oxid Med Cell Longev. 2013;2013:210563. [PMID: 24349609 DOI: 10.1155/2013/210563] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
255 Nahidi L, Leach ST, Lemberg DA, Day AS. Osteoprotegerin exerts its pro-inflammatory effects through nuclear factor-κB activation. Dig Dis Sci 2013;58:3144-55. [PMID: 24048682 DOI: 10.1007/s10620-013-2851-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
256 Wen XD, Wang CZ, Yu C, Zhao L, Zhang Z, Matin A, Wang Y, Li P, Xiao SY, Du W, He TC, Yuan CS. Panax notoginseng attenuates experimental colitis in the azoxymethane/dextran sulfate sodium mouse model. Phytother Res. 2014;28:892-898. [PMID: 24142591 DOI: 10.1002/ptr.5066] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
257 Mo JS, Na KS, Yu JI, Chae SC. Identification of the polymorphisms in IFITM1 gene and their association in a Korean population with ulcerative colitis. Immunol Lett 2013;156:118-22. [PMID: 24120510 DOI: 10.1016/j.imlet.2013.09.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
258 Mimura S, Ando T, Ishiguro K, Maeda O, Watanabe O, Ujihara M, Hirayama Y, Morise K, Maeda K, Matsushita M, Funasaka K, Nakamura M, Miyahara R, Ozaki N, Goto H. Dipeptidyl peptidase-4 inhibitor anagliptin facilitates restoration of dextran sulfate sodium-induced colitis. Scand J Gastroenterol 2013;48:1152-9. [PMID: 24047394 DOI: 10.3109/00365521.2013.832366] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
259 Hausmann M, Rechsteiner T, Caj M, Benden C, Fried M, Boehler A, Rogler G. A new heterotopic transplant animal model of intestinal fibrosis. Inflamm Bowel Dis 2013;19:2302-14. [PMID: 24013360 DOI: 10.1097/MIB.0b013e3182a6a0f3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
260 Nunes T, Etchevers MJ, Domènech E, García-Sánchez V, Ber Y, Peñalva M, Merino O, Nos P, Garcia-Planella E, Casbas AG, Esteve M, Taxonera Samsó C, Montoro Huguet M, Gisbert JP, Martín Arranz MD, García-Sepulcre MF, Barreiro-de Acosta M, Beltrán B, Alcaide Suárez N, Saro Gismera C, Cabriada JL, Cañas-Ventura A, Gomollón F, Panés J; Tobacco-Eneida Study Group of GETECCU. Smoking does influence disease behaviour and impacts the need for therapy in Crohn's disease in the biologic era. Aliment Pharmacol Ther 2013;38:752-60. [PMID: 23980933 DOI: 10.1111/apt.12440] [Cited by in Crossref: 59] [Cited by in F6Publishing: 40] [Article Influence: 5.9] [Reference Citation Analysis]
261 Aktaş B, Altınbaş A, Başar O, Yılmaz B, Ekiz F, Giniş Z, Oztürk G, Coban S, Tuna Y, Uçar E, Erarslan E, Yüksel O. Serum m 30 levels reflects ulcerative colitis activity. Inflamm Bowel Dis 2013;19:2400-3. [PMID: 23945185 DOI: 10.1097/MIB.0b013e3182a0ea38] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
262 Yu Q, Zhu S, Zhou R, Yi F, Bing Y, Huang S, Wang Z, Wang C, Xia B. Effects of sinomenine on the expression of microRNA-155 in 2,4,6-trinitrobenzenesulfonic acid-induced colitis in mice. PLoS One 2013;8:e73757. [PMID: 24066068 DOI: 10.1371/journal.pone.0073757] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
263 Gonçalves CC, Hernandes L, Bersani-Amado CA, Franco SL, Silva JF, Natali MR. Use of propolis hydroalcoholic extract to treat colitis experimentally induced in rats by 2,4,6-trinitrobenzenesulfonic Acid. Evid Based Complement Alternat Med 2013;2013:853976. [PMID: 24101941 DOI: 10.1155/2013/853976] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
264 Rana SV, Sharma S, Malik A, Kaur J, Prasad KK, Sinha SK, Singh K. Small intestinal bacterial overgrowth and orocecal transit time in patients of inflammatory bowel disease. Dig Dis Sci 2013;58:2594-8. [PMID: 23649377 DOI: 10.1007/s10620-013-2694-x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 7.0] [Reference Citation Analysis]
265 Yang C, Chen X, Yang G. Inflammation-Induced Esophageal and Colon Adenocarcinoma Formation in Animal Models. Inflammation, Oxidative Stress, and Cancer 2013. [DOI: 10.1201/b15323-5] [Reference Citation Analysis]
266 Chakilam S, Gandesiri M, Rau TT, Agaimy A, Vijayalakshmi M, Ivanovska J, Wirtz RM, Schulze-Luehrmann J, Benderska N, Wittkopf N, Chellappan A, Ruemmele P, Vieth M, Rave-Fränk M, Christiansen H, Hartmann A, Neufert C, Atreya R, Becker C, Steinberg P, Schneider-Stock R. Death-associated protein kinase controls STAT3 activity in intestinal epithelial cells. Am J Pathol 2013;182:1005-20. [PMID: 23438478 DOI: 10.1016/j.ajpath.2012.11.026] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
267 Nahidi L, Leach ST, Mitchell HM, Kaakoush NO, Lemberg DA, Munday JS, Huinao K, Day AS. Inflammatory bowel disease therapies and gut function in a colitis mouse model. Biomed Res Int. 2013;2013:909613. [PMID: 24027765 DOI: 10.1155/2013/909613] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
268 Banerjee R, Balaji M, Sasikala M, Anuradha S, Rao GV, Nageshwar Reddy D. Granulomas of intestinal tuberculosis and Crohn's disease can be differentiated by CD73 cell surface marker expression: a pilot study. Dig Dis Sci 2013;58:2301-7. [PMID: 23625284 DOI: 10.1007/s10620-013-2667-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
269 Al-Dasooqi N, Sonis ST, Bowen JM, Bateman E, Blijlevens N, Gibson RJ, Logan RM, Nair RG, Stringer AM, Yazbeck R, Elad S, Lalla RV; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Emerging evidence on the pathobiology of mucositis. Support Care Cancer 2013;21:3233-41. [PMID: 23842598 DOI: 10.1007/s00520-013-1900-x] [Cited by in Crossref: 86] [Cited by in F6Publishing: 89] [Article Influence: 8.6] [Reference Citation Analysis]
270 Al-Mofarreh MA, Al-Mofleh IA. Emerging inflammatory bowel disease in saudi outpatients: a report of 693 cases. Saudi J Gastroenterol. 2013;19:16-22. [PMID: 23319033 DOI: 10.4103/1319-3767.105915] [Cited by in Crossref: 21] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
271 Motavallian A, Minaiyan M, Rabbani M, Andalib S, Mahzouni P. Involvement of 5HT3 Receptors in Anti-Inflammatory Effects of Tropisetron on Experimental TNBS-Induced Colitis in Rat. Bioimpacts. 2013;3:169-176. [PMID: 24455480 DOI: 10.5681/bi.2013.021] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
272 Finnberg NK, Liu Y, El-Deiry WS. Detection of DSS-induced gastrointestinal mucositis in mice by non-invasive optical near-infrared (NIR) imaging of cathepsin activity. Cancer Biol Ther. 2013;14:736-741. [PMID: 23792573 DOI: 10.4161/cbt.25094] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
273 Hasegawa A, Iwamura C, Kitajima M, Hashimoto K, Otsuyama K, Ogino H, Nakayama T, Shirai M. Crucial role for CD69 in the pathogenesis of dextran sulphate sodium-induced colitis. PLoS One 2013;8:e65494. [PMID: 23785429 DOI: 10.1371/journal.pone.0065494] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
274 Huang YT, Wen CC, Chen YH, Huang WC, Huang LT, Lin WC, Arulselvan P, Liao JW, Lin SH, Hsiao PW, Kuo SC, Yang NS. Dietary uptake of Wedelia chinensis extract attenuates dextran sulfate sodium-induced colitis in mice. PLoS One 2013;8:e64152. [PMID: 23734189 DOI: 10.1371/journal.pone.0064152] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
275 Smyth CM, Akasheh N, Woods S, Kay E, Morgan RK, Thornton MA, O'Grady A, Cummins R, Sheils O, Smyth P, Gleich GJ, Murray FM, Costello RW. Activated eosinophils in association with enteric nerves in inflammatory bowel disease. PLoS One 2013;8:e64216. [PMID: 23717571 DOI: 10.1371/journal.pone.0064216] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
276 Scaldaferri F, Petito V, Lopetuso L, Bruno G, Gerardi V, Ianiro G, Sgambato A, Gasbarrini A, Cammarota G. Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives. Mediators Inflamm 2013;2013:391473. [PMID: 23737647 DOI: 10.1155/2013/391473] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
277 Liao CM, Zimmer MI, Wang CR. The functions of type I and type II natural killer T cells in inflammatory bowel diseases. Inflamm Bowel Dis 2013;19:1330-8. [PMID: 23518808 DOI: 10.1097/MIB.0b013e318280b1e3] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 4.0] [Reference Citation Analysis]
278 Al-Dasooqi N, Sonis ST, Bowen JM, Bateman E, Blijlevens N, Gibson RJ, Logan RM, Nair RG, Stringer AM, Yazbeck R, Elad S, Lalla RV; Mucositis Study Group of Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Emerging evidence on the pathobiology of mucositis. Support Care Cancer 2013;21:2075-83. [PMID: 23604521 DOI: 10.1007/s00520-013-1810-y] [Cited by in Crossref: 96] [Cited by in F6Publishing: 82] [Article Influence: 9.6] [Reference Citation Analysis]
279 McDermott E, Murphy S, Keegan D, O'Donoghue D, Mulcahy H, Doherty G. Efficacy of Adalimumab as a long term maintenance therapy in ulcerative colitis. J Crohns Colitis 2013;7:150-3. [PMID: 22520592 DOI: 10.1016/j.crohns.2012.03.016] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
280 Hozumi H, Hokari R, Kurihara C, Narimatsu K, Sato H, Sato S, Ueda T, Higashiyama M, Okada Y, Watanabe C, Komoto S, Tomita K, Kawaguchi A, Nagao S, Miura S. Endoscopic finding of spontaneous hemorrhage correlates with tumor necrosis factor alpha expression in colonic mucosa of patients with ulcerative colitis. Int J Colorectal Dis 2013;28:1049-55. [PMID: 23377880 DOI: 10.1007/s00384-013-1654-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
281 Zanin V, Segat L, Bianco AM, Padovan L, Tavares Nde A, Crovella S. DEFB1 gene 5' untranslated region (UTR) polymorphisms in inflammatory bowel diseases. Clinics (Sao Paulo) 2012;67:395-8. [PMID: 22522766 DOI: 10.6061/clinics/2012(04)14] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
282 Denis MC, Furtos A, Dudonné S, Montoudis A, Garofalo C, Desjardins Y, Delvin E, Levy E. Apple peel polyphenols and their beneficial actions on oxidative stress and inflammation. PLoS One 2013;8:e53725. [PMID: 23372666 DOI: 10.1371/journal.pone.0053725] [Cited by in Crossref: 88] [Cited by in F6Publishing: 90] [Article Influence: 8.8] [Reference Citation Analysis]
283 Choi EW. Experimental (Preclinical) Studies and Clinical Trials of Adipose Tissue-Derived Mesenchymal Stem Cells for Autoimmune Diseases. Stem Cells and Cancer Stem Cells, Volume 10 2013. [DOI: 10.1007/978-94-007-6262-6_2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
284 Vinolo M, Rodrigues H, Nachbar R, Curi R. Modulation of inflammatory and immune responses by short-chain fatty acids. Diet, Immunity and Inflammation 2013. [DOI: 10.1533/9780857095749.3.435] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
285 Zhu XC, Macdermott RP. A Primer on IBD: Phenotypes, Diagnosis, Treatment, and Clinical Challenges. Molecular Genetics of Inflammatory Bowel Disease 2013. [DOI: 10.1007/978-1-4614-8256-7_1] [Reference Citation Analysis]
286 El-darouti MA. Different Granulomatous and Pustular Skin Lesions Caused by One Underlying Disorder. Challenging Cases in Dermatology 2013. [DOI: 10.1007/978-1-4471-4249-2_88] [Reference Citation Analysis]
287 Nunes T, Etchevers MJ, Merino O, Gallego S, García-Sánchez V, Marín-Jiménez I, Menchén L, Barreiro-de Acosta M, Bastida G, García S, Gento E, Ginard D, Gomollón F, Arroyo M, Monfort D, García-Planella E, Gonzalez B, Loras C, Agustí C, Figueroa C, Sans M; TABACROHN Study Group of GETECCU, Spanish Working Group in Crohn's Disease and Ulcerative Colitis. Does smoking influence Crohn's disease in the biologic era? The TABACROHN study. Inflamm Bowel Dis 2013;19:23-9. [PMID: 22467185 DOI: 10.1002/ibd.22959] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
288 Valdez-morales E, Guerrero-alba R, Ochoa-cortes F, Benson J, Spreadbury I, Hurlbut D, Miranda-morales M, Lomax AE, Vanner S. Release of endogenous opioids during a chronic IBD model suppresses the excitability of colonic DRG neurons. Neurogastroenterology & Motility 2013;25:39-e4. [DOI: 10.1111/nmo.12008] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
289 Al-dasooqi N, Keefe DM, Keefe DM, Sonis ST. Mucositis. Pathobiology of Cancer Regimen-Related Toxicities 2013. [DOI: 10.1007/978-1-4614-5438-0_7] [Reference Citation Analysis]
290 Wolowczuk I, Pariente B, Allez M, Chamaillard M. IL17 and/or IL22 as Potential Target(s) for Crohn’s Disease. IL-17, IL-22 and Their Producing Cells: Role in Inflammation and Autoimmunity 2013. [DOI: 10.1007/978-3-0348-0522-3_20] [Reference Citation Analysis]
291 Nishiyama Y, Kataoka T, Yamato K, Taguchi T, Yamaoka K. Suppression of dextran sulfate sodium-induced colitis in mice by radon inhalation. Mediators Inflamm 2012;2012:239617. [PMID: 23365486 DOI: 10.1155/2012/239617] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 4.5] [Reference Citation Analysis]
292 Chen L, Lin MJ, Zhan LL, Lv XP. Analysis of TLR4 and TLR2 polymorphisms in inflammatory bowel disease in a Guangxi Zhuang population. World J Gastroenterol 2012; 18(46): 6856-6860 [PMID: 23239925 DOI: 10.3748/wjg.v18.i46.6856] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
293 Ludwig K, Fassan M, Mescoli C, Pizzi M, Balistreri M, Albertoni L, Pucciarelli S, Scarpa M, Sturniolo GC, Angriman I. PDCD4/miR-21 dysregulation in inflammatory bowel disease-associated carcinogenesis. Virchows Arch. 2013;462:57-63. [PMID: 23224068 DOI: 10.1007/s00428-012-1345-5] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 4.4] [Reference Citation Analysis]
294 Erickson AR, Cantarel BL, Lamendella R, Darzi Y, Mongodin EF, Pan C, Shah M, Halfvarson J, Tysk C, Henrissat B. Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn’s disease. PLoS One. 2012;7:e49138. [PMID: 23209564 DOI: 10.1371/journal.pone.0049138] [Cited by in Crossref: 321] [Cited by in F6Publishing: 329] [Article Influence: 29.2] [Reference Citation Analysis]
295 Majumdar D, Tiernan JP, Lobo AJ, Evans CA, Corfe BM. Keratins in colorectal epithelial function and disease. Int J Exp Pathol 2012;93:305-18. [PMID: 22974212 DOI: 10.1111/j.1365-2613.2012.00830.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
296 Cho MK, Park MK, Kang SA, Choi SH, Ahn SC, Yu HS. Trichinella spiralis infection suppressed gut inflammation with CD4(+)CD25(+)Foxp3(+) T cell recruitment. Korean J Parasitol 2012;50:385-90. [PMID: 23230342 DOI: 10.3347/kjp.2012.50.4.385] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
297 Desreumaux P, Foussat A, Allez M, Beaugerie L, Hébuterne X, Bouhnik Y, Nachury M, Brun V, Bastian H, Belmonte N, Ticchioni M, Duchange A, Morel-Mandrino P, Neveu V, Clerget-Chossat N, Forte M, Colombel JF. Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease. Gastroenterology 2012;143:1207-1217.e2. [PMID: 22885333 DOI: 10.1053/j.gastro.2012.07.116] [Cited by in Crossref: 244] [Cited by in F6Publishing: 259] [Article Influence: 22.2] [Reference Citation Analysis]
298 Courreges MC, Kantake N, Goetz DJ, Schwartz FL, McCall KD. Phenylmethimazole blocks dsRNA-induced IRF3 nuclear translocation and homodimerization. Molecules 2012;17:12365-77. [PMID: 23090018 DOI: 10.3390/molecules171012365] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
299 Zhang DK, Yu JJ, Li YM, Wei LN, Yu Y, Feng YH, Wang X. A Picrorhiza kurroa derivative, picroliv, attenuates the development of dextran-sulfate-sodium-induced colitis in mice. Mediators Inflamm. 2012;2012:751629. [PMID: 23125487 DOI: 10.1155/2012/751629] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
300 Millán Scheiding M, Rodriguez Moranta F, Kreisler Moreno E, Golda T, Fraccalvieri D, Biondo S. [Current status of elective surgical treatment of ulcerative colitis. A systematic review]. Cir Esp 2012;90:548-57. [PMID: 23063060 DOI: 10.1016/j.ciresp.2012.07.019] [Reference Citation Analysis]
301 La Scaleia R, Stoppacciaro A, Oliva S, Morrone S, Di Nardo G, Santoni A, Cucchiara S, Palmieri G. NKG2D/Ligand dysregulation and functional alteration of innate immunity cell populations in pediatric IBD. Inflamm Bowel Dis 2012;18:1910-22. [PMID: 22294522 DOI: 10.1002/ibd.22899] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
302 Iwasa T, Ogino H, Nakamura K, Ihara E, Akiho H, Takayanagi R. Feeding administration of Daikenchuto suppresses colitis induced by naive CD4+ T cell transfer into SCID mice. Dig Dis Sci 2012;57:2571-9. [PMID: 22610884 DOI: 10.1007/s10620-012-2218-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
303 Groβ P, Doser K, Falk W, Obermeier F, Hofmann C. IL-33 attenuates development and perpetuation of chronic intestinal inflammation. Inflamm Bowel Dis 2012;18:1900-9. [PMID: 22508383 DOI: 10.1002/ibd.22900] [Cited by in Crossref: 82] [Cited by in F6Publishing: 82] [Article Influence: 7.5] [Reference Citation Analysis]
304 Katsurada T, Kobayashi W, Tomaru U, Baba T, Furukawa S, Ishizu A, Takeda K, Sakamoto N, Asaka M, Takeda H, Kasahara M. Decrease of peripheral and intestinal NKG2A-positive T cells in patients with ulcerative colitis. PLoS One 2012;7:e44113. [PMID: 22970169 DOI: 10.1371/journal.pone.0044113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
305 Poudyal D, Cui X, Mai Le P, Davis T, Hofseth AB, Jin Y, Chumanevich AA, Wargovich MJ, Nagarkatti M, Nagarkatti PS. A limited role of p53 on the ability of a Hexane fraction of American ginseng to suppress mouse colitis. J Biomed Biotechnol. 2012;2012:785739. [PMID: 22899889 DOI: 10.1155/2012/785739] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
306 Zimmerman MA, Rahman NT, Yang D, Lahat G, Lazar AJ, Pollock RE, Lev D, Liu K. Unphosphorylated STAT1 promotes sarcoma development through repressing expression of Fas and bad and conferring apoptotic resistance. Cancer Res 2012;72:4724-32. [PMID: 22805310 DOI: 10.1158/0008-5472.CAN-12-1347] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
307 D'Argenio G, Mazzone G, Tuccillo C, Ribecco MT, Graziani G, Gravina AG, Caserta S, Guido S, Fogliano V, Caporaso N, Romano M. Apple polyphenols extract (APE) improves colon damage in a rat model of colitis. Dig Liver Dis 2012;44:555-62. [PMID: 22381211 DOI: 10.1016/j.dld.2012.01.009] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 3.6] [Reference Citation Analysis]
308 Yu JI, Kang IH, Seo GS, Choi SC, Yun KJ, Chae SC. Promoter polymorphism of the EED gene is associated with the susceptibility to ulcerative colitis. Dig Dis Sci 2012;57:1537-43. [PMID: 22271413 DOI: 10.1007/s10620-012-2045-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
309 Choi I, Kim Y, Kee J, Kim M, Lee D, Cho S, Ko J, Kim D, Jeon Y, Yoon C, Park Y, Um J, Hong S. Mori Folium regulates DSS-induced ulcerative colitis in mice and cytokine production in mast cells. Orient Pharm Exp Med 2012;12:107-111. [DOI: 10.1007/s13596-012-0055-5] [Reference Citation Analysis]
310 Ismail Y, Mahendran V, Octavia S, Day AS, Riordan SM, Grimm MC, Lan R, Lemberg D, Tran TA, Zhang L. Investigation of the enteric pathogenic potential of oral Campylobacter concisus strains isolated from patients with inflammatory bowel disease. PLoS One 2012;7:e38217. [PMID: 22666490 DOI: 10.1371/journal.pone.0038217] [Cited by in Crossref: 55] [Cited by in F6Publishing: 60] [Article Influence: 5.0] [Reference Citation Analysis]
311 Suárez J, Romero-Zerbo Y, Márquez L, Rivera P, Iglesias M, Bermúdez-Silva FJ, Andreu M, Rodríguez de Fonseca F. Ulcerative colitis impairs the acylethanolamide-based anti-inflammatory system reversal by 5-aminosalicylic acid and glucocorticoids. PLoS One 2012;7:e37729. [PMID: 22662201 DOI: 10.1371/journal.pone.0037729] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
312 Fruet AC, Seito LN, Rall VL, Di Stasi LC. Dietary intervention with narrow-leaved cattail rhizome flour (Typha angustifolia L.) prevents intestinal inflammation in the trinitrobenzenesulphonic acid model of rat colitis. BMC Complement Altern Med 2012;12:62. [PMID: 22559191 DOI: 10.1186/1472-6882-12-62] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
313 Abimosleh SM, Tran CD, Howarth GS. Emu Oil: a novel therapeutic for disorders of the gastrointestinal tract? J Gastroenterol Hepatol 2012;27:857-61. [PMID: 22369065 DOI: 10.1111/j.1440-1746.2012.07098.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
314 Ustyugova IV, Zhi L, Abramowitz J, Birnbaumer L, Wu MX. IEX-1 deficiency protects against colonic cancer. Mol Cancer Res 2012;10:760-7. [PMID: 22550081 DOI: 10.1158/1541-7786.MCR-11-0556] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
315 Lin YH, Zhou P, Ma PE, Guo XQ, Xia TY, Shen BF, Li Y, Han GC. Expression of IL-17 in inflammatory bowel disease and synergistic action of IL-17 and LPS on IL-8 expression in intestinal epithelial cells. Shijie Huaren Xiaohua Zazhi 2012; 20(12): 991-997 [DOI: 10.11569/wcjd.v20.i12.991] [Reference Citation Analysis]
316 Samanta AK, Torok VA, Percy NJ, Abimosleh SM, Howarth GS. Microbial fingerprinting detects unique bacterial communities in the faecal microbiota of rats with experimentally-induced colitis. J Microbiol. 2012;50:218-225. [PMID: 22538649 DOI: 10.1007/s12275-012-1362-8] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
317 Tajdini M, Hosseini SMR, Mirbagheri SA, Modabbernia A. Interleukin-11 for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews 2012. [DOI: 10.1002/14651858.cd009822] [Reference Citation Analysis]
318 Shahidi F, Zhong Y, Chandrasekara A. Antioxidants and Human Health. Cereals and Pulses 2012. [DOI: 10.1002/9781118229415.ch19] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
319 Abimosleh SM, Lindsay RJ, Butler RN, Cummins AG, Howarth GS. Emu oil increases colonic crypt depth in a rat model of ulcerative colitis. Dig Dis Sci 2012;57:887-96. [PMID: 22147247 DOI: 10.1007/s10620-011-1979-1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 3.4] [Reference Citation Analysis]
320 Yanaba K, Asano Y, Tada Y, Sugaya M, Kadono T, Sato S. Proteasome inhibitor bortezomib ameliorates intestinal injury in mice. PLoS One. 2012;7:e34587. [PMID: 22479648 DOI: 10.1371/journal.pone.0034587] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
321 Alt C, Lam JS, Harrison MT, Kershaw KM, Samuelsson S, Toll L, D'Andrea A. Nociceptin/orphanin FQ inhibition with SB612111 ameliorates dextran sodium sulfate-induced colitis. Eur J Pharmacol 2012;683:285-93. [PMID: 22449384 DOI: 10.1016/j.ejphar.2012.03.014] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
322 Rossignol DA. Hyperbaric oxygen treatment for inflammatory bowel disease: a systematic review and analysis. Med Gas Res. 2012;2:6. [PMID: 22417628 DOI: 10.1186/2045-9912-2-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
323 Zhang H, Kuai XY, Yu P, Lin L, Shi R. Protective role of uncoupling protein-2 against dextran sodium sulfate-induced colitis. J Gastroenterol Hepatol 2012;27:603-8. [PMID: 21871020 DOI: 10.1111/j.1440-1746.2011.06879.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
324 Riboulet-Bisson E, Sturme MH, Jeffery IB, O'Donnell MM, Neville BA, Forde BM, Claesson MJ, Harris H, Gardiner GE, Casey PG, Lawlor PG, O'Toole PW, Ross RP. Effect of Lactobacillus salivarius bacteriocin Abp118 on the mouse and pig intestinal microbiota. PLoS One 2012;7:e31113. [PMID: 22363561 DOI: 10.1371/journal.pone.0031113] [Cited by in Crossref: 103] [Cited by in F6Publishing: 110] [Article Influence: 9.4] [Reference Citation Analysis]
325 Al‐dasooqi N, Gibson RJ, Bowen JM, Keefe DM. HER2 Targeted Therapy‐Induced Gastrointestinal Toxicity: From the Clinical Experience to Possible Molecular Mechanisms. Molecular and Cellular Therapeutics 2012. [DOI: 10.1002/9781119967309.ch3] [Reference Citation Analysis]
326 Oron T, Elad-Sfadia G, Haklai R, Aizman E, Brazowski E, Kloog Y, Reif S. Prevention of induced colitis in mice by the ras antagonist farnesylthiosalicylic acid. Dig Dis Sci 2012;57:320-6. [PMID: 21901261 DOI: 10.1007/s10620-011-1880-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
327 Kanaan ZM, Eichenberger MR, Ahmad S, Weller C, Roberts H, Pan J, Rai SN, Petras R, Weller EB Jr, Galandiuk S. Clinical predictors of inflammatory bowel disease in a genetically well-defined Caucasian population. J Negat Results Biomed 2012;11:7. [PMID: 22269043 DOI: 10.1186/1477-5751-11-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
328 Zaki MH, Vogel P, Malireddi RK, Body-Malapel M, Anand PK, Bertin J, Green DR, Lamkanfi M, Kanneganti TD. The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis. Cancer Cell. 2011;20:649-660. [PMID: 22094258 DOI: 10.1016/j.ccr.2011.10.022] [Cited by in Crossref: 266] [Cited by in F6Publishing: 286] [Article Influence: 24.2] [Reference Citation Analysis]
329 Sheng YH, Hasnain SZ, Florin TH, McGuckin MA. Mucins in inflammatory bowel diseases and colorectal cancer. J Gastroenterol Hepatol 2012;27:28-38. [PMID: 21913981 DOI: 10.1111/j.1440-1746.2011.06909.x] [Cited by in Crossref: 129] [Cited by in F6Publishing: 122] [Article Influence: 11.7] [Reference Citation Analysis]
330 Kanayama K, Nakamura K, Ogino H, Sumida Y, Ihara E, Akiho H, Takayanagi R. Th1 responses are more susceptible to infliximab-mediated immunosuppression than Th17 responses. Dig Dis Sci 2011;56:3525-33. [PMID: 21678051 DOI: 10.1007/s10620-011-1780-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
331 Wight TN, Potter-Perigo S. The extracellular matrix: an active or passive player in fibrosis? Am J Physiol Gastrointest Liver Physiol 2011;301:G950-5. [PMID: 21512158 DOI: 10.1152/ajpgi.00132.2011] [Cited by in Crossref: 151] [Cited by in F6Publishing: 159] [Article Influence: 12.6] [Reference Citation Analysis]
332 Prager M, Büttner J, Haas V, Baumgart DC, Sturm A, Zeitz M, Büning C. The JAK2 variant rs10758669 in Crohn's disease: altering the intestinal barrier as one mechanism of action. Int J Colorectal Dis 2012;27:565-73. [PMID: 22065112 DOI: 10.1007/s00384-011-1345-y] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
333 Li C, Zhou HM. The role of manganese superoxide dismutase in inflammation defense. Enzyme Res 2011;2011:387176. [PMID: 21977313 DOI: 10.4061/2011/387176] [Cited by in Crossref: 46] [Cited by in F6Publishing: 61] [Article Influence: 3.8] [Reference Citation Analysis]
334 Riello L, Talbotec C, Garnier-Lengliné H, Pigneur B, Svahn J, Canioni D, Goulet O, Schmitz J, Ruemmele FM. Tolerance and efficacy of azathioprine in pediatric Crohn's disease. Inflamm Bowel Dis 2011;17:2138-43. [PMID: 21910176 DOI: 10.1002/ibd.21612] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
335 Jang SW, Cho MK, Park MK, Kang SA, Na BK, Ahn SC, Kim DH, Yu HS. Parasitic helminth cystatin inhibits DSS-induced intestinal inflammation via IL-10(+)F4/80(+) macrophage recruitment. Korean J Parasitol 2011;49:245-54. [PMID: 22072824 DOI: 10.3347/kjp.2011.49.3.245] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 3.6] [Reference Citation Analysis]
336 Mahendran V, Riordan SM, Grimm MC, Tran TA, Major J, Kaakoush NO, Mitchell H, Zhang L. Prevalence of Campylobacter species in adult Crohn’s disease and the preferential colonization sites of Campylobacter species in the human intestine. PLoS One. 2011;6:e25417. [PMID: 21966525 DOI: 10.1371/journal.pone.0025417] [Cited by in Crossref: 87] [Cited by in F6Publishing: 93] [Article Influence: 7.3] [Reference Citation Analysis]
337 Thornton NL, Cody MJ, Yost CC. Toll-like receptor 1/2 stimulation induces elevated interleukin-8 secretion in polymorphonuclear leukocytes isolated from preterm and term newborn infants. Neonatology 2012;101:140-6. [PMID: 21952587 DOI: 10.1159/000330567] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
338 Lee JH, Regmi SC, Kim JA, Cho MH, Yun H, Lee CS, Lee J. Apple flavonoid phloretin inhibits Escherichia coli O157:H7 biofilm formation and ameliorates colon inflammation in rats. Infect Immun 2011;79:4819-27. [PMID: 21930760 DOI: 10.1128/IAI.05580-11] [Cited by in Crossref: 134] [Cited by in F6Publishing: 135] [Article Influence: 11.2] [Reference Citation Analysis]
339 Liu X, Wang JM. Iridoid glycosides fraction of Folium syringae leaves modulates NF-κB signal pathway and intestinal epithelial cells apoptosis in experimental colitis. PLoS One. 2011;6:e24740. [PMID: 21931839 DOI: 10.1371/journal.pone.0024740] [Cited by in Crossref: 25] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
340 Takagi T, Naito Y, Uchiyama K, Okuda T, Mizushima K, Suzuki T, Handa O, Ishikawa T, Yagi N, Kokura S, Ichikawa H, Yoshikawa T. Rebamipide promotes healing of colonic ulceration through enhanced epithelial restitution. World J Gastroenterol 2011; 17(33): 3802-3809 [PMID: 21987622 DOI: 10.3748/wjg.v17.i33.3802] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
341 Harel E, Rubinstein A, Nissan A, Khazanov E, Nadler Milbauer M, Barenholz Y, Tirosh B. Enhanced transferrin receptor expression by proinflammatory cytokines in enterocytes as a means for local delivery of drugs to inflamed gut mucosa. PLoS One 2011;6:e24202. [PMID: 21915296 DOI: 10.1371/journal.pone.0024202] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 3.7] [Reference Citation Analysis]
342 Circu ML, Aw TY. Redox biology of the intestine. Free Radic Res. 2011;45:1245-1266. [PMID: 21831010 DOI: 10.3109/10715762.2011.611509] [Cited by in Crossref: 132] [Cited by in F6Publishing: 136] [Article Influence: 11.0] [Reference Citation Analysis]
343 Bouzid D, Haddouk S, Amouri A, Ben Hadj Hmida Y, Tahri N, Masmoudi H. Contribution of immunofluorescence to identification and characterization of antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Indian J Gastroenterol 2011;30:229-32. [PMID: 21986855 DOI: 10.1007/s12664-011-0127-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
344 Ogawa C, Liu YJ, Kobayashi KS. Muramyl dipeptide and its derivatives: peptide adjuvant in immunological disorders and cancer therapy. Curr Bioact Compd 2011;7:180-97. [PMID: 22180736 DOI: 10.2174/157340711796817913] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 5.7] [Reference Citation Analysis]
345 Okada Y, Maeda N, Takakura S, Miyata K, Koshiba M. Preventive and therapeutic effects of tacrolimus in an interleukin-10-deficient mouse model of colitis. Inflamm Res 2011;60:1049-59. [PMID: 21830095 DOI: 10.1007/s00011-011-0366-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
346 Kanodia L, Borgohain M, Das S. Effect of fruit extract of Fragaria vesca L. on experimentally induced inflammatory bowel disease in albino rats. Indian J Pharmacol 2011;43:18-21. [PMID: 21455415 DOI: 10.4103/0253-7613.75660] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
347 McLaughlin SD, Clark SK, Tekkis PP, Nicholls RJ, Ciclitira PJ. The bacterial pathogenesis and treatment of pouchitis. Therap Adv Gastroenterol. 2010;3:335-348. [PMID: 21180613 DOI: 10.1177/1756283x10370611] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
348 Prakash S, Urbanska AM. Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells. Biologics 2008;2:355-78. [PMID: 19707368 DOI: 10.2147/btt.s2372] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
349 Toedter G, Li K, Marano C, Ma K, Sague S, Huang CC, Song XY, Rutgeerts P, Baribaud F. Gene expression profiling and response signatures associated with differential responses to infliximab treatment in ulcerative colitis. Am J Gastroenterol 2011;106:1272-80. [PMID: 21448149 DOI: 10.1038/ajg.2011.83] [Cited by in Crossref: 73] [Cited by in F6Publishing: 74] [Article Influence: 6.1] [Reference Citation Analysis]
350 Smith JP, Bingaman SI, Ruggiero F, Mauger DT, Mukherjee A, McGovern CO, Zagon IS. Therapy with the opioid antagonist naltrexone promotes mucosal healing in active Crohn's disease: a randomized placebo-controlled trial. Dig Dis Sci 2011;56:2088-97. [PMID: 21380937 DOI: 10.1007/s10620-011-1653-7] [Cited by in Crossref: 78] [Cited by in F6Publishing: 78] [Article Influence: 6.5] [Reference Citation Analysis]
351 Cestari SH, Bastos JK, Di Stasi LC. Intestinal Anti-Inflammatory Activity of Baccharis dracunculifolia in the Trinitrobenzenesulphonic Acid Model of Rat Colitis. Evid Based Complement Alternat Med 2011;2011:524349. [PMID: 19592480 DOI: 10.1093/ecam/nep081] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
352 Hayashi Y, Narumi K, Tsuji S, Tsubokawa T, Nakaya MA, Wakayama T, Zuka M, Ohshima T, Yamagishi M, Okada T. Impact of adrenomedullin on dextran sulfate sodium-induced inflammatory colitis in mice: insights from in vitro and in vivo experimental studies. Int J Colorectal Dis. 2011;26:1453-1462. [PMID: 21674139 DOI: 10.1007/s00384-011-1254-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
353 Nunes T, Fiorino G, Danese S, Sans M. Familial aggregation in inflammatory bowel disease: Is it genes or environment? World J Gastroenterol 2011; 17(22): 2715-2722 [PMID: 21734779 DOI: 10.3748/wjg.v17.i22.2715] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
354 Zaki MH, Lamkanfi M, Kanneganti TD. The Nlrp3 inflammasome: contributions to intestinal homeostasis. Trends Immunol. 2011;32:171-179. [PMID: 21388882 DOI: 10.1016/j.it.2011.02.002] [Cited by in Crossref: 182] [Cited by in F6Publishing: 193] [Article Influence: 15.2] [Reference Citation Analysis]
355 Morimoto K, Hosomi S, Yamagami H, Watanabe K, Kamata N, Sogawa M, Machida H, Okazaki H, Tanigawa T, Nagahara H, Noda E, Tominaga K, Watanabe T, Fujiwara Y, Maeda K, Hirakawa K, Arakawa T. Dysregulated upregulation of T-cell immunoglobulin and mucin domain-3 on mucosal T helper 1 cells in patients with Crohn's disease. Scand J Gastroenterol 2011;46:701-9. [PMID: 21463244 DOI: 10.3109/00365521.2011.568518] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
356 Yanaba K, Yoshizaki A, Asano Y, Kadono T, Tedder TF, Sato S. IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model. Am J Pathol. 2011;178:735-743. [PMID: 21281806 DOI: 10.1016/j.ajpath.2010.10.022] [Cited by in Crossref: 134] [Cited by in F6Publishing: 138] [Article Influence: 11.2] [Reference Citation Analysis]
357 Künzli BM, Berberat PO, Dwyer K, Deaglio S, Csizmadia E, Cowan P, d'Apice A, Moore G, Enjyoji K, Friess H, Robson SC. Variable impact of CD39 in experimental murine colitis. Dig Dis Sci 2011;56:1393-403. [PMID: 20936356 DOI: 10.1007/s10620-010-1425-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
358 Pawar P, Gilda S, Sharma S, Jagtap S, Paradkar A, Mahadik K, Ranjekar P, Harsulkar A. Rectal gel application of Withania somnifera root extract expounds anti-inflammatory and muco-restorative activity in TNBS-induced inflammatory bowel disease. BMC Complement Altern Med 2011;11:34. [PMID: 21527003 DOI: 10.1186/1472-6882-11-34] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 3.6] [Reference Citation Analysis]
359 Kriegel C, Amiji MM. Dual TNF-α/Cyclin D1 Gene Silencing With an Oral Polymeric Microparticle System as a Novel Strategy for the Treatment of Inflammatory Bowel Disease. Clin Transl Gastroenterol. 2011;2:e2. [PMID: 23237848 DOI: 10.1038/ctg.2011.1] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 4.7] [Reference Citation Analysis]
360 Datta De D, Bhattacharjya S, Maitra M, Datta A, Choudhury A, Dhali GK, Roychoudhury S. IL1B induced Smad 7 negatively regulates gastrin expression. PLoS One. 2011;6:e14775. [PMID: 21445336 DOI: 10.1371/journal.pone.0014775] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
361 Kato K, Fukunaga K, Kamikozuru K, Kashiwamura S, Hida N, Ohda Y, Takeda N, Yoshida K, Iimuro M, Yokoyama Y, Kikuyama R, Miwa H, Matsumoto T. Infliximab therapy impacts the peripheral immune system of immunomodulator and corticosteroid naïve patients with Crohn's disease. Gut Liver 2011;5:37-45. [PMID: 21461070 DOI: 10.5009/gnl.2011.5.1.37] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
362 Luna J, Masamunt MC, Rickmann M, Mora R, España C, Delgado S, Llach J, Vaquero E, Sans M. Tocotrienols have potent antifibrogenic effects in human intestinal fibroblasts. Inflamm Bowel Dis 2011;17:732-41. [PMID: 20684017 DOI: 10.1002/ibd.21411] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
363 Choi I, Lee K, Kim M, Kim S, Kim D, Jeon Y, Park Y, Kim HS, Lee DW, Um J, Hong S. Anti-inflammatory effects of Cheongilppong on DSS-induced ulcerative colitis in mice. Orient Pharm Exp Med 2011;11:35-39. [DOI: 10.1007/s13596-011-0009-3] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
364 Qualtrough D, Smallwood K, Littlejohns D, Pignatelli M. The actin-bundling protein fascin is overexpressed in inflammatory bowel disease and may be important in tissue repair. BMC Gastroenterol 2011;11:14. [PMID: 21345224 DOI: 10.1186/1471-230X-11-14] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
365 Jones NP, Siegle GJ, Proud L, Silk JS, Hardy D, Keljo DJ, Dahl RE, Szigethy E. Impact of inflammatory bowel disease and high-dose steroid exposure on pupillary responses to negative information in pediatric depression. Psychosom Med. 2011;73:151-157. [PMID: 21217099 DOI: 10.1097/PSY.0b013e318207ffea] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
366 Moussata D, Goetz M, Gloeckner A, Kerner M, Campbell B, Hoffman A, Biesterfeld S, Flourie B, Saurin JC, Galle PR, Neurath MF, Watson AJ, Kiesslich R. Confocal laser endomicroscopy is a new imaging modality for recognition of intramucosal bacteria in inflammatory bowel disease in vivo. Gut 2011;60:26-33. [PMID: 20980342 DOI: 10.1136/gut.2010.213264] [Cited by in Crossref: 84] [Cited by in F6Publishing: 72] [Article Influence: 7.0] [Reference Citation Analysis]
367 Intestinal Crohn's disease: management. Revista da Associação Médica Brasileira (English Edition) 2011;57:10-13. [DOI: 10.1016/s2255-4823(11)70006-6] [Reference Citation Analysis]
368 Kirsner JB. The Influence of Twentieth-Century Biomedical Thought on the Origins of Inflammatory Bowel Disease Therapy. Inflammatory Bowel Disease 2011. [DOI: 10.1007/978-1-60327-433-3_1] [Reference Citation Analysis]
369 Intestinal Crohn's disease: management. Revista da Associação Médica Brasileira 2011;57:10-13. [DOI: 10.1016/s0104-4230(11)70006-9] [Reference Citation Analysis]
370 Mönch W, Breuker D, Middermann U. Bauchschmerzen und gynäkologische Schmerzen. Schmerzpsychotherapie 2011. [DOI: 10.1007/978-3-642-12783-0_25] [Reference Citation Analysis]
371 Glick SR, Carvalho RS. Inflammatory Bowel Disease. Pediatrics In Review 2011;32:14-25. [DOI: 10.1542/pir.32.1.14] [Reference Citation Analysis]
372 Vos AC, Wildenberg ME, Duijvestein M, Verhaar AP, van den Brink GR, Hommes DW. Anti-tumor necrosis factor-α antibodies induce regulatory macrophages in an Fc region-dependent manner. Gastroenterology 2011;140:221-30. [PMID: 20955706 DOI: 10.1053/j.gastro.2010.10.008] [Cited by in Crossref: 147] [Cited by in F6Publishing: 151] [Article Influence: 12.3] [Reference Citation Analysis]
373 Cravo M, Guerreiro CS, dos Santos PM, Brito M, Ferreira P, Fidalgo C, Tavares L, Pereira AD. Risk factors for metabolic bone disease in Crohn's disease patients. Inflamm Bowel Dis 2010;16:2117-24. [PMID: 20848459 DOI: 10.1002/ibd.21297] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
374 Kaakoush NO, Holmes J, Octavia S, Man SM, Zhang L, Castaño-Rodríguez N, Day AS, Leach ST, Lemberg DA, Dutt S, Stormon M, O'Loughlin EV, Magoffin A, Mitchell H. Detection of Helicobacteraceae in intestinal biopsies of children with Crohn's disease. Helicobacter 2010;15:549-57. [PMID: 21073612 DOI: 10.1111/j.1523-5378.2010.00792.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]
375 Hosomi S, Oshitani N, Kamata N, Sogawa M, Okazaki H, Tanigawa T, Yamagami H, Watanabe K, Tominaga K, Watanabe T, Fujiwara Y, Maeda K, Hirakawa K, Arakawa T. Increased numbers of immature plasma cells in peripheral blood specifically overexpress chemokine receptor CXCR3 and CXCR4 in patients with ulcerative colitis. Clin Exp Immunol 2011;163:215-24. [PMID: 21087446 DOI: 10.1111/j.1365-2249.2010.04290.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 3.2] [Reference Citation Analysis]
376 Noor SO, Ridgway K, Scovell L, Kemsley EK, Lund EK, Jamieson C, Johnson IT, Narbad A. Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota. BMC Gastroenterol. 2010;10:134. [PMID: 21073731 DOI: 10.1186/1471-230x-10-134] [Cited by in Crossref: 157] [Cited by in F6Publishing: 162] [Article Influence: 12.1] [Reference Citation Analysis]
377 Wagner J, Sim WH, Ellis JA, Ong EK, Catto-Smith AG, Cameron DJ, Bishop RF, Kirkwood CD. Interaction of Crohn's disease susceptibility genes in an Australian paediatric cohort. PLoS One 2010;5:e15376. [PMID: 21079743 DOI: 10.1371/journal.pone.0015376] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
378 La Scaleia R, Morrone S, Stoppacciaro A, Scarpino S, Antonelli M, Bianchi E, Di Nardo G, Oliva S, Viola F, Cucchiara S, Santoni A, Palmieri G, Uccini S. Peripheral and intestinal CD4+ T cells with a regulatory phenotype in pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2010;51:563-72. [PMID: 20890221 DOI: 10.1097/MPG.0b013e3181e4d323] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
379 Homsak E, Micetić-Turk D, Bozic B. Autoantibodies pANCA, GAB and PAB in inflammatory bowel disease: prevalence, characteristics and diagnostic value. Wien Klin Wochenschr 2010;122 Suppl 2:19-25. [PMID: 20517666 DOI: 10.1007/s00508-010-1344-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
380 Kim SJ, Kim MC, Um JY, Hong SH. The beneficial effect of vanillic acid on ulcerative colitis. Molecules 2010;15:7208-17. [PMID: 20959795 DOI: 10.3390/molecules15107208] [Cited by in Crossref: 105] [Cited by in F6Publishing: 109] [Article Influence: 8.1] [Reference Citation Analysis]
381 Koon HW, Shih D, Karagiannides I, Zhao D, Fazelbhoy Z, Hing T, Xu H, Lu B, Gerard N, Pothoulakis C. Substance P modulates colitis-associated fibrosis. Am J Pathol 2010;177:2300-9. [PMID: 20889569 DOI: 10.2353/ajpath.2010.100314] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 4.1] [Reference Citation Analysis]
382 Simms LA, Doecke JD, Roberts RL, Fowler EV, Zhao ZZ, McGuckin MA, Huang N, Hayward NK, Webb PM, Whiteman DC, Cavanaugh JA, McCallum R, Florin TH, Barclay ML, Gearry RB, Merriman TR, Montgomery GW, Radford-Smith GL. KCNN4 gene variant is associated with ileal Crohn's Disease in the Australian and New Zealand population. Am J Gastroenterol 2010;105:2209-17. [PMID: 20407432 DOI: 10.1038/ajg.2010.161] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 3.8] [Reference Citation Analysis]
383 Veluswamy H, Suryawala K, Sheth A, Wells S, Salvatierra E, Cromer W, Chaitanya GV, Painter A, Patel M, Manas K. African-American inflammatory bowel disease in a Southern U.S. health center. BMC Gastroenterol. 2010;10:104. [PMID: 20828408 DOI: 10.1186/1471-230x-10-104] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
384 Damin DC, Santos FS, Heck R, Rosito MA, Meurer L, Kliemann LM, Roesler R, Schwartsmann G. Effects of the gastrin-releasing peptide antagonist RC-3095 in a rat model of ulcerative colitis. Dig Dis Sci 2010;55:2203-10. [PMID: 19894117 DOI: 10.1007/s10620-009-1032-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
385 Vaji S, Salehi Z, Aminian K. Association of p53 codon 72 genetic polymorphism with the risk of ulcerative colitis in northern Iran. Int J Colorectal Dis 2011;26:235-8. [PMID: 20669023 DOI: 10.1007/s00384-010-1021-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
386 Keita AV, Söderholm JD. The intestinal barrier and its regulation by neuroimmune factors. Neurogastroenterol Motil 2010;22:718-33. [PMID: 20377785 DOI: 10.1111/j.1365-2982.2010.01498.x] [Cited by in Crossref: 186] [Cited by in F6Publishing: 174] [Article Influence: 14.3] [Reference Citation Analysis]
387 Kim M, Kim S, Choi I, Ki J, Kim D, Jeon Y, Bae G, Choi S, Jeong H, Park Y, Kim H, Um J, Hong S. The improving effects of Saengmaeksan on ulcerative colitis. Oriental Pharmacy and Experimental Medicine 2010;10:116-22. [DOI: 10.3742/opem.2010.10.2.116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
388 Seo GS, Lee JK, Yu JI, Yun KJ, Chae SC, Choi SC. Identification of the polymorphisms in IFITM3 gene and their association in a Korean population with ulcerative colitis. Exp Mol Med 2010;42:99-104. [PMID: 19946179 DOI: 10.3858/emm.2010.42.2.011] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
389 Singh UP, Singh NP, Singh B, Mishra MK, Nagarkatti M, Nagarkatti PS, Singh SR. Stem cells as potential therapeutic targets for inflammatory bowel disease. Front Biosci (Schol Ed). 2010;2:993-1008. [PMID: 20515838 DOI: 10.2741/s115] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 2.8] [Reference Citation Analysis]
390 Danese S, Fiorino G, Angelucci E, Vetrano S, Pagano N, Rando G, Spinelli A, Malesci A, Repici A. Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: A pilot study. World J Gastroenterol 2010; 16(19): 2396-2400 [PMID: 20480525 DOI: 10.3748/wjg.v16.i19.2396] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 41] [Article Influence: 2.8] [Reference Citation Analysis]
391 Smalley-Freed WG, Efimov A, Burnett PE, Short SP, Davis MA, Gumucio DL, Washington MK, Coffey RJ, Reynolds AB. p120-catenin is essential for maintenance of barrier function and intestinal homeostasis in mice. J Clin Invest 2010;120:1824-35. [PMID: 20484816 DOI: 10.1172/JCI41414] [Cited by in Crossref: 96] [Cited by in F6Publishing: 103] [Article Influence: 7.4] [Reference Citation Analysis]
392 Wang K, Yuan CP, Wang W, Yang ZQ, Cui W, Mu LZ, Yue ZP, Yin XL, Hu ZM, Liu JX. Expression of interleukin 6 in brain and colon of rats with TNBS-induced colitis. World J Gastroenterol 2010; 16(18): 2252-2259 [PMID: 20458762 DOI: 10.3748/wjg.v16.i18.2252] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
393 Lee JH, Cheon JH, Kim ES, Chung MJ, Kang W, Kim DH, Ha YJ, Park JJ, Kim TI, Kim WH. The prevalence and clinical significance of perinuclear anti-neutrophil cytoplasmic antibody in Korean patients with ulcerative colitis. Dig Dis Sci 2010;55:1406-12. [PMID: 19507028 DOI: 10.1007/s10620-009-0847-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
394 McNamee EN, Wermers JD, Masterson JC, Collins CB, Lebsack MD, Fillon S, Robinson ZD, Grenawalt J, Lee JJ, Jedlicka P, Furuta GT, Rivera-Nieves J. Novel model of TH2-polarized chronic ileitis: the SAMP1 mouse. Inflamm Bowel Dis 2010;16:743-52. [PMID: 19856411 DOI: 10.1002/ibd.21148] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
395 Parekh AB. Store-operated CRAC channels: function in health and disease. Nat Rev Drug Discov 2010;9:399-410. [PMID: 20395953 DOI: 10.1038/nrd3136] [Cited by in Crossref: 238] [Cited by in F6Publishing: 217] [Article Influence: 18.3] [Reference Citation Analysis]
396 Ko IK, Kim BG, Awadallah A, Mikulan J, Lin P, Letterio JJ, Dennis JE. Targeting improves MSC treatment of inflammatory bowel disease. Mol Ther. 2010;18:1365-1372. [PMID: 20389289 DOI: 10.1038/mt.2010.54] [Cited by in Crossref: 131] [Cited by in F6Publishing: 139] [Article Influence: 10.1] [Reference Citation Analysis]
397 Flier SN, Tanjore H, Kokkotou EG, Sugimoto H, Zeisberg M, Kalluri R. Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis. J Biol Chem. 2010;285:20202-20212. [PMID: 20363741 DOI: 10.1074/jbc.m110.102012] [Cited by in Crossref: 187] [Cited by in F6Publishing: 199] [Article Influence: 14.4] [Reference Citation Analysis]
398 Lundgren BA, Rorsman F, Portela-Gomes GM, Grimelius L, Ekdahl KN, Nilsson B, Ekwall O. Identification of complement C3 as an autoantigen in inflammatory bowel disease. Eur J Gastroenterol Hepatol 2010;22:429-36. [PMID: 19829122 DOI: 10.1097/MEG.0b013e32833283b1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
399 Day AS, Gearry RB. Rifaximin and Crohn's disease: a new solution to an old problem? Dig Dis Sci 2010;55:877-9. [PMID: 20155320 DOI: 10.1007/s10620-010-1140-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
400 Kim ES, Kim WH. Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics. Gut Liver. 2010;4:1-14. [PMID: 20479907 DOI: 10.5009/gnl.2010.4.1.1] [Cited by in Crossref: 66] [Cited by in F6Publishing: 72] [Article Influence: 5.1] [Reference Citation Analysis]
401 Zaki MH, Boyd KL, Vogel P, Kastan MB, Lamkanfi M, Kanneganti TD. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 2010;32:379-91. [PMID: 20303296 DOI: 10.1016/j.immuni.2010.03.003] [Cited by in Crossref: 674] [Cited by in F6Publishing: 706] [Article Influence: 51.8] [Reference Citation Analysis]
402 Utech M, Mennigen R, Bruewer M. Endocytosis and recycling of tight junction proteins in inflammation. J Biomed Biotechnol 2010;2010:484987. [PMID: 20011071 DOI: 10.1155/2010/484987] [Cited by in Crossref: 60] [Cited by in F6Publishing: 66] [Article Influence: 4.6] [Reference Citation Analysis]
403 Choi SY, Hur SJ, An CS, Jeon YH, Jeoung YJ, Bak JP, Lim BO. Anti-inflammatory effects of Inonotus obliquus in colitis induced by dextran sodium sulfate. J Biomed Biotechnol 2010;2010:943516. [PMID: 20300439 DOI: 10.1155/2010/943516] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 2.2] [Reference Citation Analysis]
404 Karakoyun B, Yüksel M, Ercan F, Salva E, Işik I, Yeğen BC. Halofuginone, a specific inhibitor of collagen type 1 synthesis, ameliorates oxidant colonic damage in rats with experimental colitis. Dig Dis Sci 2010;55:607-16. [PMID: 19390970 DOI: 10.1007/s10620-009-0798-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
405 Hayakawa Y, Hirata Y, Nakagawa H, Sakamoto K, Hikiba Y, Otsuka M, Ijichi H, Ikenoue T, Tateishi K, Akanuma M, Ogura K, Yoshida H, Ichijo H, Omata M, Maeda S. Apoptosis signal-regulating kinase 1 regulates colitis and colitis-associated tumorigenesis by the innate immune responses. Gastroenterology 2010;138:1055-67.e1-4. [PMID: 19931259 DOI: 10.1053/j.gastro.2009.11.015] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 3.5] [Reference Citation Analysis]
406 Ruyssers NE, De Winter BY, De Man JG, Ruyssers ND, Van Gils AJ, Loukas A, Pearson MS, Weinstock JV, Pelckmans PA, Moreels TG. Schistosoma mansoni proteins attenuate gastrointestinal motility disturbances during experimental colitis in mice. World J Gastroenterol 2010; 16(6): 703-712 [PMID: 20135718 DOI: 10.3748/wjg.v16.i6.703] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
407 de Silva S, Devlin S, Panaccione R. Optimizing the safety of biologic therapy for IBD. Nat Rev Gastroenterol Hepatol 2010;7:93-101. [PMID: 20134491 DOI: 10.1038/nrgastro.2009.221] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
408 Sina C, Arlt A, Gavrilova O, Midtling E, Kruse ML, Müerköster SS, Kumar R, Fölsch UR, Schreiber S, Rosenstiel P, Schäfer H. Ablation of gly96/immediate early gene-X1 (gly96/iex-1) aggravates DSS-induced colitis in mice: role for gly96/iex-1 in the regulation of NF-kappaB. Inflamm Bowel Dis 2010;16:320-31. [PMID: 19714745 DOI: 10.1002/ibd.21066] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
409 Zhang Z, Rosenbaum JT, Zhong W, Lim C, Hinrichs DJ. Costimulation of Th17 cells: Adding fuel or putting out the fire in the inflamed gut? Semin Immunopathol 2010;32:55-70. [PMID: 20119686 DOI: 10.1007/s00281-009-0190-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
410 Sfar I, Aleya WB, Mouelhi L, Aouadi H, Rhomdhane TB, Makhlouf M, Ayed-Jendoubi S, Gargaoui H, Najjar T, Abdallah TB, Ayed K, Gorgi Y. Lymphoid tyrosine phosphatase R620W variant and inflammatory bowel disease in Tunisia. World J Gastroenterol 2010; 16(4): 479-483 [PMID: 20101775 DOI: 10.3748/wjg.v16.i4.479] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
411 Garg P, Sarma D, Jeppsson S, Patel NR, Gewirtz AT, Merlin D, Sitaraman SV. Matrix metalloproteinase-9 functions as a tumor suppressor in colitis-associated cancer. Cancer Res 2010;70:792-801. [PMID: 20068187 DOI: 10.1158/0008-5472.CAN-09-3166] [Cited by in Crossref: 68] [Cited by in F6Publishing: 70] [Article Influence: 5.2] [Reference Citation Analysis]
412 Owczarek D, Cibor D, Mach T. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), arginine, and 8-iso-prostaglandin F2alpha (8-iso-PGF2alpha) level in patients with inflammatory bowel diseases. Inflamm Bowel Dis 2010;16:52-7. [PMID: 19575355 DOI: 10.1002/ibd.20994] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 3.0] [Reference Citation Analysis]
413 Oz HS, Ebersole JL. Green tea polyphenols mediated apoptosis in intestinal epithelial cells by a FADD-dependent pathway. J Cancer Ther. 2010;1:105-113. [PMID: 21687829 DOI: 10.4236/jct.2010.13018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
414 Bocci V. The Actual Six Therapeutic Modalities. OZONE 2010. [DOI: 10.1007/978-90-481-9234-2_6] [Reference Citation Analysis]
415 Cho YB, Kim MS, Kang MJ, Shin HJ, Kim S, Kim HC, Yun SH, Lee WY, Chun H. Immunomodulatory Effects of Mesenchymal Stem Cells in a Murine Model of TNBS-Induced Colitis. J Korean Surg Soc 2010;79:317. [DOI: 10.4174/jkss.2010.79.5.317] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
416 Ben Alaya W, Sfar I, Aouadi H, Jendoubi S, Najjar T, Filali A, Gorgi Y, Ben Abdallah T, Mouelhi L, Matri S. Association between CTLA-4 gene promoter (49 A/G) in exon 1 polymorphisms and inflammatory bowel disease in the Tunisian population. Saudi J Gastroenterol. 2009;15:29-34. [PMID: 19568552 DOI: 10.4103/1319-3767.43285] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
417 Al-Mofarreh MA, Al Mofleh IA, Al-Teimi IN, Al-Jebreen AM. Crohn's disease in a Saudi outpatient population: is it still rare? Saudi J Gastroenterol 2009;15:111-6. [PMID: 19568575 DOI: 10.4103/1319-3767.45357] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
418 Pagnini C, Saeed R, Bamias G, Arseneau KO, Pizarro TT, Cominelli F. Probiotics promote gut health through stimulation of epithelial innate immunity. Proc Natl Acad Sci USA. 2010;107:454-459. [PMID: 20018654 DOI: 10.1073/pnas.0910307107] [Cited by in Crossref: 242] [Cited by in F6Publishing: 251] [Article Influence: 17.3] [Reference Citation Analysis]
419 Li Y, Tian Y, Yu C, Zhu W, Li J. A systematic review and meta-analysis of anti-adhesion molecule therapy in patients with active Crohn's disease. Scand J Gastroenterol 2009;44:1435-42. [PMID: 19883269 DOI: 10.3109/00365520903367254] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
420 Ebert EC, Geng X, Bajpai M, Pan Z, Tatar E, Das KM. Antibody to tropomyosin isoform 5 and complement induce the lysis of colonocytes in ulcerative colitis. Am J Gastroenterol 2009;104:2996-3003. [PMID: 19690525 DOI: 10.1038/ajg.2009.455] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
421 Singh UP, Singh NP, Singh B, Hofseth LJ, Price RL, Nagarkatti M, Nagarkatti PS. Resveratrol (trans-3,5,4'-trihydroxystilbene) induces silent mating type information regulation-1 and down-regulates nuclear transcription factor-kappaB activation to abrogate dextran sulfate sodium-induced colitis. J Pharmacol Exp Ther. 2010;332:829-839. [PMID: 19940103 DOI: 10.1124/jpet.109.160838] [Cited by in Crossref: 139] [Cited by in F6Publishing: 149] [Article Influence: 9.9] [Reference Citation Analysis]
422 Varzakas T, Arvanitoyannis I, Bezirtzoglou E. Functional Dairy Foods and Flora Modulation. Development and Manufacture of Yogurt and Other Functional Dairy Products 2009. [DOI: 10.1201/9781420082081-c12] [Reference Citation Analysis]
423 Puga Yung GL, Fidler M, Albani E, Spermon N, Teklenburg G, Newbury R, Schechter N, van den Broek T, Prakken B, Billetta R, Dohil R, Albani S. Heat shock protein-derived T-cell epitopes contribute to autoimmune inflammation in pediatric Crohn's disease. PLoS One 2009;4:e7714. [PMID: 19888320 DOI: 10.1371/journal.pone.0007714] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
424 Kirkwood CD, Wagner J, Boniface K, Vaughan J, Michalski WP, Catto-Smith AG, Cameron DJ, Bishop RF. Mycobacterium avium subspecies paratuberculosis in children with early-onset Crohn's disease. Inflamm Bowel Dis 2009;15:1643-55. [PMID: 19462429 DOI: 10.1002/ibd.20967] [Cited by in Crossref: 67] [Cited by in F6Publishing: 69] [Article Influence: 4.8] [Reference Citation Analysis]
425 Kazi HA, Qian Z. Crocetin reduces TNBS-induced experimental colitis in mice by downregulation of NFkB. Saudi J Gastroenterol 2009;15:181-7. [PMID: 19636180 DOI: 10.4103/1319-3767.54750] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
426 Choi Y, Kim D, Chun M, Choi H, Lee Y. Comparison of Oral versus Rectal Administration of Processed-Scutellaria baicalensis on Colonic Inflammation in Mice. Journal of Korean Pharmaceutical Sciences 2009;39:381-386. [DOI: 10.4333/kps.2009.39.5.381] [Reference Citation Analysis]
427 Watanabe O, Ando T, El-Omar EM, Shimada M, Ina K, Ishiguro K, Hasegawa M, Miyake N, Nakamura M, Miyahara R, Ohmiya N, Niwa Y, Goto H. Role of endoscopic ultrasonography in predicting the response to cyclosporin A in ulcerative colitis refractory to steroids. Dig Liver Dis 2009;41:735-9. [PMID: 19403349 DOI: 10.1016/j.dld.2009.03.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
428 Landaverde C, Ng V, Sato A, Tabibian J, Durazo F, Busuttil R. De-novo cholangiocarcinoma in native common bile duct remnant following OLT for primary sclerosing cholangitis. Ann Hepatol 2009;8:379-83. [PMID: 20009140] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
429 Tsay TB, Chang CJ, Chen PH, Hsu CM, Chen LW. Nod2 mutation enhances NF-kappa B activity and bacterial killing activity of macrophages. Inflammation 2009;32:372-8. [PMID: 19728064 DOI: 10.1007/s10753-009-9145-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
430 Ben Aleya W, Sfar I, Mouelhi L, Aouadi H, Makhlouf M, Ayed-Jendoubi S, Matri S, Filali A, Najjar T, Ben Abdallah T, Ayed K, Gorgi Y. Association of Fas/Apo1 gene promoter (-670 A/G) polymorphism in Tunisian patients with IBD. World J Gastroenterol 2009; 15(29): 3643-3648 [PMID: 19653342 DOI: 10.3748/wjg.15.3643] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
431 Sato K, Shiota M, Fukuda S, Iwamoto E, Machida H, Inamine T, Kondo S, Yanagihara K, Isomoto H, Mizuta Y, Kohno S, Tsukamoto K. Strong evidence of a combination polymorphism of the tyrosine kinase 2 gene and the signal transducer and activator of transcription 3 gene as a DNA-based biomarker for susceptibility to Crohn's disease in the Japanese population. J Clin Immunol. 2009;29:815-825. [PMID: 19653082 DOI: 10.1007/s10875-009-9320-x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 3.5] [Reference Citation Analysis]
432 Kindt S, Tertychnyy A, de Hertogh G, Geboes K, Tack J. Intestinal immune activation in presumed post-infectious functional dyspepsia. Neurogastroenterol Motil 2009;21:832-e56. [PMID: 19460107 DOI: 10.1111/j.1365-2982.2009.01299.x] [Cited by in Crossref: 83] [Cited by in F6Publishing: 65] [Article Influence: 5.9] [Reference Citation Analysis]
433 Kim YH, Kwon HS, Kim DH, Shin EK, Kang YH, Park JH, Shin HK, Kim JK. 3,3'-diindolylmethane attenuates colonic inflammation and tumorigenesis in mice. Inflamm Bowel Dis 2009;15:1164-73. [PMID: 19334074 DOI: 10.1002/ibd.20917] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 5.1] [Reference Citation Analysis]
434 Boussetta T, Raad H, Lettéron P, Gougerot-Pocidalo MA, Marie JC, Driss F, El-Benna J. Punicic acid a conjugated linolenic acid inhibits TNFalpha-induced neutrophil hyperactivation and protects from experimental colon inflammation in rats. PLoS One. 2009;4:e6458. [PMID: 19649246 DOI: 10.1371/journal.pone.0006458] [Cited by in Crossref: 80] [Cited by in F6Publishing: 84] [Article Influence: 5.7] [Reference Citation Analysis]
435 Treede I, Braun A, Jeliaskova P, Giese T, Füllekrug J, Griffiths G, Stremmel W, Ehehalt R. TNF-alpha-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells. BMC Gastroenterol 2009;9:53. [PMID: 19594939 DOI: 10.1186/1471-230X-9-53] [Cited by in Crossref: 67] [Cited by in F6Publishing: 72] [Article Influence: 4.8] [Reference Citation Analysis]
436 Caviglia R, Boskoski I, Cicala M. Maintenance treatment with infliximab for the management of Crohn's disease in adults. Biologics 2009;3:39-49. [PMID: 19707394 DOI: 10.2147/btt.2009.2763] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
437 Neurath M, Holtmann M. Biologic Therapies For Inflammatory Bowel Disease. Emerging Protein Biotherapeutics 2009. [DOI: 10.1201/9781420063219.ch5] [Reference Citation Analysis]
438 Weber B, Saurer L, Mueller C. Intestinal macrophages: differentiation and involvement in intestinal immunopathologies. Semin Immunopathol. 2009;31:171-184. [PMID: 19533135 DOI: 10.1007/s00281-009-0156-5] [Cited by in Crossref: 50] [Cited by in F6Publishing: 55] [Article Influence: 3.6] [Reference Citation Analysis]
439 Arribas B, Rodríguez-Cabezas ME, Camuesco D, Comalada M, Bailón E, Utrilla P, Nieto A, Concha A, Zarzuelo A, Gálvez J. A probiotic strain of Escherichia coli, Nissle 1917, given orally exerts local and systemic anti-inflammatory effects in lipopolysaccharide-induced sepsis in mice. Br J Pharmacol. 2009;157:1024-1033. [PMID: 19486007 DOI: 10.1111/j.1476-5381.2009.00270.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 45] [Article Influence: 2.8] [Reference Citation Analysis]
440 Pimentel-Nunes P, Dinis-Ribeiro M, Magro F. Systematic review on drug and diet-induced endoscopic remission in Crohn's disease. Eur J Gastroenterol Hepatol 2009;21:491-503. [PMID: 19293722 DOI: 10.1097/MEG.0b013e3283196b03] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
441 Mennigen R, Nolte K, Rijcken E, Utech M, Loeffler B, Senninger N, Bruewer M. Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol 2009;296:G1140-9. [PMID: 19221015 DOI: 10.1152/ajpgi.90534.2008] [Cited by in Crossref: 331] [Cited by in F6Publishing: 325] [Article Influence: 23.6] [Reference Citation Analysis]
442 Schoultz I, Verma D, Halfvarsson J, Törkvist L, Fredrikson M, Sjöqvist U, Lördal M, Tysk C, Lerm M, Söderkvist P, Söderholm JD. Combined polymorphisms in genes encoding the inflammasome components NALP3 and CARD8 confer susceptibility to Crohn's disease in Swedish men. Am J Gastroenterol 2009;104:1180-8. [PMID: 19319132 DOI: 10.1038/ajg.2009.29] [Cited by in Crossref: 114] [Cited by in F6Publishing: 120] [Article Influence: 8.1] [Reference Citation Analysis]
443 Ruyssers NE, De Winter BY, De Man JG, Loukas A, Pearson MS, Weinstock JV, Van den Bossche RM, Martinet W, Pelckmans PA, Moreels TG. Therapeutic potential of helminth soluble proteins in TNBS-induced colitis in mice. Inflamm Bowel Dis 2009;15:491-500. [PMID: 19023900 DOI: 10.1002/ibd.20787] [Cited by in Crossref: 124] [Cited by in F6Publishing: 120] [Article Influence: 8.9] [Reference Citation Analysis]
444 Shen Z, Feng Y, Rogers AB, Rickman B, Whary MT, Xu S, Clapp KM, Boutin SR, Fox JG. Cytolethal distending toxin promotes Helicobacter cinaedi-associated typhlocolitis in interleukin-10-deficient mice. Infect Immun 2009;77:2508-16. [PMID: 19307212 DOI: 10.1128/IAI.00166-09] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 3.9] [Reference Citation Analysis]
445 Pena Rossi C, Hanauer SB, Tomasevic R, Hunter JO, Shafran I, Graffner H. Interferon beta-1a for the maintenance of remission in patients with Crohn’s disease: results of a phase II dose-finding study. BMC Gastroenterol. 2009;9:22. [PMID: 19302707 DOI: 10.1186/1471-230x-9-22] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
446 Shao LM, Chen MY, Cai JT. Meta-analysis: the efficacy and safety of certolizumab pegol in Crohn's disease. Aliment Pharmacol Ther 2009;29:605-14. [PMID: 19183161 DOI: 10.1111/j.1365-2036.2009.03929.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
447 Salzman NH, Bevins CL. Negative interactions with the microbiota: IBD. Adv Exp Med Biol 2008;635:67-78. [PMID: 18841704 DOI: 10.1007/978-0-387-09550-9_6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
448 Belmiro CL, Castelo-Branco MT, Melim LM, Schanaider A, Elia C, Madi K, Pavão MS, de Souza HS. Unfractionated heparin and new heparin analogues from ascidians (chordate-tunicate) ameliorate colitis in rats. J Biol Chem 2009;284:11267-78. [PMID: 19258310 DOI: 10.1074/jbc.M807211200] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
449 Ruemmele FM, Lachaux A, Cézard JP, Morali A, Maurage C, Giniès JL, Viola S, Goulet O, Lamireau T, Scaillon M, Breton A, Sarles J; Groupe Francophone d'Hépatologie, Gastroentérologie et Nutrition Pédiatrique. Efficacy of infliximab in pediatric Crohn's disease: a randomized multicenter open-label trial comparing scheduled to on demand maintenance therapy. Inflamm Bowel Dis 2009;15:388-94. [PMID: 19023899 DOI: 10.1002/ibd.20788] [Cited by in Crossref: 77] [Cited by in F6Publishing: 60] [Article Influence: 5.5] [Reference Citation Analysis]
450 Fichtner-Feigl S, Strober W, Geissler EK, Schlitt HJ. Cytokines mediating the induction of chronic colitis and colitis-associated fibrosis. Mucosal Immunol. 2008;1 Suppl 1:S24-S27. [PMID: 19079223 DOI: 10.1038/mi.2008.41] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 3.5] [Reference Citation Analysis]
451 Joo YE, Karrasch T, Mühlbauer M, Allard B, Narula A, Herfarth HH, Jobin C. Tomato lycopene extract prevents lipopolysaccharide-induced NF-kappaB signaling but worsens dextran sulfate sodium-induced colitis in NF-kappaBEGFP mice. PLoS One 2009;4:e4562. [PMID: 19234608 DOI: 10.1371/journal.pone.0004562] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 3.5] [Reference Citation Analysis]
452 Lichtenstein GR, Hanauer SB, Sandborn WJ; Practice Parameters Committee of American College of Gastroenterology. Management of Crohn's disease in adults. Am J Gastroenterol 2009;104:465-83; quiz 464, 484. [PMID: 19174807 DOI: 10.1038/ajg.2008.168] [Cited by in Crossref: 619] [Cited by in F6Publishing: 618] [Article Influence: 44.2] [Reference Citation Analysis]
453 Ostanin DV, Bao J, Koboziev I, Gray L, Robinson-Jackson SA, Kosloski-Davidson M, Price VH, Grisham MB. T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am J Physiol Gastrointest Liver Physiol 2009;296:G135-46. [PMID: 19033538 DOI: 10.1152/ajpgi.90462.2008] [Cited by in Crossref: 290] [Cited by in F6Publishing: 249] [Article Influence: 20.7] [Reference Citation Analysis]
454 Khazen D, Jendoubi-Ayed S, Aleya WB, Sfar I, Mouelhi L, Matri S, Najjar T, Filali A, Gorgi Y, Abdallah TB, Ayed K. Polymorphism in ICAM-1, PECAM-1, E-selectin, and L-selectin genes in Tunisian patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2009;21:167-75. [PMID: 19212205 DOI: 10.1097/MEG.0b013e32830e6fc8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
455 Narumi Y, Isomoto H, Shiota M, Sato K, Kondo S, Machida H, Yanagihara K, Mizuta Y, Kohno S, Tsukamoto K. Polymorphisms of PTPN11 coding SHP-2 as biomarkers for ulcerative colitis susceptibility in the Japanese population. J Clin Immunol. 2009;29:303-310. [PMID: 19160029 DOI: 10.1007/s10875-008-9272-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
456 Chen J, Gao ML, Bai XR, Cui H, Wang MZ. Expression of NF-κB and cytokines in human ulcerative colitis and its significance. Shijie Huaren Xiaohua Zazhi 2009; 17(2): 209-212 [DOI: 10.11569/wcjd.v17.i2.209] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
457 Wolowczuk I, Allez M, Chamaillard M. IL-17/23, potential targets for Crohn’s disease. Th 17 Cells: Role in Inflammation and Autoimmune Disease 2009. [DOI: 10.1007/978-3-7643-8681-8_18] [Reference Citation Analysis]
458 Cianci R, Iacopini F, Petruzziello L, Cammarota G, Pandolfi F, Costamagna G. Involvement of central immunity in uncomplicated diverticular disease. Scand J Gastroenterol 2009;44:108-15. [PMID: 18759154 DOI: 10.1080/00365520802321204] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
459 Russo A, Krigsman A, Jepson B, Wakefield A. Anti-PR3 and Anti-MPO IgG ANCA in Autistic Children with Chronic GI Disease. Immunol Immunogenet Insights 2009;1:III.S1040. [DOI: 10.4137/iii.s1040] [Reference Citation Analysis]
460 Shaoul R, Karban A, Reif S, Weiss B, Shamir R, Tamir A, Davidovich O, Halevi J, Silver EL, Levine A. Disease behavior in children with Crohn's disease: the effect of disease duration, ethnicity, genotype, and phenotype. Dig Dis Sci 2009;54:142-50. [PMID: 18594982 DOI: 10.1007/s10620-008-0326-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
461 Lubbad AS, Oriowo MA, Khan I. Curcumin reverses attenuated carbachol-induced contraction of the colon in a rat model of colitis. Scand J Gastroenterol 2009;44:187-94. [PMID: 18830899 DOI: 10.1080/00365520802449302] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
462 Sasaki S, Ishida Y, Nishio N, Ito S, Isobe K. Thymic involution correlates with severe ulcerative colitis induced by oral administration of dextran sulphate sodium in C57BL/6 mice but not in BALB/c mice. Inflammation. 2008;31:319-328. [PMID: 18696222 DOI: 10.1007/s10753-008-9081-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
463 Ando T, Watanabe O, Ishiguro K, Maeda O, Ishikawa D, Minami M, Hasegawa M, Kondo S, Goto Y, Ohmiya N, Niwa Y, Goto H. Relationships between Helicobacter pylori infection status, endoscopic, histopathological findings, and cytokine production in the duodenum of Crohn's disease patients. J Gastroenterol Hepatol 2008;23 Suppl 2:S193-7. [PMID: 19120897 DOI: 10.1111/j.1440-1746.2008.05438.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
464 Fichtner-Feigl S, Young CA, Kitani A, Geissler EK, Schlitt HJ, Strober W. IL-13 signaling via IL-13R alpha2 induces major downstream fibrogenic factors mediating fibrosis in chronic TNBS colitis. Gastroenterology 2008;135:2003-13, 2013.e1-7. [PMID: 18938165 DOI: 10.1053/j.gastro.2008.08.055] [Cited by in Crossref: 115] [Cited by in F6Publishing: 125] [Article Influence: 7.7] [Reference Citation Analysis]
465 Rivera-Nieves J, Gorfu G, Ley K. Leukocyte adhesion molecules in animal models of inflammatory bowel disease. Inflamm Bowel Dis 2008;14:1715-35. [PMID: 18523998 DOI: 10.1002/ibd.20501] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 3.2] [Reference Citation Analysis]
466 Collins CB, Ho J, Wilson TE, Wermers JD, Tlaxca JL, Lawrence MB, Solga M, Lannigan J, Rivera-Nieves J. CD44 deficiency attenuates chronic murine ileitis. Gastroenterology 2008;135:1993-2002. [PMID: 18854186 DOI: 10.1053/j.gastro.2008.08.053] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
467 Lubbad A, Oriowo MA, Khan I. Curcumin attenuates inflammation through inhibition of TLR-4 receptor in experimental colitis. Mol Cell Biochem. 2009;322:127-135. [PMID: 19002562 DOI: 10.1007/s11010-008-9949-4] [Cited by in Crossref: 104] [Cited by in F6Publishing: 98] [Article Influence: 6.9] [Reference Citation Analysis]
468 Guzy C, Schirbel A, Paclik D, Wiedenmann B, Dignass A, Sturm A. Enteral and parenteral nutrition distinctively modulate intestinal permeability and T cell function in vitro. Eur J Nutr 2009;48:12-21. [PMID: 18998044 DOI: 10.1007/s00394-008-0754-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
469 Chen J, Yang S, Hu S, Choudhry MA, Bland KI, Chaudry IH. Estrogen prevents intestinal inflammation after trauma-hemorrhage via downregulation of angiotensin II and angiotensin II subtype I receptor. Am J Physiol Gastrointest Liver Physiol 2008;295:G1131-7. [PMID: 18832446 DOI: 10.1152/ajpgi.90443.2008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
470 Kurnatowski M, Kudzin J, Wąsowska-królikowska K. Terapia biologiczna nieswoistych zapaleń jelit u dzieci. Pediatria Polska 2008;83:691-696. [DOI: 10.1016/s0031-3939(08)70196-3] [Reference Citation Analysis]
471 Lanas A. Role of nitric oxide in the gastrointestinal tract. Arthritis Res Ther 2008;10 Suppl 2:S4. [PMID: 19007429 DOI: 10.1186/ar2465] [Cited by in Crossref: 111] [Cited by in F6Publishing: 112] [Article Influence: 7.4] [Reference Citation Analysis]
472 Das KM, Biancone L. Is IBD an autoimmune disorder? Inflamm Bowel Dis 2008;14 Suppl 2:S97-101. [PMID: 18816728 DOI: 10.1002/ibd.20723] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
473 Fina D, Pallone F. What is the role of cytokines and chemokines in IBD? Inflamm Bowel Dis 2008;14 Suppl 2:S117-8. [PMID: 18816719 DOI: 10.1002/ibd.20677] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
474 Saruta M, Papadakis KA. Why are cytokines targeted for biological therapy in IBD? Inflamm Bowel Dis 2008;14 Suppl 2:S121-2. [PMID: 18816684 DOI: 10.1002/ibd.20631] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
475 Eveson JW. Mundhöhle. Pathologie. [DOI: 10.1007/978-3-540-72885-6_3] [Reference Citation Analysis]
476 Li K, Wang B, Sui H, Liu S, Yao S, Guo L, Mao D. Polymorphisms of the macrophage inflammatory protein 1 alpha and ApoE genes are associated with ulcerative colitis. Int J Colorectal Dis. 2009;24:13-17. [PMID: 18762952 DOI: 10.1007/s00384-008-0575-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
477 Dessein R, Chamaillard M, Danese S. Innate immunity in Crohn's disease: the reverse side of the medal. J Clin Gastroenterol 2008;42 Suppl 3 Pt 1:S144-7. [PMID: 18806708 DOI: 10.1097/MCG.0b013e3181662c90] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
478 Hosomi S, Oshitani N, Kamata N, Sogawa M, Yamagami H, Watanabe K, Tominaga K, Watanabe T, Fujiwara Y, Maeda K, Hirakawa K, Arakawa T. Phenotypical and functional study of ghrelin and its receptor in the pathogenesis of Crohn's disease. Inflamm Bowel Dis 2008;14:1205-13. [PMID: 18425803 DOI: 10.1002/ibd.20477] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
479 Eriksson A, Flach CF, Lindgren A, Kvifors E, Lange S. Five mucosal transcripts of interest in ulcerative colitis identified by quantitative real-time PCR: a prospective study. BMC Gastroenterol 2008;8:34. [PMID: 18700007 DOI: 10.1186/1471-230X-8-34] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
480 Erzin Y, Uzun H, Karatas A, Celik AF. Serum YKL-40 as a marker of disease activity and stricture formation in patients with Crohn's disease. J Gastroenterol Hepatol 2008;23:e357-62. [PMID: 17725598 DOI: 10.1111/j.1440-1746.2007.05121.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
481 Beynon V, Cotofana S, Brand S, Lohse P, Mair A, Wagner S, Mussack T, Ochsenkühn T, Folwaczny M, Folwaczny C, Glas J, Török HP. NOD2/CARD15 genotype influences MDP-induced cytokine release and basal IL-12p40 levels in primary isolated peripheral blood monocytes. Inflamm Bowel Dis 2008;14:1033-40. [PMID: 18383179 DOI: 10.1002/ibd.20441] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
482 Paclik D, Danese S, Berndt U, Wiedenmann B, Dignass A, Sturm A. Galectin-4 controls intestinal inflammation by selective regulation of peripheral and mucosal T cell apoptosis and cell cycle. PLoS One. 2008;3:e2629. [PMID: 18612433 DOI: 10.1371/journal.pone.0002629] [Cited by in Crossref: 77] [Cited by in F6Publishing: 80] [Article Influence: 5.1] [Reference Citation Analysis]
483 Hussein IAH, Tohme R, Barada K, Mostafa MH, Freund JN, Jurjus RA, Karam W, Jurjus A. Inflammatory bowel disease in rats: Bacterial and chemical interaction. World J Gastroenterol 2008; 14(25): 4028-4039 [PMID: 18609687 DOI: 10.3748/wjg.14.4028] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
484 Vetrano S, Rescigno M, Cera MR, Correale C, Rumio C, Doni A, Fantini M, Sturm A, Borroni E, Repici A, Locati M, Malesci A, Dejana E, Danese S. Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease. Gastroenterology 2008;135:173-84. [PMID: 18514073 DOI: 10.1053/j.gastro.2008.04.002] [Cited by in Crossref: 180] [Cited by in F6Publishing: 186] [Article Influence: 12.0] [Reference Citation Analysis]
485 Biancone L, Onali S, Calabrese E, Petruzziello C, Zorzi F, Condino G, Sica GS, Pallone F. Non-invasive techniques for assessing postoperative recurrence in Crohn's disease. Dig Liver Dis 2008;40 Suppl 2:S265-70. [PMID: 18598999 DOI: 10.1016/S1590-8658(08)60536-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.2] [Reference Citation Analysis]
486 Bailón E, Comalada M, Román J, Michelena P, Ramis I, Merlos M, Nieto A, Concha A, Zarzuelo A, Gálvez J. UR-1505, a salicylate able to selectively block T-cell activation, shows intestinal anti-inflammatory activity in the chronic phase of the DSS model of rat colitis. Inflamm Bowel Dis 2008;14:888-97. [PMID: 18253952 DOI: 10.1002/ibd.20381] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
487 Danese S. Mechanisms of action of infliximab in inflammatory bowel disease: an anti-inflammatory multitasker. Dig Liver Dis 2008;40 Suppl 2:S225-8. [PMID: 18598993 DOI: 10.1016/S1590-8658(08)60530-7] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 3.3] [Reference Citation Analysis]
488 Sakata Y, Iwakiri R, Amemori S, Yamaguchi K, Fujise T, Otani H, Shimoda R, Tsunada S, Sakata H, Ikeda Y, Ando T, Nakafusa Y, Fujimoto K. Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study. Eur J Gastroenterol Hepatol 2008;20:629-33. [PMID: 18679064 DOI: 10.1097/MEG.0b013e3282f5e9a4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
489 Yan Y, Vasudevan S, Nguyen HT, Merlin D. Intestinal epithelial CD98: an oligomeric and multifunctional protein. Biochim Biophys Acta 2008;1780:1087-92. [PMID: 18625289 DOI: 10.1016/j.bbagen.2008.06.007] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]
490 Ruyssers NE, De Winter BY, De Man JG, Loukas A, Herman AG, Pelckmans PA, Moreels TG. Worms and the treatment of inflammatory bowel disease: are molecules the answer? Clin Dev Immunol 2008;2008:567314. [PMID: 18509490 DOI: 10.1155/2008/567314] [Cited by in Crossref: 35] [Cited by in F6Publishing: 42] [Article Influence: 2.3] [Reference Citation Analysis]
491 Shi BB, Huang CF, Zhu Q. Clinical analysis and colonoscopic manifestations in 120 patients with ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2008; 16(17): 1951-1953 [DOI: 10.11569/wcjd.v16.i17.1951] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
492 Müller M, Fink K, Geisel J, Kahl F, Jilge B, Reimann J, Mach N, Autenrieth IB, Frick JS. Intestinal colonization of IL-2 deficient mice with non-colitogenic B. vulgatus prevents DC maturation and T-cell polarization. PLoS One. 2008;3:e2376. [PMID: 18545662 DOI: 10.1371/journal.pone.0002376] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
493 Singh UP, Singh R, Singh S, Karls RK, Quinn FD, Taub DD, Lillard JW Jr. CXCL10+ T cells and NK cells assist in the recruitment and activation of CXCR3+ and CXCL11+ leukocytes during Mycobacteria-enhanced colitis. BMC Immunol 2008;9:25. [PMID: 18533024 DOI: 10.1186/1471-2172-9-25] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
494 Sica GS, Iaculli E, Benavoli D, Biancone L, Calabrese E, Onali S, Gaspari AL. Laparoscopic versus open ileo-colonic resection in Crohn's disease: short- and long-term results from a prospective longitudinal study. J Gastrointest Surg 2008;12:1094-102. [PMID: 18027061 DOI: 10.1007/s11605-007-0394-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
495 Hanai H, Iida T, Takeuchi K, Watanabe F, Maruyama Y, Kageoka M, Ikeya K, Yamada M, Kikuyama M, Iwaoka Y, Hirayama K, Nagata S, Sato Y, Hosoda Y. Intensive granulocyte and monocyte adsorption versus intravenous prednisolone in patients with severe ulcerative colitis: an unblinded randomised multi-centre controlled study. Dig Liver Dis 2008;40:433-40. [PMID: 18296130 DOI: 10.1016/j.dld.2008.01.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 2.1] [Reference Citation Analysis]
496 Sica GS, Iaculli E, Benavoli D, Biancone L, Calabrese E, Onali S, Gaspari AL. Laparoscopic versus open ileo-colonic resection in Crohn's disease: short- and long-term results from a prospective longitudinal study. J Gastrointest Surg 2008;12:1094-102. [PMID: 18027061 DOI: 10.1007/s11605-007-0394-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
497 Billerey-Larmonier C, Uno JK, Larmonier N, Midura AJ, Timmermann B, Ghishan FK, Kiela PR. Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent. Inflamm Bowel Dis 2008;14:780-93. [PMID: 18200517 DOI: 10.1002/ibd.20348] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 3.3] [Reference Citation Analysis]
498 Zhang QF, Qiu XF, Zhang CP, Yang JB, Chen ZL. Pathogenic role of macrophage migration inhibitory factor in inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2008; 16(15): 1645-1648 [DOI: 10.11569/wcjd.v16.i15.1645] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
499 Deban L, Correale C, Vetrano S, Malesci A, Danese S. Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a Jack of all trades. Am J Pathol. 2008;172:1457-1466. [PMID: 18458096 DOI: 10.2353/ajpath.2008.070593] [Cited by in Crossref: 90] [Cited by in F6Publishing: 99] [Article Influence: 6.0] [Reference Citation Analysis]
500 Deban L, Correale C, Vetrano S, Malesci A, Danese S. Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a Jack of all trades. Am J Pathol. 2008;172:1457-1466. [PMID: 18458096 DOI: 10.2353/ajpath.2008070593] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
501 Hanai H, Iida T, Takeuchi K, Watanabe F, Yamada M, Kikuyama M, Maruyama Y, Iwaoka Y, Hirayama K, Nagata S, Takai K. Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease. Am J Gastroenterol 2008;103:1210-6. [PMID: 18177452 DOI: 10.1111/j.1572-0241.2007.01714.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 82] [Article Influence: 5.2] [Reference Citation Analysis]
502 Ardesjö B, Portela-Gomes GM, Rorsman F, Gerdin E, Lööf L, Grimelius L, Kämpe O, Ekwall O. Immunoreactivity against Goblet cells in patients with inflammatory bowel disease. Inflamm Bowel Dis 2008;14:652-61. [PMID: 18213698 DOI: 10.1002/ibd.20370] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
503 Singh UP, Singh S, Singh R, Cong Y, Taub DD, Lillard JW. CXCL10-producing mucosal CD4+ T cells, NK cells, and NKT cells are associated with chronic colitis in IL-10(-/-) mice, which can be abrogated by anti-CXCL10 antibody inhibition. J Interferon Cytokine Res. 2008;28:31-43. [PMID: 18370870 DOI: 10.1089/jir.2007.0059] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 2.8] [Reference Citation Analysis]
504 Jarry A, Bossard C, Bou-Hanna C, Masson D, Espaze E, Denis MG, Laboisse CL. Mucosal IL-10 and TGF-beta play crucial roles in preventing LPS-driven, IFN-gamma-mediated epithelial damage in human colon explants. J Clin Invest. 2008;118:1132-1142. [PMID: 18259614 DOI: 10.1172/jci32140] [Cited by in Crossref: 26] [Cited by in F6Publishing: 69] [Article Influence: 1.7] [Reference Citation Analysis]
505 Ho J, Kurtz CC, Naganuma M, Ernst PB, Cominelli F, Rivera-Nieves J. A CD8+/CD103high T cell subset regulates TNF-mediated chronic murine ileitis. J Immunol 2008;180:2573-80. [PMID: 18250468 DOI: 10.4049/jimmunol.180.4.2573] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 3.5] [Reference Citation Analysis]
506 Torres M, Ríos A. Current view of the immunopathogenesis in inflammatory bowel disease and its implications for therapy. World J Gastroenterol 2008; 14(13): 1972-1980 [PMID: 18395894 DOI: 10.3748/wjg.14.1972] [Cited by in CrossRef: 66] [Cited by in F6Publishing: 69] [Article Influence: 4.4] [Reference Citation Analysis]
507 Holland N, Dong J, Garnett E, Shaikh N, Huen K, Harmatz P, Olive A, Winter HS, Gold BD, Cohen SA, Baldassano RN, Kirschner BS, Heyman MB. Reduced intracellular T-helper 1 interferon-gamma in blood of newly diagnosed children with Crohn's disease and age-related changes in Th1/Th2 cytokine profiles. Pediatr Res 2008;63:257-62. [PMID: 18287963 DOI: 10.1203/PDR.0b013e318163a897] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
508 Shimamoto M, Ueno Y, Tanaka S, Onitake T, Hanaoka R, Yoshioka K, Hatakeyama T, Chayama K. Selective decrease in colonic CD56(+) T and CD161(+) T cells in the inflamed mucosa of patients with ulcerative colitis. World J Gastroenterol 2007;13:5995-6002. [PMID: 18023089 DOI: 10.3748/wjg.v13.45.5995] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
509 Kaliora AC, Stathopoulou MG, Triantafillidis JK, Dedoussis GV, Andrikopoulos NK. Alterations in the function of circulating mononuclear cells derived from patients with Crohn’s disease treated with mastic. World J Gastroenterol. 2007;13:6031-6036. [PMID: 18023095 DOI: 10.3748/wjg.13.6031] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
510 Popivanova BK, Kitamura K, Wu Y, Kondo T, Kagaya T, Kaneko S, Oshima M, Fujii C, Mukaida N. Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest 2008;118:560-70. [PMID: 18219394 DOI: 10.1172/JCI32453] [Cited by in Crossref: 109] [Cited by in F6Publishing: 420] [Article Influence: 7.3] [Reference Citation Analysis]
511 Kaliora AC, Stathopoulou MG, Triantafillidis JK, Dedoussis GV, Andrikopoulos NK. Alterations in the function of circulating mononuclear cells derived from patients with Crohn's disease treated with mastic. World J Gastroenterol 2007;13:6031-6. [PMID: 18023095 DOI: 10.3748/wjg.v13.45.6031] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 17] [Article Influence: 0.1] [Reference Citation Analysis]
512 Milia AF, Manetti M, Generini S, Polidori L, Benelli G, Cinelli M, Messerini L, Ibba-Manneschi L, Matucci-Cerinic M. TNFalpha blockade prevents the development of inflammatory bowel disease in HLA-B27 transgenic rats. J Cell Mol Med. 2009;13:164-176. [PMID: 18363845 DOI: 10.1111/j.1582-4934.2008.00310.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
513 Cuadrado E, Alonso M, Juan MD, Echaniz P, Arenas JI. Regulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis. World J Gastroenterol 2008; 14(10): 1521-1527 [PMID: 18330941 DOI: 10.3748/wjg.14.1521] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
514 Sidler MA, Leach ST, Day AS. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children. Inflamm Bowel Dis 2008;14:359-66. [PMID: 18050298 DOI: 10.1002/ibd.20336] [Cited by in Crossref: 100] [Cited by in F6Publishing: 88] [Article Influence: 6.7] [Reference Citation Analysis]
515 Wynands J, Belbouab R, Candon S, Talbotec C, Mougenot JF, Chatenoud L, Schmitz J, Cézard JP, Goulet O, Hugot JP, Ruemmele FM. 12-month follow-up after successful infliximab therapy in pediatric crohn disease. J Pediatr Gastroenterol Nutr 2008;46:293-8. [PMID: 18376247 DOI: 10.1097/MPG.0b013e31815604cd] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
516 Sakiyama T, Fujita H, Tsubouchi H. Autoantibodies against ubiquitination factor E4A (UBE4A) are associated with severity of Crohn's disease. Inflamm Bowel Dis 2008;14:310-7. [PMID: 18069675 DOI: 10.1002/ibd.20328] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
517 Stronati L, Negroni A, Merola P, Pannone V, Borrelli O, Cirulli M, Annese V, Cucchiara S. Mucosal NOD2 expression and NF-kappaB activation in pediatric Crohn's disease. Inflamm Bowel Dis 2008;14:295-302. [PMID: 18092345 DOI: 10.1002/ibd.20332] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
518 Sitohy B, Hammarström S, Danielsson A, Hammarström ML. Basal lymphoid aggregates in ulcerative colitis colon: a site for regulatory T cell action. Clin Exp Immunol 2008;151:326-33. [PMID: 18190460 DOI: 10.1111/j.1365-2249.2007.03566.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
519 André MF, Aumaître O, Piette JC, Grateau G, Cardoso MC, Ouchchane L, Kémény JL, Dastugue B, Delpech M, Creveaux I. Analysis of the NOD2/CARD15 gene in patients affected with the aseptic abscesses syndrome with or without inflammatory bowel disease. Dig Dis Sci 2008;53:490-9. [PMID: 17570063 DOI: 10.1007/s10620-007-9871-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
520 Sun X, Somada S, Shibata K, Muta H, Yamada H, Yoshihara H, Honda K, Nakamura K, Takayanagi R, Tani K, Podack ER, Yoshikai Y. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice. Gastroenterology 2008;134:447-58. [PMID: 18242212 DOI: 10.1053/j.gastro.2007.11.004] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 3.4] [Reference Citation Analysis]
521 Sturm A, Dignass AU. Epithelial restitution and wound healing in inflammatory bowel disease. World J Gastroenterol 2008; 14(3): 348-353 [PMID: 18200658 DOI: 10.3748/wjg.14.348] [Cited by in CrossRef: 235] [Cited by in F6Publishing: 247] [Article Influence: 15.7] [Reference Citation Analysis]
522 Garcia Vilela E, De Lourdes De Abreu Ferrari M, Oswaldo Da Gama Torres H, Guerra Pinto A, Carolina Carneiro Aguirre A, Paiva Martins F, Marcos Andrade Goulart E, Sales Da Cunha A. Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn's disease in remission. Scand J Gastroenterol 2008;43:842-8. [PMID: 18584523 DOI: 10.1080/00365520801943354] [Cited by in Crossref: 125] [Cited by in F6Publishing: 119] [Article Influence: 8.3] [Reference Citation Analysis]
523 Leach ST, Messina I, Lemberg DA, Novick D, Rubenstein M, Day AS. Local and systemic interleukin-18 and interleukin-18-binding protein in children with inflammatory bowel disease. Inflamm Bowel Dis 2008;14:68-74. [PMID: 17879274 DOI: 10.1002/ibd.20272] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
524 AETIOLOGY, PATHOLOGY AND MEDICAL ASPECTS OF ULCERATIVE COLITIS. Surgery of the Anus, Rectum & Colon 2008. [DOI: 10.1016/b978-0-7020-2723-9.50040-3] [Reference Citation Analysis]
525 Hodin RA, Matthews JB. Small Intestine. Surgery 2008. [DOI: 10.1007/978-0-387-68113-9_50] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
526 Mönch W, Breuker D, Schulze C. Bauchschmerzen und gynäkologische Schmerzen. Schmerzpsychotherapie. [DOI: 10.1007/978-3-540-72284-7_23] [Reference Citation Analysis]
527 Fiocchi C. State-of-the Art Lecture: The multifactorial pathogenesis of inflammatory bowel disease. Falk Symposium. [DOI: 10.1007/978-1-4020-6116-5_1] [Reference Citation Analysis]
528 Paclik D, Berndt U, Guzy C, Dankof A, Danese S, Holzloehner P, Rosewicz S, Wiedenmann B, Wittig BM, Dignass AU. Galectin-2 induces apoptosis of lamina propria T lymphocytes and ameliorates acute and chronic experimental colitis in mice. J Mol Med (Berl). 2008;86:1395-1406. [PMID: 18064431 DOI: 10.1007/s00109-007-0290-2] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 4.4] [Reference Citation Analysis]
529 Kaliora AC, Stathopoulou MG, Triantafillidis JK, Dedoussis GV, Andrikopoulos NK. Alterations in the function of circulating mononuclear cells derived from patients with Crohn’s disease treated with mastic. World J Gastroenterol 2007; 13(45): 6031-6036 [DOI: 10.3748/wjg.v13.i45.6031] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
530 Shimamoto M, Ueno Y, Tanaka S, Onitake T, Hanaoka R, Yoshioka K, Hatakeyama T, Chayama K. Selective decrease in colonic CD56+ T and CD161+ T cells in the inflamed mucosa of patients with ulcerative colitis. World J Gastroenterol 2007; 13(45): 5995-6002 [DOI: 10.3748/wjg.v13.i45.5995] [Reference Citation Analysis]
531 Kugathasan S, Saubermann LJ, Smith L, Kou D, Itoh J, Binion DG, Levine AD, Blumberg RS, Fiocchi C. Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease. Gut 2007;56:1696-705. [PMID: 17682002 DOI: 10.1136/gut.2006.116467] [Cited by in Crossref: 132] [Cited by in F6Publishing: 99] [Article Influence: 8.3] [Reference Citation Analysis]
532 Jäghult S, Larson J, Wredling R, Kapraali M. A multiprofessional education programme for patients with inflammatory bowel disease: a randomized controlled trial. Scand J Gastroenterol 2007;42:1452-9. [PMID: 17852871 DOI: 10.1080/00365520701439685] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
533 Juyal G, Amre D, Midha V, Sood A, Seidman E, Thelma BK. Evidence of allelic heterogeneity for associations between the NOD2/CARD15 gene and ulcerative colitis among North Indians. Aliment Pharmacol Ther 2007;26:1325-32. [PMID: 17892524 DOI: 10.1111/j.1365-2036.2007.03524.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
534 Kwon HS, Oh SM, Kim JK. Glabridin, a functional compound of liquorice, attenuates colonic inflammation in mice with dextran sulphate sodium-induced colitis. Clin Exp Immunol. 2008;151:165-173. [PMID: 18005263 DOI: 10.1111/j.1365-2249.2007.03539.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 78] [Article Influence: 4.8] [Reference Citation Analysis]
535 Moser G. Psychosomatische Aspekte chronisch entzündlicher Darmerkrankungen. Psychosomatik in der Gastroenterologie und Hepatologie. [DOI: 10.1007/978-3-211-69159-5_13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
536 Leach ST, Yang Z, Messina I, Song C, Geczy CL, Cunningham AM, Day AS. Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease. Scand J Gastroenterol 2007;42:1321-31. [PMID: 17852869 DOI: 10.1080/00365520701416709] [Cited by in Crossref: 124] [Cited by in F6Publishing: 110] [Article Influence: 7.8] [Reference Citation Analysis]
537 Seiderer J, Herrmann K, Diepolder H, Schoenberg SO, Wagner AC, Göke B, Ochsenkühn T, Schäfer C. Double-balloon enteroscopy versus magnetic resonance enteroclysis in diagnosing suspected small-bowel Crohn's disease: results of a pilot study. Scand J Gastroenterol 2007;42:1376-85. [PMID: 17852865 DOI: 10.1080/00365520701397867] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]
538 Saibeni S, Spina L, Virgilio T, Folcioni A, Borsi G, de Franchis R, Cugno M, Vecchi M. Angiotensin-converting enzyme insertion/deletion gene polymorphism in inflammatory bowel diseases. Eur J Gastroenterol Hepatol 2007;19:976-81. [PMID: 18049167 DOI: 10.1097/MEG.0b013e3282efa3fc] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
539 Abreu MT, Plevy S, Sands BE, Weinstein R. Selective leukocyte apheresis for the treatment of inflammatory bowel disease. J Clin Gastroenterol 2007;41:874-88. [PMID: 18090155 DOI: 10.1097/MCG.0b013e3180479435] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
540 Caviglia R, Ribolsi M, Rizzi M, Emerenziani S, Annunziata ML, Cicala M. Maintenance of remission with infliximab in inflammatory bowel disease: Efficacy and safety long-term follow-up. World J Gastroenterol 2007; 13(39): 5238-5244 [PMID: 17876895 DOI: 10.3748/wjg.v13.i39.5238] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 39] [Article Influence: 2.3] [Reference Citation Analysis]
541 Freeman HJ. Application of the Montreal classification for Crohn’s disease to a single clinician database of 1015 patients. Can J Gastroenterol. 2007;21:363-366. [PMID: 17571169 DOI: 10.1155/2007/951526] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 2.1] [Reference Citation Analysis]
542 De Simone M, Ciulla MM, Cioffi U, Poggi L, Oreggia B, Paliotti R, Botti F, Carrara A, Agosti F, Sartorio A, Contessini-Avesani E. Effects of surgery on peripheral N-terminal propeptide of type III procollagen in patients with Crohn's disease. J Gastrointest Surg 2007;11:1361-4. [PMID: 17687618 DOI: 10.1007/s11605-007-0233-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
543 Ghia JE, Blennerhassett P, El-Sharkawy RT, Collins SM. The protective effect of the vagus nerve in a murine model of chronic relapsing colitis. Am J Physiol Gastrointest Liver Physiol 2007;293:G711-8. [PMID: 17673544 DOI: 10.1152/ajpgi.00240.2007] [Cited by in Crossref: 100] [Cited by in F6Publishing: 91] [Article Influence: 6.3] [Reference Citation Analysis]
544 Leshinsky-Silver E, Karban A, Dalal I, Eliakim R, Shirin H, Tzofi T, Boaz M, Levine A. Evaluation of the interleukin-23 receptor gene coding variant R381Q in pediatric and adult Crohn disease. J Pediatr Gastroenterol Nutr 2007;45:405-8. [PMID: 18030204 DOI: 10.1097/MPG.0b013e318141a1de] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
545 Selmeczy Z, Csóka B, Pacher P, Vizi ES, Haskó G. The adenosine A2A receptor agonist CGS 21680 fails to ameliorate the course of dextran sulphate-induced colitis in mice. Inflamm Res 2007;56:204-9. [PMID: 17588136 DOI: 10.1007/s00011-006-6150-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
546 Scaldaferri F, Sans M, Vetrano S, Graziani C, De Cristofaro R, Gerlitz B, Repici A, Arena V, Malesci A, Panes J. Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease. J Clin Invest. 2007;117:1951-1960. [PMID: 17557119 DOI: 10.1172/jci31027] [Cited by in Crossref: 94] [Cited by in F6Publishing: 99] [Article Influence: 5.9] [Reference Citation Analysis]
547 Brown SJ, Mayer L. The immune response in inflammatory bowel disease. Am J Gastroenterol 2007;102:2058-69. [PMID: 17561966 DOI: 10.1111/j.1572-0241.2007.01343.x] [Cited by in Crossref: 158] [Cited by in F6Publishing: 162] [Article Influence: 9.9] [Reference Citation Analysis]
548 Ghia JE, Blennerhassett P, Collins SM. Vagus nerve integrity and experimental colitis. Am J Physiol Gastrointest Liver Physiol 2007;293:G560-7. [PMID: 17585014 DOI: 10.1152/ajpgi.00098.2007] [Cited by in Crossref: 70] [Cited by in F6Publishing: 68] [Article Influence: 4.4] [Reference Citation Analysis]
549 Treede I, Braun A, Sparla R, Kühnel M, Giese T, Turner JR, Anes E, Kulaksiz H, Füllekrug J, Stremmel W, Griffiths G, Ehehalt R. Anti-inflammatory effects of phosphatidylcholine. J Biol Chem 2007;282:27155-64. [PMID: 17636253 DOI: 10.1074/jbc.M704408200] [Cited by in Crossref: 172] [Cited by in F6Publishing: 179] [Article Influence: 10.8] [Reference Citation Analysis]
550 Lomax AE, O'Reilly M, Neshat S, Vanner SJ. Sympathetic vasoconstrictor regulation of mouse colonic submucosal arterioles is altered in experimental colitis. J Physiol 2007;583:719-30. [PMID: 17615098 DOI: 10.1113/jphysiol.2007.136838] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
551 Wu F, Dassopoulos T, Cope L, Maitra A, Brant SR, Harris ML, Bayless TM, Parmigiani G, Chakravarti S. Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis. Inflamm Bowel Dis 2007;13:807-21. [PMID: 17262812 DOI: 10.1002/ibd.20110] [Cited by in Crossref: 188] [Cited by in F6Publishing: 176] [Article Influence: 11.8] [Reference Citation Analysis]
552 Jergens AE, Wilson-Welder JH, Dorn A, Henderson A, Liu Z, Evans RB, Hostetter J, Wannemuehler MJ. Helicobacter bilis triggers persistent immune reactivity to antigens derived from the commensal bacteria in gnotobiotic C3H/HeN mice. Gut 2007;56:934-40. [PMID: 17145736 DOI: 10.1136/gut.2006.099242] [Cited by in Crossref: 79] [Cited by in F6Publishing: 81] [Article Influence: 4.9] [Reference Citation Analysis]
553 Chidlow JH Jr, Shukla D, Grisham MB, Kevil CG. Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues. Am J Physiol Gastrointest Liver Physiol 2007;293:G5-G18. [PMID: 17463183 DOI: 10.1152/ajpgi.00107.2007] [Cited by in Crossref: 110] [Cited by in F6Publishing: 101] [Article Influence: 6.9] [Reference Citation Analysis]
554 Danese S. Inflammation and the mucosal microcirculation in inflammatory bowel disease: the ebb and flow. Curr Opin Gastroenterol 2007;23:384-9. [PMID: 17545773 DOI: 10.1097/MOG.0b013e32810c8de3] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 2.4] [Reference Citation Analysis]
555 Nam SY, Kim N, Kim JS, Lim SH, Jung HC, Song IS. Heat shock protein gene 70-2 polymorphism is differentially associated with the clinical phenotypes of ulcerative colitis and Crohn's disease. J Gastroenterol Hepatol 2007;22:1032-8. [PMID: 17532782 DOI: 10.1111/j.1440-1746.2007.04927.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
556 Eijkelkamp N, Heijnen CJ, Lucas A, Premont RT, Elsenbruch S, Schedlowski M, Kavelaars A. G protein-coupled receptor kinase 6 controls chronicity and severity of dextran sodium sulphate-induced colitis in mice. Gut 2007;56:847-54. [PMID: 17229795 DOI: 10.1136/gut.2006.107094] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 2.4] [Reference Citation Analysis]
557 Dotan I, Allez M, Nakazawa A, Brimnes J, Schulder-Katz M, Mayer L. Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+ T cells to proliferate and secrete interferon-gamma. Am J Physiol Gastrointest Liver Physiol 2007;292:G1630-40. [PMID: 17347451 DOI: 10.1152/ajpgi.00294.2006] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 3.4] [Reference Citation Analysis]
558 Sari S, Egritas O, Dalgic B. The familial Mediterranean fever (MEFV) gene may be a modifier factor of inflammatory bowel disease in infancy. Eur J Pediatr. 2008;167:391-393. [PMID: 17520284 DOI: 10.1007/s00431-007-0508-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 1.6] [Reference Citation Analysis]
559 Marteau P, Shanahan F. Role of antibiotics and probiotics in the management of inflammatory bowel disease. Inflammatory Bowel Disease: From Bench to Bedside. [DOI: 10.1007/0-387-25808-6_28] [Reference Citation Analysis]
560 Hershberg R, Blumberg RS. The lymphocyte-epithelial-bacterial interface. Inflammatory Bowel Disease: From Bench to Bedside. [DOI: 10.1007/0-387-25808-6_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
561 Göke MN, Podolsky DK. Remission, relapse, intestinal healing and repair. Inflammatory Bowel Disease: From Bench to Bedside. [DOI: 10.1007/0-387-25808-6_9] [Reference Citation Analysis]
562 Grisham MB, Laroux FS, Granger DN. Role of the microcirculation in chronic gut inflammation. Inflammatory Bowel Disease: From Bench to Bedside. [DOI: 10.1007/0-387-25808-6_8] [Reference Citation Analysis]
563 Collins SM, Croitoru K. Pathophysiology of inflammatory bowel disease: the effect of inflammation on intestinal function. Inflammatory Bowel Disease: From Bench to Bedside. [DOI: 10.1007/0-387-25808-6_11] [Reference Citation Analysis]
564 Sartor RB, Lichtman SN. Mechanisms of systemic inflammation associated with intestinal injury. Inflammatory Bowel Disease: From Bench to Bedside. [DOI: 10.1007/0-387-25808-6_16] [Reference Citation Analysis]
565 Katsinelos P, Kountouras J, Paroutoglou G, Zavos C. Alopecia areata, primary sclerosing cholangitis, and ulcerative colitis: autoimmunity and apoptosis as common links? Dig Dis Sci 2007;52:1288-92. [PMID: 17372831 DOI: 10.1007/s10620-006-9265-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
566 Magyari L, Faragó B, Bene J, Horvatovich K, Lakner L, Varga M, Figler M, Gasztonyi B, Mózsik G, Melegh B. No association of the cytotoxic T-lymphocyte associated gene CTLA4 +49A/G polymorphisms with Crohn’s disease and ulcerative colitis in Hungarian population samples. World J Gastroenterol 2007; 13(15): 2205-2208 [PMID: 17465502 DOI: 10.3748/wjg.v13.i15.2205] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
567 Carvalho AT, Souza H, Carneiro AJ, Castelo-Branco M, Madi K, Schanaider A, Silva F, Pereira Jứnior FA, Pereira MG, Tortori C, Dines I, Carvalho J, Rocha E, Elia C. Therapeutic and prophylactic thalidomide in TNBS-induced colitis: Synergistic effects on TNF-α, IL-12 and VEGF production. World J Gastroenterol 2007; 13(15): 2166-2173 [PMID: 17465495 DOI: 10.3748/wjg.v13.i15.2166] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 22] [Article Influence: 1.1] [Reference Citation Analysis]
568 Uzoigwe JC, Khaitsa ML, Gibbs PS. Epidemiological evidence for Mycobacterium avium subspecies paratuberculosis as a cause of Crohn's disease. Epidemiol Infect 2007;135:1057-68. [PMID: 17445316 DOI: 10.1017/S0950268807008448] [Cited by in Crossref: 63] [Cited by in F6Publishing: 68] [Article Influence: 3.9] [Reference Citation Analysis]
569 Bishop RF, Kirkwood CD. The search for an infectious cause of Crohn’s disease. Falk Symposium. [DOI: 10.1007/978-1-4020-5702-1_9] [Reference Citation Analysis]
570 Zhao J, de Vera J, Narushima S, Beck EX, Palencia S, Shinkawa P, Kim KA, Liu Y, Levy MD, Berg DJ, Abo A, Funk WD. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice. Gastroenterology 2007;132:1331-43. [PMID: 17408649 DOI: 10.1053/j.gastro.2007.02.001] [Cited by in Crossref: 100] [Cited by in F6Publishing: 105] [Article Influence: 6.3] [Reference Citation Analysis]
571 Smith JP, Stock H, Bingaman S, Mauger D, Rogosnitzky M, Zagon IS. Low-dose naltrexone therapy improves active Crohn's disease. Am J Gastroenterol 2007;102:820-8. [PMID: 17222320 DOI: 10.1111/j.1572-0241.2007.01045.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 92] [Article Influence: 5.3] [Reference Citation Analysis]
572 Spencer AU, Yang H, Haxhija EQ, Wildhaber BE, Greenson JK, Teitelbaum DH. Reduced severity of a mouse colitis model with angiotensin converting enzyme inhibition. Dig Dis Sci 2007;52:1060-70. [PMID: 17342403 DOI: 10.1007/s10620-006-9124-2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 2.8] [Reference Citation Analysis]
573 De Vry CG, Prasad S, Komuves L, Lorenzana C, Parham C, Le T, Adda S, Hoffman J, Kahoud N, Garlapati R, Shyamsundar R, Mai K, Zhang J, Muchamuel T, Dajee M, Schryver B, McEvoy LM, Ehrhardt RO. Non-viral delivery of nuclear factor-kappaB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis. Gut 2007;56:524-33. [PMID: 16950831 DOI: 10.1136/gut.2006.096487] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 2.5] [Reference Citation Analysis]
574 Zahn A, Moehle C, Langmann T, Ehehalt R, Autschbach F, Stremmel W, Schmitz G. Aquaporin-8 expression is reduced in ileum and induced in colon of patients with ulcerative colitis. World J Gastroenterol 2007; 13(11): 1687-1695 [PMID: 17461471 DOI: 10.3748/wjg.v13.i11.1687] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 42] [Article Influence: 2.5] [Reference Citation Analysis]
575 Polese L, De Franchis G, Scarpa M, Sturniolo GC, Ruffolo C, Norberto L, Frego M, D'Amico DF, Angriman I. B1a lymphocytes in ulcerative colitis. Int J Colorectal Dis. 2007;22:1005-1011. [PMID: 17372743 DOI: 10.1007/s00384-007-0298-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
576 Shen C, de Hertogh G, Bullens DM, Van Assche G, Geboes K, Rutgeerts P, Ceuppens JL. Remission-inducing effect of anti-TNF monoclonal antibody in TNBS colitis: mechanisms beyond neutralization? Inflamm Bowel Dis 2007;13:308-16. [PMID: 17206708 DOI: 10.1002/ibd.20005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 2.8] [Reference Citation Analysis]
577 Kanai T, Makita S, Kawamura T, Nemoto Y, Kubota D, Nagayama K, Totsuka T, Watanabe M. Extracorporeal elimination of TNF-alpha-producing CD14(dull)CD16(+) monocytes in leukocytapheresis therapy for ulcerative colitis. Inflamm Bowel Dis 2007;13:284-90. [PMID: 17206704 DOI: 10.1002/ibd.20017] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
578 Schmidt C, Giese T, Goebel R, Schilling M, Marth T, Ruether A, Schreiber S, Zeuzem S, Meuer SC, Stallmach A. Interleukin-18 is increased only in a minority of patients with active Crohn's disease. Int J Colorectal Dis. 2007;22:1013-1020. [PMID: 17318554 DOI: 10.1007/s00384-007-0282-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
579 Pavlick KP, Grisham MB. Lymphocyte integrins and the pathogenesis of experimental colitis. Falk Symposium. [DOI: 10.1007/1-4020-2912-8_8] [Reference Citation Analysis]
580 Tilg H. Role of cytokines and their receptors in inflammatory bowel diseases. Falk Symposium. [DOI: 10.1007/1-4020-2912-8_9] [Reference Citation Analysis]
581 Pele L, Powell JJ. Microparticles: a link between modern life and inflammatory bowel disease? Falk Symposium. [DOI: 10.1007/1-4020-2912-8_13] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
582 Furuta R, Ando T, Watanabe O, Maeda O, Ishiguro K, Ina K, Kusugami K, Goto H. Rebamipide enema therapy as a treatment for patients with active distal ulcerative colitis. J Gastroenterol Hepatol 2007;22:261-7. [PMID: 17295881 DOI: 10.1111/j.1440-1746.2006.04399.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
583 Ljung T, Thomsen OØ, Vatn M, Karlén P, Karlsen LN, Tysk C, Nilsson SU, Kilander A, Gillberg R, Grip O, Lindgren S, Befrits R, Löfberg R. Granulocyte, monocyte/macrophage apheresis for inflammatory bowel disease: the first 100 patients treated in Scandinavia. Scand J Gastroenterol 2007;42:221-7. [PMID: 17327942 DOI: 10.1080/00365520600979369] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
584 Yan Y, Dalmasso G, Sitaraman S, Merlin D. Characterization of the human intestinal CD98 promoter and its regulation by interferon-gamma. Am J Physiol Gastrointest Liver Physiol 2007;292:G535-45. [PMID: 17023546 DOI: 10.1152/ajpgi.00385.2006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
585 Marshall D, Cameron J, Lightwood D, Lawson AD. Blockade of colony stimulating factor-1 (CSF-I) leads to inhibition of DSS-induced colitis. Inflamm Bowel Dis 2007;13:219-24. [PMID: 17206685 DOI: 10.1002/ibd.20055] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 2.8] [Reference Citation Analysis]
586 Rufo PA, Bousvaros A. Current therapy of inflammatory bowel disease in children. Paediatr Drugs 2006;8:279-302. [PMID: 17037946 DOI: 10.2165/00148581-200608050-00002] [Cited by in Crossref: 74] [Cited by in F6Publishing: 81] [Article Influence: 4.6] [Reference Citation Analysis]
587 Stephens MC, Kugathasan S. Inflammatory Bowel Disease. Comprehensive Pediatric Hospital Medicine 2007. [DOI: 10.1016/b978-032303004-5.50102-2] [Reference Citation Analysis]
588 Schreiber S, Keshavarzian A, Isaacs KL, Schollenberger J, Guzman JP, Orlandi C, Hanauer SB. A randomized, placebo-controlled, phase II study of tetomilast in active ulcerative colitis. Gastroenterology 2007;132:76-86. [PMID: 17241861 DOI: 10.1053/j.gastro.2006.11.029] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 2.6] [Reference Citation Analysis]
589 Batra A, Siegmund B. Leptin and Gastrointestinal Inflammation. Adipose Tissue and Adipokines in Health and Disease 2007. [DOI: 10.1007/978-1-59745-370-7_8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
590 Connors JM. Crohn's Disease of the Stomach and Duodenum. xPharm: The Comprehensive Pharmacology Reference 2007. [DOI: 10.1016/b978-008055232-3.60714-7] [Reference Citation Analysis]
591 Bragagni G, Brogna R, Franceschetti P, Zoli G. Cardiac involvement in Crohn's disease: echocardiographic study. J Gastroenterol Hepatol 2007;22:18-22. [PMID: 17201875 DOI: 10.1111/j.1440-1746.2006.04384.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
592 Santucci L, Agostini M, Bruscoli S, Mencarelli A, Ronchetti S, Ayroldi E, Morelli A, Baldoni M, Riccardi C. GITR modulates innate and adaptive mucosal immunity during the development of experimental colitis in mice. Gut 2007;56:52-60. [PMID: 16763055 DOI: 10.1136/gut.2006.091181] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 3.4] [Reference Citation Analysis]
593 Rieder F, Brenmoehl J, Leeb S, Schölmerich J, Rogler G. Wound healing and fibrosis in intestinal disease. Gut 2007;56:130-9. [PMID: 17172588 DOI: 10.1136/gut.2006.090456] [Cited by in Crossref: 219] [Cited by in F6Publishing: 182] [Article Influence: 13.7] [Reference Citation Analysis]
594 Hanai H. Positions of selective leukocytapheresis in the medical therapy of ulcerative colitis. World J Gastroenterol 2006; 12(47): 7568-7577 [PMID: 17171783 DOI: 10.3748/wjg.v12.i47.7568] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 38] [Article Influence: 1.9] [Reference Citation Analysis]
595 Seiderer J, Schnitzler F, Brand S, Staudinger T, Pfennig S, Herrmann K, Hofbauer K, Dambacher J, Tillack C, Sackmann M, Göke B, Lohse P, Ochsenkühn T. Homozygosity for the CARD15 frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis. Scand J Gastroenterol 2006;41:1421-32. [PMID: 17101573 DOI: 10.1080/00365520600703900] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 3.4] [Reference Citation Analysis]
596 Gonzalez-Rey E, Delgado M. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide. Gastroenterology 2006;131:1799-811. [PMID: 17087944 DOI: 10.1053/j.gastro.2006.10.023] [Cited by in Crossref: 74] [Cited by in F6Publishing: 79] [Article Influence: 4.4] [Reference Citation Analysis]
597 Seiderer J, Brand S, Herrmann KA, Schnitzler F, Hatz R, Crispin A, Pfennig S, Schoenberg SO, Göke B, Lohse P, Ochsenkuhn T. Predictive value of the CARD15 variant 1007fs for the diagnosis of intestinal stenoses and the need for surgery in Crohn's disease in clinical practice: results of a prospective study. Inflamm Bowel Dis 2006;12:1114-21. [PMID: 17119385 DOI: 10.1097/01.mib.0000235836.32176.5e] [Cited by in Crossref: 71] [Cited by in F6Publishing: 61] [Article Influence: 4.2] [Reference Citation Analysis]
598 Rivera-Nieves J, Ho J, Bamias G, Ivashkina N, Ley K, Oppermann M, Cominelli F. Antibody blockade of CCL25/CCR9 ameliorates early but not late chronic murine ileitis. Gastroenterology 2006;131:1518-29. [PMID: 17101325 DOI: 10.1053/j.gastro.2006.08.031] [Cited by in Crossref: 98] [Cited by in F6Publishing: 106] [Article Influence: 5.8] [Reference Citation Analysis]
599 Oostenbrug LE, Nolte IM, Oosterom E, van der Steege G, te Meerman GJ, van Dullemen HM, Drenth JP, de Jong DJ, van der Linde K, Jansen PL, Kleibeuker JH. CARD15 in inflammatory bowel disease and Crohn's disease phenotypes: an association study and pooled analysis. Dig Liver Dis 2006;38:834-45. [PMID: 16920047 DOI: 10.1016/j.dld.2006.06.042] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
600 Kiyosue M, Fujisawa M, Kinoshita K, Hori M, Ozaki H. Different susceptibilities of spontaneous rhythmicity and myogenic contractility to intestinal muscularis inflammation in the hapten-induced colitis. Neurogastroenterol Motil 2006;18:1019-30. [PMID: 17040413 DOI: 10.1111/j.1365-2982.2006.00841.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
601 Van Assche G, Sandborn WJ, Feagan BG, Salzberg BA, Silvers D, Monroe PS, Pandak WM, Anderson FH, Valentine JF, Wild GE, Geenen DJ, Sprague R, Targan SR, Rutgeerts P, Vexler V, Young D, Shames RS. Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial. Gut 2006;55:1568-74. [PMID: 16603634 DOI: 10.1136/gut.2005.089854] [Cited by in Crossref: 107] [Cited by in F6Publishing: 92] [Article Influence: 6.3] [Reference Citation Analysis]
602 Cousins L, Graham M, Tooze R, Carter C, Miller JR, Powrie FM, Macpherson GG, Butcher GW. Eosinophilic bowel disease controlled by the BB rat-derived lymphopenia/Gimap5 gene. Gastroenterology 2006;131:1475-85. [PMID: 17064701 DOI: 10.1053/j.gastro.2006.09.023] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 1.6] [Reference Citation Analysis]
603 Videla S, Lugea A, Vilaseca J, Guarner F, Treserra F, Salas A, Crespo E, Medina C, Malagelada JR. Polyethylene glycol enhances colonic barrier function and ameliorates experimental colitis in rats. Int J Colorectal Dis. 2007;22:571-580. [PMID: 17061105 DOI: 10.1007/s00384-006-0232-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
604 Baldwin A. NF-_B and IKK as Key Mediators of Inflammation andOncogenic Progression. Handbook of Transcription Factor NF-kappaB 2006. [DOI: 10.1201/9781420004274.ch8] [Reference Citation Analysis]
605 Morohoshi Y, Matsuoka K, Chinen H, Kamada N, Sato T, Hisamatsu T, Okamoto S, Inoue N, Takaishi H, Ogata H. Inhibition of neutrophil elastase prevents the development of murine dextran sulfate sodium-induced colitis. J Gastroenterol. 2006;41:318-324. [PMID: 16741610 DOI: 10.1007/s00535-005-1768-8] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 3.1] [Reference Citation Analysis]
606 Helwig U, Lammers KM, Rizzello F, Brigidi P, Rohleder V, Caramelli E, Gionchetti P, Schrezenmeir J, Foelsch UR, Schreiber S, Campieri M. Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells. World J Gastroenterol 2006; 12(37): 5978-5986 [PMID: 17009396 DOI: 10.3748/wjg.v12.i37.5978] [Cited by in CrossRef: 88] [Cited by in F6Publishing: 92] [Article Influence: 5.2] [Reference Citation Analysis]
607 Oostenbrug LE, Dijkstra G, Nolte IM, van Dullemen HM, Oosterom E, Faber KN, de Jong DJ, van der Linde K, te Meerman GJ, van der Steege G, Kleibeuker JH, Jansen PL. Absence of association between the multidrug resistance (MDR1) gene and inflammatory bowel disease. Scand J Gastroenterol 2006;41:1174-82. [PMID: 16990202 DOI: 10.1080/00365520600575746] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
608 Ghia JE, Blennerhassett P, Kumar-Ondiveeran H, Verdu EF, Collins SM. The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology 2006;131:1122-30. [PMID: 17030182 DOI: 10.1053/j.gastro.2006.08.016] [Cited by in Crossref: 282] [Cited by in F6Publishing: 290] [Article Influence: 16.6] [Reference Citation Analysis]
609 Tamaki H, Nakamura H, Nishio A, Nakase H, Ueno S, Uza N, Kido M, Inoue S, Mikami S, Asada M, Kiriya K, Kitamura H, Ohashi S, Fukui T, Kawasaki K, Matsuura M, Ishii Y, Okazaki K, Yodoi J, Chiba T. Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production. Gastroenterology 2006;131:1110-21. [PMID: 17030181 DOI: 10.1053/j.gastro.2006.08.023] [Cited by in Crossref: 89] [Cited by in F6Publishing: 95] [Article Influence: 5.2] [Reference Citation Analysis]
610 Eloy P, Leruth E, Goffart Y, Nollevaux MC, Fridman V, Dartevelle M, Melange M, Daele J, Bertrand B. Sinonasal involvement as a rare extraintestinal manifestation of Crohn's disease. Eur Arch Otorhinolaryngol 2007;264:103-8. [PMID: 17021783 DOI: 10.1007/s00405-006-0146-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
611 Nishihara T, Matsuda M, Araki H, Oshima K, Kihara S, Funahashi T, Shimomura I. Effect of adiponectin on murine colitis induced by dextran sulfate sodium. Gastroenterology 2006;131:853-61. [PMID: 16952554 DOI: 10.1053/j.gastro.2006.06.015] [Cited by in Crossref: 101] [Cited by in F6Publishing: 107] [Article Influence: 5.9] [Reference Citation Analysis]
612 Bohn E, Bechtold O, Zahir N, Frick JS, Reimann J, Jilge B, Autenrieth IB. Host gene expression in the colon of gnotobiotic interleukin-2-deficient mice colonized with commensal colitogenic or noncolitogenic bacterial strains: common patterns and bacteria strain specific signatures. Inflamm Bowel Dis 2006;12:853-62. [PMID: 16954804 DOI: 10.1097/01.mib.0000231574.73559.75] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 1.6] [Reference Citation Analysis]
613 Porras M, Martín MT, Yang PC, Jury J, Perdue MH, Vergara P. Correlation between cyclical epithelial barrier dysfunction and bacterial translocation in the relapses of intestinal inflammation. Inflamm Bowel Dis 2006;12:843-52. [PMID: 16954803 DOI: 10.1097/01.mib.0000231571.88806.62] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 2.9] [Reference Citation Analysis]
614 Flach CF, Eriksson A, Jennische E, Lange S, Gunnerek C, Lönnroth I. Detection of elafin as a candidate biomarker for ulcerative colitis by whole-genome microarray screening. Inflamm Bowel Dis 2006;12:837-42. [PMID: 16954802 DOI: 10.1097/01.mib.0000232469.23574.11] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
615 Grabig A, Paclik D, Guzy C, Dankof A, Baumgart DC, Erckenbrecht J, Raupach B, Sonnenborn U, Eckert J, Schumann RR. Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways. Infect Immun. 2006;74:4075-4082. [PMID: 16790781 DOI: 10.1128/iai.01449-05] [Cited by in Crossref: 134] [Cited by in F6Publishing: 142] [Article Influence: 7.9] [Reference Citation Analysis]
616 Grémy O, Benderitter M, Linard C. Caffeic acid phenethyl ester modifies the Th1/Th2 balance in ileal mucosa after γ-irradiation in the rat by modulating the cytokine pattern. World J Gastroenterol 2006; 12(31): 4996-5004 [PMID: 16937495 DOI: 10.3748/wjg.v12.i31.4996] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
617 Bartsch H, Nair J. Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair. Langenbecks Arch Surg. 2006;391:499-510. [PMID: 16909291 DOI: 10.1007/s00423-006-0073-1] [Cited by in Crossref: 335] [Cited by in F6Publishing: 279] [Article Influence: 19.7] [Reference Citation Analysis]
618 Nakamura K, Honda K, Mizutani T, Akiho H, Harada N. Novel strategies for the treatment of inflammatory bowel disease: Selective inhibition of cytokines and adhesion molecules. World J Gastroenterol 2006; 12(29): 4628-4635 [PMID: 16937430 DOI: 10.3748/wjg.v12.i29.4628] [Cited by in CrossRef: 76] [Cited by in F6Publishing: 80] [Article Influence: 4.5] [Reference Citation Analysis]
619 Eveson JW. Oral Cavity. Pathology of the Head and Neck. [DOI: 10.1007/3-540-30629-3_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
620 Yamamoto T, Saniabadi AR, Umegae S, Matsumoto K. Impact of selective leukocytapheresis on mucosal inflammation and ulcerative colitis: cytokine profiles and endoscopic findings. Inflamm Bowel Dis 2006;12:719-26. [PMID: 16917227 DOI: 10.1097/00054725-200608000-00008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
621 Uno JK, Kolek OI, Hines ER, Xu H, Timmermann BN, Kiela PR, Ghishan FK. The role of tumor necrosis factor alpha in down-regulation of osteoblast Phex gene expression in experimental murine colitis. Gastroenterology 2006;131:497-509. [PMID: 16890604 DOI: 10.1053/j.gastro.2006.05.020] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 2.5] [Reference Citation Analysis]
622 Andoh A, Fujiyama Y. Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease. World J Gastroenterol 2006; 12(28): 4452-4460 [PMID: 16874854 DOI: 10.3748/wjg.v12.i28.4452] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
623 Kanai T, Uraushihara K, Totsuka T, Nemoto Y, Fujii R, Kawamura T, Makita S, Sawada D, Yagita H, Okumura K, Watanabe M. Ameliorating effect of saporin-conjugated anti-CD11b monoclonal antibody in a murine T-cell-mediated chronic colitis. J Gastroenterol Hepatol 2006;21:1136-42. [PMID: 16824065 DOI: 10.1111/j.1440-1746.2006.04391.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
624 Shaoul R, Eliakim R, Tamir A, Karban A. Ileal lymphonodular hyperplasia is not associated with NOD2/CARD15 mutations. J Pediatr Gastroenterol Nutr 2006;43:30-4. [PMID: 16819374 DOI: 10.1097/01.mpg.0000226381.48989.f8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
625 Van der Sluis M, De Koning BA, De Bruijn AC, Velcich A, Meijerink JP, Van Goudoever JB, Büller HA, Dekker J, Van Seuningen I, Renes IB, Einerhand AW. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 2006;131:117-29. [PMID: 16831596 DOI: 10.1053/j.gastro.2006.04.020] [Cited by in Crossref: 1038] [Cited by in F6Publishing: 1068] [Article Influence: 61.1] [Reference Citation Analysis]
626 Sheil B, MacSharry J, O'Callaghan L, O'Riordan A, Waters A, Morgan J, Collins JK, O'Mahony L, Shanahan F. Role of interleukin (IL-10) in probiotic-mediated immune modulation: an assessment in wild-type and IL-10 knock-out mice. Clin Exp Immunol 2006;144:273-80. [PMID: 16634801 DOI: 10.1111/j.1365-2249.2006.03051.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 2.5] [Reference Citation Analysis]
627 Heuschen G, Leowardi C, Hinz U, Autschbach F, Stallmach A, Herfarth C, Heuschen UA. Differential expression of toll-like receptor 3 and 5 in ileal pouch mucosa of ulcerative colitis patients. Int J Colorectal Dis 2007;22:293-301. [PMID: 16770571 DOI: 10.1007/s00384-006-0133-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
628 Hanai H, Iida T, Yamada M, Sato Y, Takeuchi K, Tanaka T, Kondo K, Kikuyama M, Maruyama Y, Iwaoka Y, Nakamura A, Hirayama K, Saniabadi AR, Watanabe F. Effects of adacolumn selective leukocytapheresis on plasma cytokines during active disease in patients with active ulcerative colitis. World J Gastroenterol 2006; 12(21): 3393-3399 [PMID: 16733857 DOI: 10.3748/wjg.v12.i21.3393] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 40] [Article Influence: 2.2] [Reference Citation Analysis]
629 Prantera C. Probiotics for Crohn's disease: what have we learned? Gut 2006;55:757-9. [PMID: 16698749 DOI: 10.1136/gut.2005.085381] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
630 Gonzalez-Rey E, Fernandez-Martin A, Chorny A, Delgado M. Therapeutic effect of urocortin and adrenomedullin in a murine model of Crohn's disease. Gut 2006;55:824-32. [PMID: 16401687 DOI: 10.1136/gut.2005.084525] [Cited by in Crossref: 81] [Cited by in F6Publishing: 75] [Article Influence: 4.8] [Reference Citation Analysis]
631 Babusukumar U, Wang T, McGuire E, Broeckel U, Kugathasan S. Contribution of OCTN variants within the IBD5 locus to pediatric onset Crohn's disease. Am J Gastroenterol 2006;101:1354-61. [PMID: 16771961 DOI: 10.1111/j.1572-0241.2006.00564.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 2.2] [Reference Citation Analysis]
632 Danese S, Sans M, de la Motte C, Graziani C, West G, Phillips MH, Pola R, Rutella S, Willis J, Gasbarrini A, Fiocchi C. Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroenterology 2006;130:2060-73. [PMID: 16762629 DOI: 10.1053/j.gastro.2006.03.054] [Cited by in Crossref: 273] [Cited by in F6Publishing: 296] [Article Influence: 16.1] [Reference Citation Analysis]
633 Diefenbach KA, Breuer CK. Pediatric inflammatory bowel disease. World J Gastroenterol 2006; 12(20): 3204-3212 [PMID: 16718840 DOI: 10.3748/wjg.v12.i20.3204] [Cited by in CrossRef: 78] [Cited by in F6Publishing: 84] [Article Influence: 4.6] [Reference Citation Analysis]
634 Hanada T, Kobayashi T, Chinen T, Saeki K, Takaki H, Koga K, Minoda Y, Sanada T, Yoshioka T, Mimata H. IFNgamma-dependent, spontaneous development of colorectal carcinomas in SOCS1-deficient mice. J Exp Med. 2006;203:1391-1397. [PMID: 16717119 DOI: 10.1084/jem.20060436] [Cited by in Crossref: 140] [Cited by in F6Publishing: 150] [Article Influence: 8.2] [Reference Citation Analysis]
635 Hodin RA, Matthews JB. Small Intestine. Essential Practice of Surgery. [DOI: 10.1007/0-387-22744-x_21] [Reference Citation Analysis]
636 Li C, Dandridge KS, Di A, Marrs KL, Harris EL, Roy K, Jackson JS, Makarova NV, Fujiwara Y, Farrar PL. Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactions. J Exp Med. 2005;202:975-986. [PMID: 16203867 DOI: 10.1084/jem.20050421] [Cited by in Crossref: 121] [Cited by in F6Publishing: 127] [Article Influence: 7.1] [Reference Citation Analysis]
637 García de Tena J, Manzano L, Leal JC, San Antonio E, Sualdea V, Alvarez-Mon M. Distinctive pattern of cytokine production and adhesion molecule expression in peripheral blood memory CD4+ T cells from patients with active Crohn's disease. J Clin Immunol 2006;26:233-42. [PMID: 16783463 DOI: 10.1007/s10875-006-9016-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
638 Seril DN, Liao J, West AB, Yang GY. High-iron diet: foe or feat in ulcerative colitis and ulcerative colitis-associated carcinogenesis. J Clin Gastroenterol 2006;40:391-7. [PMID: 16721219 DOI: 10.1097/00004836-200605000-00006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
639 Nishise S, Takeda Y, Takeda H, Ishihama K, Fukui T, Kawata S. Complement activation is involved in biological responses to leukocyte adsorptive apheresis. Dig Dis Sci 2006;51:934-41. [PMID: 16642423 DOI: 10.1007/s10620-005-9050-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
640 Zhang Z, Zheng M, Bindas J, Schwarzenberger P, Kolls JK. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm Bowel Dis 2006;12:382-8. [PMID: 16670527 DOI: 10.1097/01.MIB.0000218764.06959.91] [Cited by in Crossref: 354] [Cited by in F6Publishing: 341] [Article Influence: 20.8] [Reference Citation Analysis]
641 Gonzalez-Rey E, Chorny A, Delgado M. Therapeutic action of ghrelin in a mouse model of colitis. Gastroenterology 2006;130:1707-20. [PMID: 16697735 DOI: 10.1053/j.gastro.2006.01.041] [Cited by in Crossref: 186] [Cited by in F6Publishing: 202] [Article Influence: 10.9] [Reference Citation Analysis]
642 Ozaki H, Hori M, Kinoshita K, Ohama T. Intestinal dysmotility in inflammatory bowel disease: mechanisms of the reduced activity of smooth muscle contraction. Inflammopharmacology. 2005;13:103-111. [PMID: 16259732 DOI: 10.1163/156856005774423773] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
643 Mei L, Targan SR, Landers CJ, Dutridge D, Ippoliti A, Vasiliauskas EA, Papadakis KA, Fleshner PR, Rotter JI, Yang H. Familial expression of anti-Escherichia coli outer membrane porin C in relatives of patients with Crohn's disease. Gastroenterology 2006;130:1078-85. [PMID: 16618402 DOI: 10.1053/j.gastro.2006.02.013] [Cited by in Crossref: 63] [Cited by in F6Publishing: 71] [Article Influence: 3.7] [Reference Citation Analysis]
644 Kruschewski M, Anderson T, Buhr HJ, Loddenkemper C. Selective COX-2 inhibition reduces leukocyte sticking and improves the microcirculation in TNBS colitis. Dig Dis Sci 2006;51:662-70. [PMID: 16614986 DOI: 10.1007/s10620-006-3189-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
645 Takahashi M, Nakamura K, Honda K, Kitamura Y, Mizutani T, Araki Y, Kabemura T, Chijiiwa Y, Harada N, Nawata H. An inverse correlation of human peripheral blood regulatory T cell frequency with the disease activity of ulcerative colitis. Dig Dis Sci 2006;51:677-86. [PMID: 16614988 DOI: 10.1007/s10620-006-3191-2] [Cited by in Crossref: 69] [Cited by in F6Publishing: 75] [Article Influence: 4.1] [Reference Citation Analysis]
646 Rivera-Nieves J, Burcin TL, Olson TS, Morris MA, McDuffie M, Cominelli F, Ley K. Critical role of endothelial P-selectin glycoprotein ligand 1 in chronic murine ileitis. J Exp Med. 2006;203:907-917. [PMID: 16567389 DOI: 10.1084/jem.20052530] [Cited by in Crossref: 71] [Cited by in F6Publishing: 73] [Article Influence: 4.2] [Reference Citation Analysis]
647 Li YZ, Sun KX, Zhao C. Expression of Foxp3 mRNA in peripheral blood monocytes of patients with ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2006; 14(8): 810-813 [DOI: 10.11569/wcjd.v14.i8.810] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
648 Gonzalez-Rey E, Varela N, Sheibanie AF, Chorny A, Ganea D, Delgado M. Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease. Proc Natl Acad Sci U S A 2006;103:4228-33. [PMID: 16537513 DOI: 10.1073/pnas.0508997103] [Cited by in Crossref: 82] [Cited by in F6Publishing: 88] [Article Influence: 4.8] [Reference Citation Analysis]
649 Lundberg S, Lindholm J, Lindbom L, Hellström PM, Werr J. Integrin alpha2beta1 regulates neutrophil recruitment and inflammatory activity in experimental colitis in mice. Inflamm Bowel Dis 2006;12:172-7. [PMID: 16534417 DOI: 10.1097/01.MIB.0000217765.96604.83] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
650 Biancone L, Cretella M, Tosti C, Palmieri G, Petruzziello C, Geremia A, Calabrese E, Pallone F. Local injection of infliximab in the postoperative recurrence of Crohn's disease. Gastrointest Endosc 2006;63:486-92. [PMID: 16500402 DOI: 10.1016/j.gie.2005.08.047] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
651 Yoshihara K, Yajima T, Kubo C, Yoshikai Y. Role of interleukin 15 in colitis induced by dextran sulphate sodium in mice. Gut 2006;55:334-41. [PMID: 16162679 DOI: 10.1136/gut.2005.076000] [Cited by in Crossref: 76] [Cited by in F6Publishing: 74] [Article Influence: 4.5] [Reference Citation Analysis]
652 Otani T, Yamaguchi K, Scherl E, Du B, Tai HH, Greifer M, Petrovic L, Daikoku T, Dey SK, Subbaramaiah K, Dannenberg AJ. Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha. Am J Physiol Gastrointest Liver Physiol 2006;290:G361-8. [PMID: 16195422 DOI: 10.1152/ajpgi.00348.2005] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 3.2] [Reference Citation Analysis]
653 Biancone L, Orlando A, Kohn A, Colombo E, Sostegni R, Angelucci E, Rizzello F, Castiglione F, Benazzato L, Papi C, Meucci G, Riegler G, Petruzziello C, Mocciaro F, Geremia A, Calabrese E, Cottone M, Pallone F. Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study. Gut 2006;55:228-33. [PMID: 16120759 DOI: 10.1136/gut.2005.075937] [Cited by in Crossref: 98] [Cited by in F6Publishing: 62] [Article Influence: 5.8] [Reference Citation Analysis]
654 Monteleone I, Monteleone G, Fina D, Caruso R, Petruzziello C, Calabrese E, Biancone L, Pallone F. A functional role of flip in conferring resistance of Crohn's disease lamina propria lymphocytes to FAS-mediated apoptosis. Gastroenterology 2006;130:389-97. [PMID: 16472594 DOI: 10.1053/j.gastro.2005.10.021] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
655 Berkhout M, Friederich P, van Krieken JH, Peters WH, Nagengast FM. Low detoxification capacity in the ileal pouch mucosa of patients with ulcerative colitis. Inflamm Bowel Dis 2006;12:112-6. [PMID: 16432375 DOI: 10.1097/01.MIB.0000199222.50465.4f] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
656 Lankarani KB, Karbasi A, Kalantari T, Yarmohammadi H, Saberi-Firoozi M, Alizadeh-Naeeni M, Taghavi AR, Fattahi MR, Ghaderi A. Analysis of cytotoxic T lymphocyte associated antigen 4 gene polymorphisms in patients with ulcerative colitis. J Gastroenterol Hepatol 2006;21:449-53. [PMID: 16509873 DOI: 10.1111/j.1440-1746.2005.03956.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
657 Mendoza JL, Urcelay E, Lana R, Martinez A, Taxonera C, Concha EGL, Díaz-Rubio M. Polymorphisms in interleukin-10 gene according to mutations of NOD2/CARD15 gene and relation to phenotype in Spanish patients with Crohn’s disease. World J Gastroenterol 2006; 12(3): 443-448 [PMID: 16489646 DOI: 10.3748/wjg.v12.i3.443] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
658 Wittig BM, Zeitz M. Critical comment: analyzing the effect of novel therapies on cytokine expression in inflammatory bowel disease: do cytokine levels reflect clinical response? Int J Colorectal Dis. 2006;21:505-507. [PMID: 16416269 DOI: 10.1007/s00384-005-0082-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
659 Pineda AA. Developments in the apheresis procedure for the treatment of inflammatory bowel disease. Inflamm Bowel Dis 2006;12 Suppl 1:S10-4. [PMID: 16378005 DOI: 10.1097/01.mib.0000195386.19268.b3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
660 Bischoff SC, Gebhardt T. Role of Mast Cells and Eosinophils in Neuroimmune Interactions Regulating Mucosal Inflammation in Inflammatory Bowel Disease. Immune Mechanisms in Inflammatory Bowel Disease 2006. [DOI: 10.1007/0-387-33778-4_12] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
661 Thia KT, Luman W, Jin OC. Crohn's disease runs a more aggressive course in young Asian patients. Inflamm Bowel Dis 2006;12:57-61. [PMID: 16374260 DOI: 10.1097/01.mib.0000195390.11645.7d] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
662 Atreya R, Neurath MF. Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer. Clin Rev Allergy Immunol. 2005;28:187-196. [PMID: 16129903 DOI: 10.1385/criai: 28: 3: 187] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
663 Atreya R, Neurath MF. Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer. Clin Rev Allergy Immunol. 2005;28:187-196. [PMID: 16129903 DOI: 10.1385/criai:28:3:187] [Cited by in Crossref: 201] [Cited by in F6Publishing: 215] [Article Influence: 11.2] [Reference Citation Analysis]
664 Hultkrantz S, Ostman S, Telemo E. Induction of antigen-specific regulatory T cells in the liver-draining celiac lymph node following oral antigen administration. Immunology. 2005;116:362-372. [PMID: 16236126 DOI: 10.1111/j.1365-2567.2005.02236.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 1.9] [Reference Citation Analysis]
665 Caprilli R, Angelucci E, Cocco A. Early or late guided missile in the treatment of Crohn's disease? Dig Liver Dis 2005;37:973-9. [PMID: 16169305 DOI: 10.1016/j.dld.2005.07.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
666 Takagawa T, Tamura K, Takeda N, Tomita T, Ohda Y, Fukunaga K, Hida N, Ohnishi K, Hori K, Kosaka T, Fukuda Y, Ikeuchi H, Yamamura T, Miwa H, Matsumoto T. Association between IL-18 gene promoter polymorphisms and inflammatory bowel disease in a Japanese population. Inflamm Bowel Dis 2005;11:1038-43. [PMID: 16306765 DOI: 10.1097/01.mib.0000182868.67025.b9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 1.9] [Reference Citation Analysis]
667 Castaneda FE, Walia B, Vijay-Kumar M, Patel NR, Roser S, Kolachala VL, Rojas M, Wang L, Oprea G, Garg P, Gewirtz AT, Roman J, Merlin D, Sitaraman SV. Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP. Gastroenterology 2005;129:1991-2008. [PMID: 16344067 DOI: 10.1053/j.gastro.2005.09.017] [Cited by in Crossref: 194] [Cited by in F6Publishing: 204] [Article Influence: 10.8] [Reference Citation Analysis]
668 Kountouras J, Zavos C, Chatzopoulos D. Immunomodulatory benefits of cyclosporine A in inflammatory bowel disease. J Cell Mol Med 2004;8:317-28. [PMID: 15491507 DOI: 10.1111/j.1582-4934.2004.tb00321.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
669 Kawashima D, Oshitani N, Jinno Y, Watanabe K, Nakamura S, Higuchi K, Arakawa T. Augmented expression of secondary lymphoid tissue chemokine and EBI1 ligand chemokine in Crohn's disease. J Clin Pathol. 2005;58:1057-1063. [PMID: 16189151 DOI: 10.1136/jcp.2004.024828] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 1.3] [Reference Citation Analysis]
670 Danese S, Gasbarrini A. Chemokines in inflammatory bowel disease. J Clin Pathol 2005;58:1025-7. [PMID: 16189145 DOI: 10.1136/jcp.2005.030916] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 2.1] [Reference Citation Analysis]
671 Mielants H, De Keyser F, Baeten D, Van den Bosch F. Gut inflammation in the spondyloarthropathies. Curr Rheumatol Rep 2005;7:188-94. [PMID: 15918994 DOI: 10.1007/s11926-996-0038-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
672 Aceituno M, Panés J. Patogenia e inmunoterapia de la enfermedad inflamatoria intestinal: lecciones de los modelos animales. Gastroenterología y Hepatología 2005;28:576-90. [DOI: 10.1157/13080611] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
673 Villa F, Rumi MG, Signorelli C, Saibeni S, Del Ninno E, Ferrero Bogetto S, de Franchis R, Vecchi M. Onset of inflammatory bowel diseases during combined alpha-interferon and ribavirin therapy for chronic hepatitis C: report of two cases. Eur J Gastroenterol Hepatol 2005;17:1243-5. [PMID: 16215439 DOI: 10.1097/00042737-200511000-00015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
674 Ko JKS, Lam FYL, Cheung APL. Amelioration of experimental colitis by Astragalus membranaceus through anti-oxidation and inhibition of adhesion molecule synthesis. World J Gastroenterol 2005; 11(37): 5787-5794 [PMID: 16270386 DOI: 10.3748/wjg.v11.i37.5787] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 57] [Article Influence: 3.0] [Reference Citation Analysis]
675 Freeman HJ. Age-dependent phenotypic clinical expression of Crohn's disease. J Clin Gastroenterol 2005;39:774-7. [PMID: 16145338 DOI: 10.1097/01.mcg.0000177243.51967.ca] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
676 Matsumoto Y, Blanchard TG, Drakes ML, Basu M, Redline RW, Levine AD, Czinn SJ. Eradication of Helicobacter pylori and resolution of gastritis in the gastric mucosa of IL-10-deficient mice. Helicobacter 2005;10:407-15. [PMID: 16181351 DOI: 10.1111/j.1523-5378.2005.00349.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 1.9] [Reference Citation Analysis]
677 Polese L, Angriman I, Franchis GD, Cecchetto A, Sturniolo GC, D’Incà R, Scarpa M, Ruffolo C, Norberto L, Frego M, D’Amico DF. Persistence of high CD40 and CD40L expression after restorative proctocolectomy for ulcerative colitis. World J Gastroenterol 2005; 11(34): 5303-5308 [PMID: 16149136 DOI: 10.3748/wjg.v11.i34.5303] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
678 Peran L, Camuesco D, Comalada M, Nieto A, Concha A, Diaz-Ropero MP, Olivares M, Xaus J, Zarzuelo A, Galvez J. Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis. World J Gastroenterol 2005; 11(33): 5185-5192 [PMID: 16127750 DOI: 10.3748/wjg.v11.i33.5185] [Cited by in F6Publishing: 50] [Reference Citation Analysis]
679 Toiyama Y, Mizoguchi A, Kimura K, Araki T, Yoshiyama S, Sakaguchi K, Miki C, Kusunoki M. Persistence of gene expression changes in noninflamed and inflamed colonic mucosa in ulcerative colitis and their presence in colonic carcinoma. World J Gastroenterol 2005; 11(33): 5151-5155 [PMID: 16127744 DOI: 10.3748/wjg.v11.i33.5151] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
680 Gironella M, Iovanna JL, Sans M, Gil F, Peñalva M, Closa D, Miquel R, Piqué JM, Panés J. Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease. Gut 2005;54:1244-53. [PMID: 15870231 DOI: 10.1136/gut.2004.056309] [Cited by in Crossref: 80] [Cited by in F6Publishing: 73] [Article Influence: 4.4] [Reference Citation Analysis]
681 Swidsinski A, Weber J, Loening-Baucke V, Hale LP, Lochs H. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol. 2005;43:3380-3389. [PMID: 16000463 DOI: 10.1128/jcm.43.7.3380-3389.2005] [Cited by in Crossref: 595] [Cited by in F6Publishing: 633] [Article Influence: 33.1] [Reference Citation Analysis]
682 Schmidt C, Giese T, Ludwig B, Menges M, Schilling M, Meuer SC, Zeuzem S, Stallmach A. Increased cytokine transcripts in pouchitis reflect the degree of inflammation but not the underlying entity. Int J Colorectal Dis 2006;21:419-26. [PMID: 16133004 DOI: 10.1007/s00384-005-0024-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
683 Matsushita M, Takakuwa H, Matsubayashi Y, Nishio A, Ikehara S, Okazaki K. Appendix is a priming site in the development of ulcerative colitis. World J Gastroenterol 2005; 11(31): 4869-4874 [PMID: 16097061 DOI: 10.3748/wjg.v11.i31.4869] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 38] [Article Influence: 2.1] [Reference Citation Analysis]
684 Machida H, Tsukamoto K, Wen CY, Shikuwa S, Isomoto H, Mizuta Y, Takeshima F, Murase K, Matsumoto N, Murata I, Kohno S, Wen CY. Crohn’s disease in Japanese is associated with a SNP-haplotype of N-acetyltransferase 2 gene. World J Gastroenterol 2005; 11(31): 4833-4837 [PMID: 16097053 DOI: 10.3748/wjg.v11.i31.4833] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
685 Fernandez L, Martinez A, Mendoza JL, Urcelay E, Fernandez-Arquero M, Garcia-Paredes J, Diaz-Rubio M, de la Concha EG. Interleukin-10 polymorphisms in Spanish patients with IBD. Inflamm Bowel Dis 2005;11:739-43. [PMID: 16043989 DOI: 10.1097/01.mib.0000173457.64868.20] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 1.7] [Reference Citation Analysis]
686 Peran L, Camuesco D, Comalada M, Nieto A, Concha A, Adrio JL, Olivares M, Xaus J, Zarzuelo A, Galvez J. Lactobacillus fermentum, a probiotic capable to release glutathione, prevents colonic inflammation in the TNBS model of rat colitis. Int J Colorectal Dis. 2006;21:737-746. [PMID: 16052308 DOI: 10.1007/s00384-005-0773-y] [Cited by in Crossref: 94] [Cited by in F6Publishing: 90] [Article Influence: 5.2] [Reference Citation Analysis]
687 Paul G, Bataille F, Obermeier F, Bock J, Klebl F, Strauch U, Lochbaum D, Rümmele P, Farkas S, Schölmerich J. Analysis of intestinal haem-oxygenase-1 (HO-1) in clinical and experimental colitis. Clin Exp Immunol. 2005;140:547-555. [PMID: 15932518 DOI: 10.1111/j.1365-2249.2005.02775.x] [Cited by in Crossref: 95] [Cited by in F6Publishing: 102] [Article Influence: 5.3] [Reference Citation Analysis]
688 Machida H, Tsukamoto K, Wen CY, Narumi Y, Shikuwa S, Isomoto H, Takeshima F, Mizuta Y, Niikawa N, Murata I, Kohno S. Association of polymorphic alleles of CTLA4 with inflammatory bowel disease in the Japanese. World J Gastroenterol 2005; 11(27): 4188-4193 [PMID: 16015687 DOI: 10.3748/wjg.v11.i27.4188] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 30] [Article Influence: 1.4] [Reference Citation Analysis]
689 Kasran A, Boon L, Wortel CH, Hogezand RA, Schreiber S, Goldin E, Boer M, Geboes K, Rutgeerts P, Ceuppens JL. Safety and tolerability of antagonist anti-human CD40 Mab ch5D12 in patients with moderate to severe Crohn's disease. Aliment Pharmacol Ther 2005;22:111-22. [PMID: 16011669 DOI: 10.1111/j.1365-2036.2005.02526.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 3.3] [Reference Citation Analysis]
690 Stremmel W, Merle U, Zahn A, Autschbach F, Hinz U, Ehehalt R. Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis. Gut 2005;54:966-71. [PMID: 15951544 DOI: 10.1136/gut.2004.052316] [Cited by in Crossref: 114] [Cited by in F6Publishing: 107] [Article Influence: 6.3] [Reference Citation Analysis]
691 Kugathasan S, Loizides A, Babusukumar U, McGuire E, Wang T, Hooper P, Nebel J, Kofman G, Noel R, Broeckel U, Tolia V. Comparative phenotypic and CARD15 mutational analysis among African American, Hispanic, and White children with Crohn's disease. Inflamm Bowel Dis 2005;11:631-8. [PMID: 15973116 DOI: 10.1097/01.mib.0000171279.05471.21] [Cited by in Crossref: 61] [Cited by in F6Publishing: 43] [Article Influence: 3.4] [Reference Citation Analysis]
692 Vallance BA, Gunawan MI, Hewlett B, Bercik P, Van Kampen C, Galeazzi F, Sime PJ, Gauldie J, Collins SM. TGF-beta1 gene transfer to the mouse colon leads to intestinal fibrosis. Am J Physiol Gastrointest Liver Physiol 2005;289:G116-28. [PMID: 15778431 DOI: 10.1152/ajpgi.00051.2005] [Cited by in Crossref: 100] [Cited by in F6Publishing: 102] [Article Influence: 5.6] [Reference Citation Analysis]
693 Odashima M, Bamias G, Rivera-Nieves J, Linden J, Nast CC, Moskaluk CA, Marini M, Sugawara K, Kozaiwa K, Otaka M, Watanabe S, Cominelli F. Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease. Gastroenterology 2005;129:26-33. [PMID: 16012931 DOI: 10.1053/j.gastro.2005.05.032] [Cited by in Crossref: 168] [Cited by in F6Publishing: 176] [Article Influence: 9.3] [Reference Citation Analysis]
694 Schulmann K, Mori Y, Croog V, Yin J, Olaru A, Sterian A, Sato F, Wang S, Xu Y, Deacu E, Berki AT, Hamilton JP, Kan T, Abraham JM, Schmiegel W, Harpaz N, Meltzer SJ. Molecular phenotype of inflammatory bowel disease-associated neoplasms with microsatellite instability. Gastroenterology 2005;129:74-85. [PMID: 16012936 DOI: 10.1053/j.gastro.2005.04.011] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 2.9] [Reference Citation Analysis]
695 Moriyama T, Matsumoto T, Jo Y, Yada S, Hirahashi M, Yao T, Iida M. Mucosal proinflammatory cytokine and chemokine expression of gastroduodenal lesions in Crohn's disease. Aliment Pharmacol Ther 2005;21 Suppl 2:85-91. [PMID: 15943853 DOI: 10.1111/j.1365-2036.2005.02480.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
696 Yamamoto T, Umegae S, Kitagawa T, Matsumoto K. Systemic and local cytokine production in quiescent ulcerative colitis and its relationship to future relapse: a prospective pilot study. Inflamm Bowel Dis 2005;11:589-96. [PMID: 15905707 DOI: 10.1097/01.mib.0000161917.97136.e2] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 2.2] [Reference Citation Analysis]
697 Sawada K, Kusugami K, Suzuki Y, Bamba T, Munakata A, Hibi T, Shimoyama T. Leukocytapheresis in ulcerative colitis: results of a multicenter double-blind prospective case-control study with sham apheresis as placebo treatment. Am J Gastroenterol 2005;100:1362-9. [PMID: 15929771 DOI: 10.1111/j.1572-0241.2005.41089.x] [Cited by in Crossref: 103] [Cited by in F6Publishing: 101] [Article Influence: 5.7] [Reference Citation Analysis]
698 Oostenbrug LE, Drenth JP, de Jong DJ, Nolte IM, Oosterom E, van Dullemen HM, van der Linde K, te Meerman GJ, van der Steege G, Kleibeuker JH, Jansen PL. Association between Toll-like receptor 4 and inflammatory bowel disease. Inflamm Bowel Dis 2005;11:567-75. [PMID: 15905704 DOI: 10.1097/01.mib.0000161305.81198.0f] [Cited by in Crossref: 89] [Cited by in F6Publishing: 79] [Article Influence: 4.9] [Reference Citation Analysis]
699 Hanai H, Iida T, Takeuchi K, Watanabe F, Maruyama Y, Kikuyama M, Tanaka T, Kondo K, Tanaka K, Takai K. Decrease of reactive-oxygen-producing granulocytes and release of IL-10 into the peripheral blood following leukocytapheresis in patients with active ulcerative colitis. World J Gastroenterol 2005; 11(20): 3085-3090 [PMID: 15918195 DOI: 10.3748/wjg.v11.i20.3085] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
700 Matsuzaki K, Tsuzuki Y, Matsunaga H, Inoue T, Miyazaki J, Hokari R, Okada Y, Kawaguchi A, Nagao S, Itoh K. In vivo demonstration of T lymphocyte migration and amelioration of ileitis in intestinal mucosa of SAMP1/Yit mice by the inhibition of MAdCAM-1. Clin Exp Immunol. 2005;140:22-31. [PMID: 15762871 DOI: 10.1111/j.1365-2249.2005.02742.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 50] [Article Influence: 2.4] [Reference Citation Analysis]
701 Vespasiani Gentilucci U, Caviglia R, Picardi A, Carotti S, Ribolsi M, Galati G, Petitti T, Afeltra A, Cicala M. Infliximab reverses growth hormone resistance associated with inflammatory bowel disease. Aliment Pharmacol Ther 2005;21:1063-71. [PMID: 15854167 DOI: 10.1111/j.1365-2036.2005.02449.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
702 Santucci L, Wallace J, Mencarelli A, Farneti S, Morelli A, Fiorucci S. Different sensitivity of lamina propria T-cell subsets to nitric oxide-induced apoptosis explains immunomodulatory activity of a nitric oxide-releasing derivative of mesalamine in rodent colitis. Gastroenterology 2005;128:1243-57. [PMID: 15887108 DOI: 10.1053/j.gastro.2005.01.051] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
703 Cantor MJ, Nickerson P, Bernstein CN. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease. Am J Gastroenterol 2005;100:1134-42. [PMID: 15842590 DOI: 10.1111/j.1572-0241.2005.40979.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 73] [Article Influence: 3.6] [Reference Citation Analysis]
704 Seidner DL, Lashner BA, Brzezinski A, Banks PL, Goldblum J, Fiocchi C, Katz J, Lichtenstein GR, Anton PA, Kam LY, Garleb KA, Demichele SJ. An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: a randomized, controlled trial. Clin Gastroenterol Hepatol 2005;3:358-69. [PMID: 15822041 DOI: 10.1016/s1542-3565(04)00672-x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 89] [Article Influence: 4.8] [Reference Citation Analysis]
705 Seril DN, Liao J, Yang CS, Yang GY. Systemic iron supplementation replenishes iron stores without enhancing colon carcinogenesis in murine models of ulcerative colitis: comparison with iron-enriched diet. Dig Dis Sci 2005;50:696-707. [PMID: 15844705 DOI: 10.1007/s10620-005-2560-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
706 Danese S, Sgambato A, Papa A, Scaldaferri F, Pola R, Sans M, Lovecchio M, Gasbarrini G, Cittadini A, Gasbarrini A. Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease. Am J Gastroenterol 2005;100:886-95. [PMID: 15784037 DOI: 10.1111/j.1572-0241.2005.41469.x] [Cited by in Crossref: 83] [Cited by in F6Publishing: 88] [Article Influence: 4.6] [Reference Citation Analysis]
707 Sturm A, Rilling K, Baumgart DC, Gargas K, Abou-Ghazalé T, Raupach B, Eckert J, Schumann RR, Enders C, Sonnenborn U. Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling. Infect Immun. 2005;73:1452-1465. [PMID: 15731043 DOI: 10.1128/IAI.73.3.1452-1465] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
708 Moschen AR, Kaser A, Enrich B, Ludwiczek O, Gabriel M, Obrist P, Wolf AM, Tilg H. The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss. Gut 2005;54:479-87. [PMID: 15753532 DOI: 10.1136/gut.2004.044370] [Cited by in Crossref: 167] [Cited by in F6Publishing: 147] [Article Influence: 9.3] [Reference Citation Analysis]
709 Brun P, Mastrotto C, Beggiao E, Stefani A, Barzon L, Sturniolo GC, Palù G, Castagliuolo I. Neuropeptide neurotensin stimulates intestinal wound healing following chronic intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 2005;288:G621-9. [PMID: 15764810 DOI: 10.1152/ajpgi.00140.2004] [Cited by in Crossref: 69] [Cited by in F6Publishing: 69] [Article Influence: 3.8] [Reference Citation Analysis]
710 Ligumsky M, Badaan S, Lewis H, Meirow D. Effects of 6-mercaptopurine treatment on sperm production and reproductive performance: a study in male mice. Scand J Gastroenterol 2005;40:444-9. [PMID: 16028439 DOI: 10.1080/00365520510011597] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
711 Sipos F, Molnár B, Zágoni T, Berczi L, Tulassay Z. Growth in epithelial cell proliferation and apoptosis correlates specifically to the inflammation activity of inflammatory bowel diseases: ulcerative colitis shows specific p53- and EGFR expression alterations. Dis Colon Rectum 2005;48:775-86. [PMID: 15747078 DOI: 10.1007/s10350-004-0831-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 2.1] [Reference Citation Analysis]
712 Sturm A, Rilling K, Baumgart DC, Gargas K, Abou-Ghazalé T, Raupach B, Eckert J, Schumann RR, Enders C, Sonnenborn U. Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling. Infect Immun. 2005;73:1452-1465. [PMID: 15731043 DOI: 10.1128/iai.73.3.1452-1465.2005] [Cited by in Crossref: 90] [Cited by in F6Publishing: 101] [Article Influence: 5.0] [Reference Citation Analysis]
713 Zhang Z, Andoh A, Inatomi O, Bamba S, Takayanagi A, Shimizu N, Fujiyama Y. Interleukin-17 and lipopolysaccharides synergistically induce cyclooxygenase-2 expression in human intestinal myofibroblasts. J Gastroenterol Hepatol 2005;20:619-27. [PMID: 15836713 DOI: 10.1111/j.1440-1746.2004.03748.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
714 Kim SC, Tonkonogy SL, Albright CA, Tsang J, Balish EJ, Braun J, Huycke MM, Sartor RB. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 2005;128:891-906. [PMID: 15825073 DOI: 10.1053/j.gastro.2005.02.009] [Cited by in Crossref: 329] [Cited by in F6Publishing: 341] [Article Influence: 18.3] [Reference Citation Analysis]
715 Matsuura M, Okazaki K, Nishio A, Nakase H, Tamaki H, Uchida K, Nishi T, Asada M, Kawasaki K, Fukui T, Yoshizawa H, Ohashi S, Inoue S, Kawanami C, Hiai H, Tabata Y, Chiba T. Therapeutic effects of rectal administration of basic fibroblast growth factor on experimental murine colitis. Gastroenterology 2005;128:975-86. [PMID: 15825079 DOI: 10.1053/j.gastro.2005.01.006] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 2.8] [Reference Citation Analysis]
716 Zhang H, Ouyang Q, Wen ZH, Fiocchi C, Liu WP, Chen DY, Li FY. Significance of glucocorticoid receptor expression in colonic mucosal cells of patients with ulcerative colitis. World J Gastroenterol 2005; 11(12): 1775-1778 [PMID: 15793862 DOI: 10.3748/wjg.v11.i12.1775] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
717 Jian YT, Mai GF, Wang JD, Zhang YL, Luo RC, Fang YX. Preventive and therapeutic effects of NF-kappaB inhibitor curcumin in rats colitis induced by trinitrobenzene sulfonic acid. World J Gastroenterol 2005; 11(12): 1747-1752 [PMID: 15793857 DOI: 10.3748/wjg.v11.i12.1747] [Cited by in CrossRef: 90] [Cited by in F6Publishing: 96] [Article Influence: 5.0] [Reference Citation Analysis]
718 Franchimont N, Reenaers C, Lambert C, Belaiche J, Bours V, Malaise M, Delvenne P, Louis E. Increased expression of receptor activator of NF-kappaB ligand (RANKL), its receptor RANK and its decoy receptor osteoprotegerin in the colon of Crohn's disease patients. Clin Exp Immunol 2004;138:491-8. [PMID: 15544627 DOI: 10.1111/j.1365-2249.2004.02643.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 3.3] [Reference Citation Analysis]
719 Lomax AE, Mawe GM, Sharkey KA. Synaptic facilitation and enhanced neuronal excitability in the submucosal plexus during experimental colitis in guinea-pig. J Physiol. 2005;564:863-875. [PMID: 15774518 DOI: 10.1113/jphysiol.2005.084285] [Cited by in Crossref: 73] [Cited by in F6Publishing: 76] [Article Influence: 4.1] [Reference Citation Analysis]
720 Rigby RJ, Knight SC, Kamm MA, Stagg AJ. Production of interleukin (IL)-10 and IL-12 by murine colonic dendritic cells in response to microbial stimuli. Clin Exp Immunol. 2005;139:245-256. [PMID: 15654823 DOI: 10.1111/j.1365-2249.2004.02674.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [